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CHAPTER I 
 
INTRODUCTION TO INTESTINAL HOMEOSTASIS 
 
The Intestinal Epithelium: The Luminal Interface of the Gastrointestinal Tract 
The gastrointestinal (GI) tract is one of the most rapidly proliferating and 
constantly renewing tissues in the body (Barker 2014; Clevers 2013). The GI tract 
encompasses all anatomical structures from the mouth to the anus and is generally 
divided into upper and lower segments (Moore, Dalley, and Agur 2009). The upper GI 
tract includes the mouth, esophagus, and stomach, while the lower GI tract comprises the 
small and large intestines (Moore, Dalley, and Agur 2009). The liver, biliary tract, and 
pancreas are critical components of the digestive system in humans and play a supportive 
role to the GI tract in carrying out its physiological functions (Moore, Dalley, and Agur 
2009). 
The lower GI tract can be further subdivided into smaller functional segments. 
The small intestine consists of the duodenum, jejunum, and ileum, while the large 
intestine is divided into the cecum, colon, rectum, and anus (Moore, Dalley, and Agur 
2009). Although regional differences exist throughout the lower GI tract, histological 
characterization reveals tissue organization that can be divided into 4 concentric layers: 
(1) mucosa, (2) submucosa, (3) muscularis externa, and (4) adventitia or serosa (Mills 
2012; Young, O’Dowd, and Woodford 2013). The mucosa, or innermost layer, is in 
direct contact with the lumen and is comprised of an epithelium, a lamina propria, and a 
thin smooth muscle layer known as the muscularis mucosa, which facilitates peristalsis. 
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Beneath the mucosa lies the submucosa, a loose, paucicellular layer of connective tissue 
that houses blood vessels, lymphatics, and nerves that branch into the mucosa and the 
muscularis externae (Mills 2012; Moore, Dalley, and Agur 2009). The muscularis externa 
is a thick outer smooth muscle later comprised of an inner circular and outer 
longitudinally running layer of muscle that supports peristalsis and coordinates the 
movement of contents through the GI tract (Mills 2012; Moore, Dalley, and Agur 2009). 
Finally, the adventitia or serosa makes up the outermost layer of the GI tract and is 
comprised of multiple layers of connective tissue (Mills 2012; Moore, Dalley, and Agur 
2009). 
 
 
Figure 1. Components of the gastrointestinal tract. The lower GI tract comprises the 
small and large intestine. Figure from Young, O’Dowd, and Woodford 2013. 
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Figure 2. Concentric layers of the lower gastrointestinal tract. Histological 
characterization of the lower gastrointestinal tract reveals four concentric layers: a (1) 
mucosa, (2) submucosa, (3) muscularis externa, and (4) adventitia or serosa. Figure from 
Young, O’Dowd, and Woodford 2013. 
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The intestinal epithelium is the innermost component of the mucosa and the 
luminal interface of the GI tract which is responsible for carrying out many of its 
functions (Mills 2012). Intestinal homeostasis is maintained through constant 
proliferation, differentiation, and repair of this continuously renewing epithelium (Barker 
2014; Maloy and Powrie 2011). The epithelium of the small intestine contains finger-like 
projections known as villi that maximize the absorptive surface area of the small intestine 
and are critical to carrying out its primary function of absorbing ingested nutrients 
(Barker 2014; Clevers 2013; Mills 2012). Adjacent to the villi are invaginations of the 
intestinal epithelium known as intestinal crypts which are responsible for epithelial cell 
renewal (Barker 2014; Clevers 2013; Mills 2012).  
 
Figure 3. Small intestine structural organization. Scanning electron micrograph (left) 
and illustration (right). The epithelium of the small intestine contains finger-like 
projections known as villi, which project into the lumen. Adjacent to the villi are the 
intestinal crypts, which drive epithelial renewal. Figure from Barker 2014. 
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While the colon also houses these invaginations or crypts, it does not contain villi (Barker 
2014; Clevers 2013).  
 
Figure 4. Colon structural organization. Scanning electron micrograph (left) and 
illustration (right). The colonic epithelium contains crypts but no villi. Figure from 
Barker 2014.  
 
A number of differentiated cell types comprise the intestinal epithelium with 
several distinct functions (Clevers 2013; Mills 2012). The most abundant cell type is the 
absorptive enterocyte, which is a polarized columnar cell with an elaborate brush border 
(Clevers 2013; Mills 2012). Also present are goblet cells which secret mucus, a critical 
component in the regulation of epithelial barrier integrity, and enteroendocrine cells, 
which secrete a number of hormones involved in digestive processes (Clevers 2013; Mills 
2012). Tuft cells are present throughout the crypt-villus axis and are thought to serve as 
sensors of luminal contents (Clevers 2013; Mills 2012). Paneth cells, which are exclusive 
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to the small intestine, are present towards the bases of the intestinal crypts, and are 
known to secrete bactericidal products and serve as sources of ligands critical to 
maintaining the intestinal stem cell niche (Clevers 2013; Mills 2012; Sato et al. 2009; 
Sato, van Es, et al. 2011). Finally, microfold (M) cells are present in specific areas of the 
epithelium that overlie lymphoid accumulations in the GI tract, such as Peyer’s patches, 
and play a critical role in mediating mucosal immunity (Clevers 2013; Mills 2012). 
 
Figure 5. Small intestine epithelial cell types. (A) Hematoxylin and eosin staining of 
the small intestinal epithelium. (B) Periodic acid-Schiff staining for goblet cells. (C) 
Lysozyme staining for Paneth cells at the crypt base. (D) Chromogranin staining for 
enteroendocrine cells. (E) Alkaline phosphatase staining (blue, at luminal brush border) 
of villus enterocytes (F) DCAMKL-1 stained tuft cell (G) Spi-B expression in microfold 
(M) cells. Figure from Clevers 2013.  
 
Intestinal Stem Cells: Drivers of Intestinal Epithelial Renewal 
While differentiated epithelial cells are critical to the functioning of the intestinal 
epithelium, intestinal renewal is maintained by dynamic stem cell populations that reside 
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in the intestinal crypts (Barker, van de Wetering, and Clevers 2008; Barker 2014; Clevers 
2013). The intestinal epithelium is thought to renew itself approximately every 5 days, 
with cells progressively differentiating and moving out of the crypts in conveyor belt-like 
fashion, with the notable exception of Paneth cells, which remain adjacent to stem cell 
populations at the crypt bases (Barker 2014; Sato and Clevers 2013). Until recently, 
thorough characterization of intestinal stem cell populations has remained challenging 
due to the absence of specific markers for their identification (Barker 2014; Potten et al. 
2009). However, recently-discovered adult intestinal stem cell markers, and recently-
developed lineage tracing technologies and ex vivo tissue cultures or “organoid” systems 
have greatly facilitated their identification and characterization (Barker 2014; Barker et 
al. 2007; Sato et al. 2009; Sato, van Es, et al. 2011). 
Some of the first successful investigations of intestinal stem cell populations were 
conducted by Cheng, Leblond, and colleagues, who proposed the existence of 
continuously-cycling crypt base columnar (CBC) stem cells wedged between post-mitotic 
Paneth cells (Barker, van de Wetering, and Clevers 2008; Barker 2014; Cheng and 
Leblond 1974a, 1974b; Clevers 2013). Lineage tracing experiments identified that after 
3H-thymidine injection, surviving CBC cells phagocytosed dead CBC cells which 
produced radioactive, traceable “hot” phagosomes that at first appeared exclusive to the 
CBC cells but were later noted in differentiated cells (Cheng and Leblond 1974a, 1974b; 
Clevers 2013). This work was followed up by Bjerknes and Cheng who proposed a “stem 
cell zone” model in which CBC stem cells and Paneth cells, residing in the crypt base, 
occupy a niche that maintains stemness (Bjerknes and Cheng 1981a, 1981b; Clevers 
2013). Stem cell daughter cells that divide and are no longer directly adjacent to Paneth 
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cells then differentiate and migrate along the crypt axis, with the exception of Paneth cell 
progenitors, which migrate downwards (Bjerknes and Cheng 1981a, 1981b; Clevers 
2013). 
Meanwhile, Potten and colleagues reported a cell type that resided in the “+4” 
position, or directly above the Paneth cells, that was rare and DNA-label-retaining and 
thus a “label-retaining cell” or LRC (Clevers 2013; Potten, Owen, and Booth 2002; 
Potten et al. 1978). While DNA label retention is a characteristic that is associated with 
mitotic quiescence and used as a surrogate marker of stem cells, it has since been 
suggested that this retention may not be due to quiescence but instead to a process of 
asymmetric segregation of labeled and unlabeled DNA strands between these putative 
stem cells and their daughter cells, respectively (Clevers 2013; Marshman, Booth, and 
Potten 2002; Potten, Owen, and Booth 2002). 
Thus, the current model of the intestinal stem cell suggests the existence of ≥2 
intestinal stem cell (ISC) populations: (1) a rapidly-cycling, crypt-based columnar (CBC) 
stem cell population at the base of the intestinal crypts, whose markers include Lgr5, a 
transmembrane receptor for R-spondin that amplifies Wnt tone, as well as Ascl2, Olfm4, 
Msi1, Smoc2, and Sox9; and (2) a more slowly-cycling, quiescent “+4” stem cell 
population that resides primarily at the +4 position from the base of the crypt and is 
marked by Bmi1, TERT, Lrig1, and Hopx (Barker 2014; Durand et al. 2012; Van 
Landeghem et al. 2012; Li and Clevers 2010; Potten et al. 2009). The contribution of 
each of these subsets to normal intestinal epithelial renewal and repair after injury is still 
under debate, but a number of studies have identified a role for each in restoring 
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epithelial integrity after injury (Buczacki et al. 2013; Hua et al. 2012; Metcalfe et al. 
2014; Tian et al. 2011). 
 
Figure 6. Putative stem cell populations of the intestinal crypt. The current model of 
the intestinal stem cell suggests the existence of ≥2 intestinal stem cell (ISC) populations: 
(1) a rapidly-cycling, crypt-based columnar (CBC) population and (2) a more slowly-
cycling, quiescent “+4” stem cell population. Figure from Barker 2014. 
 
The development of 3D ex vivo intestinal cultures by Dr. Hans Clevers’s group in 
2009 represented a remarkable advancement in our ability to model intestinal 
architecture, and to better understand intestinal homeostasis and the stem cell niche (Sato 
and Clevers 2013; Sato et al. 2009). These Matrigel-based systems have allowed for 
culturing and serial propagation of miniguts from small intestinal tissue (“enteroids”) as 
well as colonic tissue (“colonoids”) from both mice and humans ex vivo (Li and Clevers 
2012; Sato and Clevers 2013; Sato et al. 2009; Sato, Stange, et al. 2011). Whole crypts 
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that contain CBC stem cells wedged between Paneth cells, or single Lgr5+ sorted stem 
cells are capable of generating these miniguts when supplemented with growth factors 
(Mahé et al. 2014; Sato and Clevers 2013; Sato et al. 2009).  
 
Figure 7. Minigut or “enteroid” culture systems. (A) Lgr5+ CBC cells can be sorted 
and embedded in Matrigel supplemented with growth factors to form enteroids. (B) Time 
course of growth of enteroids. Lgr5+ CBC stem cells are represented in yellow and 
Paneth cells in blue.  Figure from Sato and Clevers 2013. 
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A critical growth factor for the enteroid systems includes Rspondin, a ligand 
which binds with its receptor Lgr5 to amplify Wnt tone (Sato and Clevers 2013). Other 
growth factors include the BMP inhibitor Noggin as well as EGF (Mahé et al. 2014; Sato 
and Clevers 2013; Sato et al. 2009).  
 
Figure 8. The intestinal stem cell niche. EGF, Notch, and Wnt pathway activation is 
essential for intestinal epithelial stemness, and BMP negatively regulates stemness. For 
full activation of Wnt, Rspondin-Lgr4/5 signal is required. Figure from Sato and Clevers 
2013. 
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By many metrics, these ex vivo miniguts faithfully recapitulate characteristics of 
their in vivo counterparts (Li and Clevers 2012; Sato and Clevers 2013; Sato et al. 2009). 
They consist of a simple, polarized epithelium and develop into cysts containing a central 
lumen with multiple budding projections (Sato and Clevers 2013). The basal side of the 
miniguts is oriented towards the outside and in contact with the Matrigel, while the 
luminal sides form the central cystic structure into which cells of the miniguts are 
constantly shed (Sato and Clevers 2013). Intestinal organoids can be passaged, 
genetically manipulated, and maintained in culture for years without any apparent 
karyotypic alterations (Koo et al. 2012; Li and Clevers 2012; Sato and Clevers 2013). In 
addition to assisting with the study of intestinal crypt development, these novel modeling 
systems offer numerous therapeutic opportunities. A number of studies have shown that 
implantation of organoids in the intestines of injured mice results in successful 
engraftment as well as improvement of clinical parameters such as weight loss after 
colonic injury (Fordham et al. 2013; Li and Clevers 2012; Shaker and Rubin 2012; Yui et 
al. 2012).  
 
Figure 9. Epithelial repair with organoids. Organoids cultured in vitro can be 
successfully transplanted/engrafted into the colons of mice with superficial intestinal 
ulcerations. Figure from Shaker and Rubin 2012. 
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Moreover, development of intestinal organoid cultures for delivery of 
therapeutics, as well as high-throughput screening for drug sensitivity, remain avenues of 
great therapeutic potential (Hynds and Giangreco 2013; Sato and Clevers 2013). 
 
Figure 10. Paradigms for high-throughput screening utilizing organoids. Stem cells 
derived from patient biopsies can be cultured, expanded as organoids, and utilized for 
therapeutic screening. Organoids may predict responses to therapy given their 
resemblance to the in vivo tissues from which they are derived. Figure from Hynds and 
Giangreco 2013. 
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Of the many signaling pathways which govern intestinal homeostasis, the Wnt 
pathway, which regulates numerous biological processes ranging from development to 
malignancy, is critical to the maintenance of the intestinal stem cell niche and crypt 
proliferation (Clevers and Nusse 2012; Clevers 2013; J. H. van Es et al. 2012; Gregorieff 
and Clevers 2005; Pinto et al. 2003). Indeed, while dysregulated Wnt signaling is a 
central driver in the development of colon cancer, regulation of crypt dynamics and 
proliferation is mediated in large part by physiological Wnt signaling (Clevers and Nusse 
2012; Clevers 2013; Gregorieff and Clevers 2005; Pinto et al. 2003). As a general 
overview, Wnt stimuli support a signaling pathway which regulates free cytoplasmic 
levels of β-catenin, which is otherwise rapidly degraded by the APC destruction complex 
(Clevers and Nusse 2012; Clevers 2013; Gregorieff and Clevers 2005; Pinto et al. 2003). 
The occupancy of Frizzled-Lrp5/6 receptors by Wnt proteins results in the stabilization 
and accumulation of β-catenin, which then travels to the nucleus to couple with Tcf 
transcription factors and activate the transcription of a number of Wnt/Tcf target genes 
(Clevers and Nusse 2012; Clevers 2013; Gregorieff and Clevers 2005; Pinto et al. 2003). 
The importance of this pathway in the maintenance of intestinal crypts is underscored by 
the fact that neonatal Tcf4 knockout mice lack proliferative crypts, suggesting that Wnt 
signaling is critical to the establishment of a proliferative stem cell compartment (Clevers 
2013; Korinek et al. 1998). Moreover, multiple groups have demonstrated the persistent 
need for physiological Wnt signaling in adult intestinal crypts, through the transgenic 
expression of Wnt receptor antagonist Dkk1, as well as the conditional deletion of β-
catenin or Tcf4 (Clevers 2013; V. Es et al. 2012; Fevr et al. 2007; Pinto et al. 2003). 
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Apical Junctional Complexes: Mediators of Intestinal Epithelial Barrier Integrity  
The epithelial barrier comprises an almost 100m2 surface area which is lined by a 
simple columnar layer of intestinal epithelial cells that forms a surprisingly effective 
luminal barrier (Artis 2008; Maloy and Powrie 2011). Intestinal mucosal homeostasis 
requires competent epithelial barriers to withstand intestinal challenges, as it relies on the 
constant crosstalk between intestinal epithelial cells, immune cells, and the over 100 
trillion microbes that are thought to inhabit the intestine (Artis 2008; Baumgart and 
Carding 2007; Hooper and Macpherson 2010; Maloy and Powrie 2011). Breakdown of 
this homeostasis is thought to be a primary component in the pathogenesis of a number of 
intestinal diseases such as inflammatory bowel disease (IBD) (Baumgart and Carding 
2007; Maloy and Powrie 2011). 
Critical to the maintenance of the intestinal barrier is the sealing of the 
paracellular space between adjacent epithelial cells (Balda and Matter 1998; Balda et al. 
1992; Shen, Su, and Turner 2009; Shen 2012). This is accomplished by apical junctional 
complexes, which are primarily comprised of tight junctions, adherens junctions, and 
desmosomes (Shen, Su, and Turner 2009; Shen 2012). Most apically positioned between 
adjacent epithelial cells of the intestine are tight junctions, which form near-impermeable 
but nonetheless leaky paracellular connections that establish the division between the 
apical and basolateral plasma membrane domains (Henderson et al. 2011; Machen, Erlij, 
and Wooding 1972; Shen, Su, and Turner 2009). Below the tight junctions are adherens 
junctions, which are composed of a family of transmembrane proteins known as 
cadherins, which form strong homotypic interactions and play essential roles in the 
maintenance of cell polarity and differentiation (Henderson et al. 2011; Shen, Su, and 
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Turner 2009; Turner 2009). Below these complexes and at the basal side of the intestinal 
epithelial cells are desmosomes, which serve as anchors for keratin filaments and form 
complexes of intracellular proteins that connect the cytoskeleton to a number of adhesion 
proteins (Henderson et al. 2011; Turner 2009). 
 
Figure 11. Components of apical junctional complexes. Adjacent intestinal epithelial 
cells are connected at the (A) tight junction, (B) adherens junction, and via (C) 
desmosomes from the luminal to lamina propria side, respectively. Figure from 
Henderson 2011. 
 
Adherens junctions and desmosomes play critical supportive roles in providing 
adhesive force to maintain epithelial cell layer integrity and in regulating junctional 
signaling pathways critical to epithelial functions (Henderson et al. 2011; Hermiston and 
Gordon 1995; Shen, Su, and Turner 2009; Shen 2012). Yet, it is principally the tight 
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junctions of apical junction complexes that regulate paracellular barrier function and are 
critical to maintaining cell polarity and regulating the movement of substances such as 
water, electrolytes, lipids, and proteins across the epithelium (Henderson et al. 2011; 
Hermiston and Gordon 1995; Shen, Su, and Turner 2009; Shen 2012). Tight junctions are 
composed of complexes of transmembrane proteins, peripheral membrane or scaffolding 
proteins, and numerous regulatory proteins such as kinases (Shen, Su, and Turner 2009; 
Turner 2009). The principal transmembrane proteins of the tight junction are grouped 
intro three main families: claudins, occludin, and junctional adhesion molecules (JAMs) 
(Henderson et al. 2011; Hossain and Hirata 2008; Turner 2009). Peripheral membrane 
proteins ZO1 and ZO2 play supportive roles and are critical to tight junction assembly 
and maintenance (Turner 2009).  
There is a clear pathological relevance for defects in intercellular junctions, as 
they can lead to increased epithelial barrier permeability (Baumgart and Carding 2007; 
Henderson et al. 2011; Shen, Su, and Turner 2009; Turner 2009). The epithelial barrier is 
known to be “leaky” in patients with IBD, with a number of studies demonstrating lower 
epithelial resistance and increased permeability of both inflamed and non-inflamed 
mucosa in Crohn’s disease and ulcerative (Baumgart and Carding 2007; Pearson et al. 
1982; Söderholm, Olaison, and Peterson 2002; Ukabam, Clamp, and Cooper 1983). 
Indeed, increased intestinal permeability has been shown to predict and possibly cause 
relapse of disease (Henderson et al. 2011; Porras et al. 2006; Wyatt et al. 1993). 
Moreover, disruption of tight-junctional integrity has been proposed as a key contributing 
factor to this epithelial barrier dysfunction (Heller et al. 2005; Ma et al. 2004; Shen, Su, 
and Turner 2009; Shen 2012; Söderholm, Olaison, and Peterson 2002; Turner 2009). 
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Studies have implicated altered expression of occludin, ZO1, and JAMs, and 
dysregulation of claudin as contributing factors to compromised barrier integrity present 
in IBD (Groschwitz and Hogan 2009; Henderson et al. 2011; Kucharzik et al. 2001; Ye, 
Ma, and Ma 2006; Zeissig et al. 2007; Zolotarevsky et al. 2002). Better understanding of 
tight junctional regulation, and its contribution to the maintenance of the intestinal 
epithelial barrier thus holds therapeutic potential for inflammatory bowel disease.  
 
Modeling Intestinal Disease: Common Methods of Challenging Intestinal Epithelial 
Integrity 
 Mouse models remain among the most frequently-used models to interrogate 
intestinal disease processes given several considerations, both biological and practical 
(Eckmann 2006). Given their small size, short breeding timeline, and that over 99% of 
mouse genes possess a homolog in the human genome, they remain an excellent means of 
testing diseases possessed by their human counterparts (Eckmann 2006; Lander et al. 
2001; Waterston et al. 2002). Over the years, multiple mouse models have been used to 
interrogate barrier dysfunction and immune dysregulation that often contribute to 
intestinal diseases, including spontaneous colitis models, inducible colitis models, 
genetically modified models, and adoptive transfer models (Eckmann 2006; Madsen et al. 
1999; Neurath, Fuss, and Strober 2000; Perše and Cerar 2012; Wirtz and Neurath 2007; 
Wirtz et al. 2007). 
 Of the inducible models of murine colitis, one that has gained particular 
prominence over the years is the infectious colitis model using the epithelial-adherent 
pathogen Citrobacter rodentium (Eckmann 2006). Originally identified as the gram-
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negative bacterium responsible for transmissible colonic hyperplasia in mouse breeding 
colonies, it was later understood to be a pathogen that infects and colonizes the cecal and 
colonic epithelium, causing superficial attaching-effacing (A/E) lesions (Barthold et al. 
1976; Eckmann 2006; Luperchio and Schauer 2001; Schauer and Falkow 1993). These 
characteristic A/E lesions caused by Citrobacter rodentium resemble those formed by the 
human enteric pathogens enteropathogenic Escherichia coli (EPEC) and 
enterohemorrhagic E. coli (EHEC) (Eckmann 2006; Kaper, Nataro, and Mobley 2004; 
Welinder-Olsson and Kaijser 2005). Both pathogens remain major causes of morbidity 
and result in watery diarrhea (EPEC) or hemorrhagic colitis (EHEC) after consumption of 
undercooked meats (Eckmann 2006; Kaper, Nataro, and Mobley 2004; Welinder-Olsson 
and Kaijser 2005). 
Citrobacter rodentium remains an excellent pathogen for testing the effects of 
mucosal inflammatory injury, as it typically does not cause systemic infection like other 
pathogens such as Salmonella (Bry and Brenner 2004; Eckmann 2006). Indeed, these 
bacteria attach to the host cell membrane and cause localized destruction of the brush 
border microvilli but do not invade deeper mucosal layers, making them primarily 
mucosal pathogens. Infection with C. rodentium results in a peak colonization of the 
cecal and colonic epithelium 1 week post-inoculation, with the majority of pathogens 
being cleared over the following 2-3 weeks (Eckmann 2006; Maaser et al. 2004). Weight 
loss and diarrhea are the primary consequences of infection, with minimal overall 
mortality (Barthold et al. 1978; Eckmann 2006).  
In the colonic mucosa, infection with C. rodentium leads to a number of 
predictable features including hyperplasia of the intestinal crypts, goblet cell depletion, 
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and mucosal infiltration of lymphocytes, macrophages, neutrophils, and mast cells 
(Barthold et al. 1976; Eckmann 2006; Luperchio and Schauer 2001; Maaser et al. 2004). 
Lymphocytic responses are key mediators of C. rodentium infection and are characterized 
by mucosal infiltration of CD3+ T lymphocytes, particularly the CD4+ subset (Eckmann 
2006; Higgins et al. 1999). These T cells are critical to the clearance of the bacteria, as 
studies have consistently demonstrated that mice with CD4+ T cell deficiency cannot 
effectively control the C. rodentium infection and experience high rates of mortality (Bry 
and Brenner 2004; Eckmann 2006; Simmons et al. 2003). More specifically, responses to 
C. rodentium are typically characterized by T helper cell-type 1 and 17 immune 
responses. Interleukin-12 (IL-12) and gamma-interferon (IFN-γ) are upregulated in the 
colons of infected mice, indicative of a polarization towards the Th1 immune response 
(Eckmann 2006; Higgins et al. 1999; Simmons et al. 2002). More recently, studies have 
identified a key role for Th17 type responses, as well (Harrington et al. 2005; Mangan et 
al. 2006). Along with T-cell driven adaptive immune responses, B cells have also been 
shown to be required for bacterial clearance, and colonized mice are known to develop 
IgA and IgG antibody responses to several C. rodentium bacterial proteins (Eckmann 
2006; Maaser et al. 2004; Simmons et al. 2003).  
Finally, innate immune responses are also known to play a role in mediating 
defenses against C. rodentium. Tumor necrosis factor (TNF)-α, an acute inflammatory 
cytokine that is induced on infection, has been shown to be required for clearance, and 
IL-6, a cytokine implicated in B cell function and acute-phase response, is upregulated 
after infection, with IL-6 deficiency leading to delayed clearance (Eckmann 2006; 
Kitamura et al. 2004; Yamamoto et al. 2000). Innate immune cells including mast cells 
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have been shown to play a role in defense against C. rodentium, with mast-cell deficiency 
resulting in more severe colonic inflammation, systemic infection, and mortality 
(Eckmann 2006; Wei et al. 2005). 
While infectious colitis models such as C. rodentium can induce cecal injury, and 
genetic models such as the Il-10-/- model allow for the investigation of ileocecal 
inflammatory injury, small intestinal integrity is frequently challenged through alternate 
mechanisms (Eckmann 2006; Kühn et al. 1993). Given the rapidly proliferative nature of 
the small intestine, and the sensitivity of the various stem cell populations within the 
intestine to DNA damage induced by ionizing radiation, high dose whole body radiation 
(WBR) is frequently employed as a model to injure the small intestine and is considered 
the gold standard model to study intestinal stem cell-mediated crypt regeneration (Hua et 
al. 2012; Metcalfe et al. 2014; Potten and Hendry 1975; Potten 1977; Tian et al. 2011). 
The recent discovery of intestinal stem cell markers has allowed for investigation of the 
survival of various stem cell populations after radiation injury to the intestine (Barker 
2014; Hua et al. 2012; Van Landeghem et al. 2012; Metcalfe et al. 2014; Tian et al. 
2011). It is generally proposed that the two putative populations of intestinal stem cells 
have varying sensitivities to radiation, and studies have identified a role for each in 
repopulation of the intestinal epithelium after injury (Barker 2014; Hua et al. 2012; Tian 
et al. 2011).  
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Figure 12. Epithelial regeneration in the small intestine. Loss of Lgr5+ stem cells 
after injury can activate reserve Lgr5+ cells as well as +4 cells to restore epithelial 
renewal. Figure from Barker 2014. 
 
Gastrointestinal toxicity that occurs after ionizing radiation exposure results in 
diarrhea, dehydration, enterobacterial infection, as well as sepsis, circulatory shock, and 
death (Hauer-Jensen, Denham, and Andreyev 2014; Van Landeghem et al. 2012; Potten 
1990). After exposure to high doses of whole body radiation, intestinal stem cell death 
and diminution results in denudation of the epithelium due to compromised intestinal 
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crypt regeneration (Booth and Potten 2000; Paris et al. 2001; Potten, Booth, and Pritchard 
1997; Potten and Hendry 1975; Potten 1977; Potten et al. 2009). Between 8-12 Gray 
WBR, hematopoietic depletion and bone marrow failure are typically the causes of death 
in mice, while at higher doses, such as 14 Gy, GI toxicity precedes hematopoietic 
dysfunction and is the primary cause of death (Van Landeghem et al. 2012; Paris et al. 
2001). Thus, most studies of crypt regeneration after high-dose WBR typically focus on 
early time points (day 1-9 after WBR) because of high animal mortality from 
complications of radiation (Van Landeghem et al. 2012). 
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INTRODUCTION TO BLOOD VESSEL EPICARDIAL SUBSTANCE (BVES) 
 
BVES: Structure, Expression, and Proposed Functions 
Blood Vessel Epicardial Substance or Popeye domain containing gene 1 
(BVES/Popdc1) is a junctional-associated transmembrane protein originally discovered 
in a cDNA screen of the developing heart in the laboratories of Dr. David Bader and Dr. 
Thomas Brand (Andrée et al. 2000; Reese et al. 1999). BVES consists of 360 amino acid 
residues coding for three hydrophobic regions, two N-terminal glycosylation sites, and an 
intracellular domain of high intra-family homology termed the Popeye domain (Andrée et 
al. 2000; Knight, Bader, and Backstrom 2003; Osler, Chang, and Bader 2005). Popdc2 
and Popdc3 are the other members of the Popdc family, and proteins which are 50 
percent conserved with each other but with which BVES shares only 25 percent 
homology (Andrée et al. 2000; Hager and Bader 2009; Smith and Bader 2006).  
As BVES shares little structural homology with other identified proteins, 
establishing its function from its structural sequence has not been possible (Reese et al. 
1999). The N-terminus of BVES (amino acids 1-42) possesses two glycosylation sites, 
which are thought to facilitate recruitment of BVES to the cell membrane or prevent its 
degradation (Hager and Bader 2009; Knight, Bader, and Backstrom 2003). The 
intracellular C-terminus (amino acids 113-360) contains the Popeye domain and is highly 
conserved among the other family members (Brand 2005). BVES exists as a multimer 
through its intracellular C-terminus, which is thought to be essential for molecular 
regulation of cell-cell adhesion (Kawaguchi et al. 2008). In particular, amino acids K272 
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and K273 in the intracellular domain are critical for BVES homodimerization (Kawaguchi 
et al. 2008).  
 
Figure 13. BVES protein. BVES is a transmembrane protein that homodimerizes. It 
possesses two N-glycosylation sites and a self-associating C-terminus, which contains the 
highly conserved Popeye domain. Figure from Hager and Bader 2009. 
 
Bves is highly expressed in cells that are adherent, couple, or are interactive, such 
as those of the heart, skeletal and smooth muscle, brain, and various epithelia (Andrée et 
al. 2002; Hager and Bader 2009; Osler, Smith, and Bader 2006; Smith and Bader 2006; 
Torlopp et al. 2006; Vasavada, DiAngelo, and Duncan 2004). Within cells, BVES 
exhibits dynamic subcellular distribution: in cells that are subconfluent, BVES is 
visualized within the cell, but in cells that begin to adhere, BVES localizes to the 
membrane to points of cell-cell contact (Osler and Bader 2004; Smith and Bader 2006). 
Dr. Thomas Brand’s group has generated mice null for the Bves gene (Andrée et al. 
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2002). These mice are fit and fertile and display a normal lifespan with no overt 
phenotypes, though they demonstrate impaired skeletal muscle regeneration after 
cardiotoxin injection (Andrée et al. 2002). As BVES has been shown to be important for 
many developmental processes, lack of embryonic lethality with its deletion may be due 
to functional compensation by other Popdc family members (Andrée et al. 2002; Ripley 
et al. 2006).  
 
Figure 14. BVES expression in various tissues. Bves is highly expressed in cells that 
associate including the (A) heart, (B) skeletal muscle, (C) brain, and (D) various 
epithelia. Figure from Hager and Bader 2009. 
 27 
Some of the proposed functions of BVES include the regulation of epithelial 
integrity through the maintenance of tight junctions, conference of adhesive properties, 
and regulation of cell motility (Osler, Chang, and Bader 2005; Smith et al. 2008; 
Williams et al. 2011). BVES traffics to points of cell–cell contact early in the process, 
suggesting a role for it in cell communication or cell-cell adhesion (Osler and Bader 
2004; Osler, Chang, and Bader 2005; Wada, Reese, and Bader 2001). Transfection of 
wildtype Bves into normally non-adherent L-cells results in conspicuous formation of 
cell aggregates (Kawaguchi et al. 2008; Wada, Reese, and Bader 2001). However, 
transfection of Bves mutated or deleted at K272 and K273 results in L-cells that do not form 
continuous epithelial sheets, fail to maintain junctional proteins at the membrane, and 
demonstrate a dramatic reduction in transepithelial resistance, indicative of a loss of 
functional tight junctions (Kawaguchi et al. 2008). BVES is known to co-localize with 
ZO1 and Occludin, components of tight junctions, and GST pull-down experiments show 
an interaction between ZO1 and the intracellular C-terminal tail of BVES (Osler, Chang, 
and Bader 2005). In addition to co-localizing with junctional proteins, it has also been 
reported to co-localize with the adherens junction protein, E-cadherin (Osler, Chang, and 
Bader 2005; Smith and Bader 2006). It is possible that BVES serves as a dock or 
recruiting site for other junctional proteins which create cellular junctions (Hager and 
Bader 2009). While BVES may also regulate cellular interactions with other cells or the 
extracellular environment, as is typical of other transmembrane proteins, its extracellular 
N-terminus is thought to be too short to mediate an intercellular interaction; additionally, 
as it is not homologous across species like the highly conserved C-terminus, it is 
therefore most likely not essential (Hager and Bader 2009). 
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Moreover, BVES has been demonstrated to play a key role in regulating cell 
morphology and migration. Interfering with BVES function in human corneal epithelial 
(HCE) cells has been shown to induce mesenchymal morphology, increase proliferation 
and migration, expression of mesenchymal markers, and anchorage-independent growth 
(Kawaguchi et al. 2008; Williams et al. 2011). Conversely, restoring BVES expression in 
colorectal cancer (CRC) cells results in adoption of epithelial features, thus implicating 
BVES as a regulator of the balance between epithelial and mesenchymal phenotypes 
(Kawaguchi et al. 2008; Williams et al. 2011).  
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Figure 15. BVES regulates epithelial to mesenchymal transition in human corneal 
epithelial cells. Morphological changes in human corneal epithelial cells after BVES 
knockdown, and immunofluroescent localization of BVES, occludin, vimentin, and 
cytokeratin in confluent cultures. Figure from Williams et al. 2011. 
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Loss of BVES in HCE cells is associated with reduced E-cadherin levels, and 
both cytoplasmic and nuclear redistribution of β-catenin (Williams et al. 2011). 
Overexpression of BVES in human colon cancer cells is associated with increased E-
cadherin, redistribution of β-catenin to the cell membrane, and decreased TCF4 activity, 
suggesting that BVES modulates canonical Wnt signaling (Williams et al. 2011). An 
inverse relationship between BVES and ZEB1 expression has also been observed in 
colorectal cancer (Williams et al. 2011). ZEB1 promotes EMT via transcriptional 
repression of E-cadherin and other cell polarity genes (Aigner et al. 2007; Williams et al. 
2011). 
 
Figure 16. BVES modulates Wnt signaling. Immunofluorescence staining showing β-
catenin cytoplasmic and nuclear redistribution after BVES knockdown in human corneal 
epithelial cells (Top) and membranous redistribution after BVES expression in LIM2405 
colon cancer cell lines (Bottom). Figure from Williams et al. 2011. 
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BVES: Molecular Interactions 
Studies have begun to uncover molecular interactions of BVES. A yeast-two-
hybrid screen identified guanine nucleotide exchange factor T (GEFT) as a novel 
interacting protein (Smith et al. 2008). BVES and GEFT interact to modulate downstream 
effector proteins, Rac1 and Cdc42, Rho GTPases that induce lamellipodia and filopodia 
formation during cell migration (Guo et al. 2003; Hager and Bader 2009). However, the 
precise mechanism by which this occurs is yet to be established. Recently, BVES was 
shown to regulate RhoA signaling at least partially through its interaction with GEF-H1 
and that this modulates EMT (Russ et al. 2011; Williams et al. 2011). Collectively, these 
data implicate BVES as a regulator of junctional signaling programs that are important in 
EMT and fundamental to intestinal epithelial restitution. Additionally, BVES was 
recently found to impact vesicular trafficking through its interaction with VAMP3, a 
SNARE protein that recycles transferrin and β1-integrin receptors (Hager et al. 2010). 
Moreover, as a protein originally discovered to play a role in cardiac development, BVES 
has been shown to regulate a number of processes relevant to cardiac physiology. For 
example, BVES binds cAMP with high affinity, interacts with the potassium channel 
TREK-1, and regulates cardiac pacemaking (Froese et al. 2012). Additionally, BVES 
interacts with the caveolin Cav3 to regulate the structural and functional integrity of 
caveolae in cardiac myocytes (Alcalay et al. 2013). Thus, BVES impacts a number of 
cellular processes with broad physiological implications. It is highly likely that other 
BVES interacting proteins exist, and their identification is critical to understanding the 
role of BVES in normal and pathological junctional biology. 
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BVES in Intestinal Diseases 
BVES is a known regulator of epithelial and mesenchymal states and junctional-
associated signaling. Epithelial-to-mesenchymal transition is a critical element in normal 
wound healing processes as well as the metastatic progression of many cancers (Kalluri 
and Weinberg 2009). Recently, it has been found that BVES is significantly 
underexpressed in all stages of human colorectal cancer and in adenomatous polyps, 
suggesting that its suppression may occur early in the transformation process (Williams et 
al. 2011). A number of colorectal cancer cell lines exhibit decreased BVES expression 
and promoter hypermethylation, which is associated with transcriptional silencing 
(Williams et al. 2011). Expression of BVES was discovered to be downregulated in 
gastric cancer cell lines and in gastric cancer tissues, with the BVES promoter regions 
hypermethylated in the cancer cell lines and tissues in which BVES was silenced (Kim et 
al. 2010). Moreover, BVES has also been implicated in hepatocellular carcinoma (HCC), 
and it has been found to be downregulated in human HCC tissues and HCC cell lines 
with high metastatic potential (Han et al. 2014). BVES inhibition in Huh7 hepatocellular 
carcinoma cells results in morphological changes including cytoskeleton rearrangement, 
junctional disruption, increased cell migration and invasion, and increased expression of 
epithelial-mesenchymal transition transcription factors Snail1 and Twist1 (Han et al. 
2014).  
As the regulation of EMT is critical to normal intestinal restitution processes, and 
the imbalance of epithelial and mesenchymal states contributes to many intestinal 
diseases and cancer metastases (Bataille and Rohrmeier 2008; Kalluri and Weinberg 
2009), study of BVES may provide therapeutic opportunities. Additionally, considering 
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that disruption of tight-junctional integrity has been proposed as a key contributing factor 
to the increased intestinal permeability present in inflammatory bowel disease (Heller et 
al. 2005; Henderson et al. 2011; Ma et al. 2004; Porras et al. 2006; Shen, Su, and Turner 
2009; Shen 2012; Söderholm, Olaison, and Peterson 2002; Turner 2009; Wyatt et al. 
1993), better understanding of how BVES contributes to tight-junctional integrity may 
offer new insights into epithelial barrier dysfunction. Finally, given its role in the 
regulation of junctional signaling, particularly adherens junction-associated Wnt 
signaling, a pathway critical to intestinal stem cell signaling, crypt proliferation, and the 
development of colon cancer (Clevers and Nusse 2012; Clevers 2013; J. H. van Es et al. 
2012), BVES may play a role in the regulation of intestinal homeostasis, response to 
injury, and the development of colon cancer. 
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Hypothesis 
 
For my thesis work, it has been my hypothesis that BVES regulates intestinal 
homeostasis and response to injury. BVES is known to influence junctional-associated 
Wnt signaling, a critical regulator of intestinal stem cell signaling, crypt proliferation, and 
regeneration. Furthermore, as a tight junction-associated protein, it is possible that it 
plays a role in the regulation of intestinal epithelial barrier integrity and impacts 
responses to colonic injury. Thus, the primary objective of my work has been to 
contribute to our understanding of the role of BVES in basic intestinal biology and 
intestinal disease processes.  
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CHAPTER II 
 
BVES REGULATES INTESTINAL STEM CELL PROGRAMS AND 
INTESTINAL CRYPT VIABILITY AFTER RADIATION 
 
Abstract 
Blood Vessel Epicardial Substance (BVES/Popdc1) is a junctional-associated 
transmembrane protein that is underexpressed in a number of malignancies and regulates 
epithelial-to-mesenchymal transition. We previously identified a role for BVES in 
regulation of the Wnt pathway, a modulator of intestinal stem cell programs, but its role 
in small intestinal (SI) biology remains unexplored. We hypothesized that BVES 
influences intestinal stem cell programs and is critical to SI homeostasis after radiation 
injury. At baseline, Bves–/– mice demonstrated increased crypt height, as well as elevated 
proliferation and expression of the stem cell marker Lgr5 compared to wildtype (WT) 
mice. Intercross with Lgr5-EGFP reporter mice confirmed expansion of the stem cell 
compartment in Bves–/– mice. To examine stem cell function after BVES deletion, we 
employed ex vivo 3D-enteroid cultures. Bves–/– enteroids demonstrated increased 
stemness compared to WT, when examining parameters such as plating efficiency, stem 
spheroid formation, and retention of peripheral cystic structures. Furthermore, we 
observed increased proliferation, expression of crypt-base columnar “CBC” and “+4” 
stem cell markers, and amplified Wnt signaling in the Bves–/– enteroids. Bves expression 
was downregulated after radiation in WT mice. Moreover, after radiation, Bves–/– mice 
demonstrated significantly greater crypt viability, proliferation, and amplified Wnt 
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signaling in comparison to WT mice. Bves–/– mice also demonstrated elevation in Lgr5 
and Ascl2 expression, and putative damage-responsive stem cell populations marked by 
Bmi1 and TERT. Therefore, BVES is a key regulator of intestinal stem cell programs and 
mucosal homeostasis. 
 
Introduction 
The intestinal epithelium is a rapidly proliferating tissue that is thought to renew 
itself every 5 days (Barker 2014; Sato and Clevers 2013). Intestinal homeostasis is 
maintained by dynamic stem cell populations that reside in invaginations of the intestinal 
epithelium known as crypts (Barker, van de Wetering, and Clevers 2008; Barker 2014; 
Clevers 2013). Until recently, thorough characterization of these stem cell populations 
has remained challenging due to the absence of specific markers and suitable 
methodologies for their identification (Barker 2014; Potten et al. 2009). However, 
recently-discovered adult intestinal stem cell markers, and recently-developed lineage 
tracing technologies and innovative ex vivo 3D crypt cultures or “enteroid” systems have 
greatly facilitated their characterization (Barker 2014; Barker et al. 2007; Sato et al. 
2009; Sato, van Es, et al. 2011).  
Current evidence suggests the existence of ≥2 intestinal stem cell (ISC) 
populations: (1) a rapidly-cycling, crypt-based columnar (CBC) stem cell population at 
the base of the intestinal crypts, whose markers include Lgr5, a transmembrane receptor 
for R-spondin that amplifies Wnt tone, as well as Ascl2, Olfm4, Msi1, Smoc2, and Sox9; 
and (2) a more slowly-cycling, quiescent “+4” stem cell population that resides primarily 
at the +4 position from the base of the crypt and is marked by Bmi1, TERT, Lrig1, and 
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Hopx (Barker 2014; Durand et al. 2012; Van Landeghem et al. 2012; Li and Clevers 
2010; Potten et al. 2009). Wnt signaling, which regulates numerous biological processes 
ranging from development to malignancy, is known to be one of the many signaling 
pathways that governs intestinal homeostasis and is critical to the maintenance of the 
intestinal stem cell niche (Clevers and Nusse 2012; Clevers 2013; J. H. van Es et al. 
2012; Gregorieff and Clevers 2005; Pinto et al. 2003).  
Small intestinal (SI) regenerative responses are often assessed via radiation injury 
modeling due to the sensitivity of intestinal stem cell populations to ionizing radiation 
(Booth and Potten 2000; Hua et al. 2012; Metcalfe et al. 2014; Ottewell et al. 2006; 
Potten, Booth, and Pritchard 1997). Successful intestinal tissue recovery and regeneration 
after radiation is mediated by the survival of a subset of stem cells which reconstitute the 
injured crypt-villus unit (Booth and Potten 2000; Potten, Booth, and Pritchard 1997). The 
contribution of Lgr5+-CBC versus +4-ISC to normal intestinal epithelial renewal and 
repair after injury is still under debate, but a number of studies have identified a role for 
each in restoring epithelial integrity after injury (Buczacki et al. 2013; Hua et al. 2012; 
Metcalfe et al. 2014; Tian et al. 2011).  
Blood Vessel Epicardial Substance (BVES/Popdc1) is a junctional-associated, 
three-pass transmembrane protein that was originally isolated from a cDNA screen of the 
developing heart (Andrée et al. 2000; Reese et al. 1999). BVES is highly expressed in 
epithelial tissues and regulates epithelial-to-mesenchymal transition (EMT) (Andrée et al. 
2002; Han et al. 2014; Jayagopal et al. 2011; Kawaguchi et al. 2008; Reese et al. 1999; 
Vasavada, DiAngelo, and Duncan 2004; Williams et al. 2011). We have previously 
demonstrated that BVES regulates colonic epithelial phenotypes in vitro and is a 
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regulator of the Wnt pathway through stabilization of E-cadherin and alterations in β-
catenin subcellular localization (Williams et al. 2011). As the Wnt pathway is a critical 
regulator of small intestinal stem cell programs (Clevers 2013; Pinto et al. 2003), we 
hypothesized that BVES influences intestinal stem cell signaling and is critical to SI 
homeostasis after radiation injury.  
In the present study, we have identified BVES as a key modulator of intestinal 
epithelial stem cell programs and epithelial regeneration after radiation-induced injury. 
At baseline, Bves–/– mice exhibited higher proliferation, greater crypt depth, and an 
expanded crypt stem cell compartment. Ex vivo 3D-enteroid cultures of Bves–/– crypts 
demonstrated increased stemness, when examined by parameters such as plating 
efficiency, stem spheroid formation, and retention of peripheral cystic structures. This 
was accompanied by increased proliferation and expression of CBC rapidly-cycling stem 
cell markers, +4 stem cell markers, and amplified Wnt signaling. Furthermore, we found 
that Bves expression is downregulated in response to radiation in wildtype (WT) mice, 
and that this downregulation is biologically relevant, as Bves–/– mice are protected from 
radiation-induced injury and demonstrate greater crypt viability, more active stem cell 
populations, and amplified Wnt signaling after radiation. Finally, enteroids cultured from 
Bves–/– crypts after radiation demonstrated greater plating efficiency, indicating an 
epithelial tissue-autonomous role for BVES in modulating intestinal crypt viability. 
Results from these studies suggest that BVES regulates intestinal stem cell signaling and 
intestinal crypt viability after radiation and that it may serve as a predictive biomarker for 
patients undergoing radiotherapy. 
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Methods 
Mouse Models 
WT (C57BL/6 background) were obtained from the Jackson Laboratories. Bves–/– 
mice have been described in detail (Andrée et al. 2002). Lgr5-EGFP-ires-CreERT2 mice 
(Barker et al. 2007) (The Jackson Laboratory, Bar Harbor, ME) were obtained from R. 
Coffey (Vanderbilt University). All experiments were performed with 8 to 10 week old 
male and female mice on C57BL/6 background under guidelines approved by the 
Vanderbilt Institutional Animal Care and Use Committee (IACUC). 
 
γ-Irradiation Protocol 
WT and Bves–/– mice were placed in a plexiglass-partitioning device and onto a 
turntable delivery platform, ensuring uniform radiation dosing of all mice. WT and Bves–
/– mice received 12 Gy whole-body radiation (WBR) from a Mark I 137Cs source 
delivered at 1.58 Gy/min. Ninety-three hours after radiation, mice were injected with 0.02 
mg/kg of vincristine sulfate (Sigma-Aldrich, St. Louis, MO) to arrest cells in metaphase 
and facilitate identification of regenerative crypts (Ottewell et al. 2006; Poindexter et al. 
2015). Mice were euthanized three hours later at the ninety-six hour time point to 
examine crypt regeneration (Lund 2012; Poindexter et al. 2015). In a separate 
experiment, to assess ex vivo crypt viability after radiation, WT and Bves–/– mice were 
sacrificed four hours after 12 Gy radiation, with crypts harvested and plated for enteroid 
cultures (Poindexter et al. 2015). 
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Small Intestinal Organoid (Enteroid) Cultures 
The crypt-enteroid culture method was modified from Sato et al (Mahe et al. 
2013; Sato et al. 2009). Six centimeters of the proximal small intestine was dissected, 
flushed with ice cold phosphate buffered saline (PBS), dissected into 1 cm pieces, 
suspended in 5 mL ice cold PBS, and vortexed for 3 seconds. PBS was removed with a 
pipettor, and the wash was repeated. Tissue was transferred to 5 mL chelation buffer 
(1mM ethylenediaminetetraacetic acid (EDTA), made fresh in Dulbecco’s phosphate 
buffered saline (DPBS) and rocked for 10 minutes at 4°C prior to washing twice with 10 
mL PBS. 5 mL PBS was added, and the tissue was then shaken gently for 2 minutes. The 
supernatant was removed, 5 mL PBS was added, and the tissue was again gently shaken 
for 2 minutes. Supernatant was then decanted. 5 mL fresh chelation buffer was added and 
chelation was performed for 10 minutes at 4°C with gentle rocking. Crypts were filtered 
through a 70 µm filter into a pre-chilled 50 mL tube. The filter was rinsed with 5 mL cold 
shaking buffer (PBS with 43.3mM sucrose and 54.9mM Sorbitol). Complete crypts were 
counted and enough volume of shaking buffer was transferred for 1200 crypts to a pre-
chilled 5 mL round-bottomed tube. Crypts were centrifuged at 150 x g for 10 minutes at 
4°C. Shaking buffer was aspirated and crypts were resuspended in 50 µl of Matrigel (BD 
Bioscience, San Jose, CA, USA), per well, supplemented with 50 ng/mL EGF (R&D 
Systems, Minneapolis, MN, USA), 100 ng/mL Noggin (R&D Systems), 500 ng/mL R-
Spondin (R&D Systems), and 50 µg/mL Wnt3a (Millipore, Billerica, MA, USA). 
Matrigel was overlayed with 500 µl Minigut culture media (Advanced DMEM/F12 
(Invitrogen, Carlsbad, CA, USA)), L-Glutamine (Invitrogen), Penicillin-Streptomycin 
(Invitrogen), HEPES (Mediatech), N2 Supplement (R&D Systems), B27 Supplement 
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(Invitrogen) and growth factors. Every 4 days, media was replaced with fresh Minigut 
media. Plating efficiencies were calculated by dividing the total number of enterospheres 
formed by the original number of crypts plated at Day 0 and multiplying by 100. 
Enterospheres were visualized and counted at 24 and 48 hours after plating. Experiments 
were performed in triplicate and repeated two times.  
 
Immunohistochemistry and Immunofluorescence Staining 
At time of sacrifice, small intestines were removed, rinsed with phosphate-
buffered saline (PBS), and Swiss-rolled for histological assessment. The tissues were 
fixed in 10% formalin overnight and transferred to 70% ethanol. Tissues were submitted 
to Vanderbilt Tissue Processing Shared Resource (TPSR) core for processing and 
paraffin embedding. For immunohistochemistry (IHC), five micrometer sections were 
cut, dewaxed, hydrated, and endogenous peroxidase activity quenched with 0.03% 
hydrogen peroxide in MeOH (Barrett et al. 2011, 2012, 2013; Williams et al. 2013). 
Antigen retrieval was conducted using Antigen Unmasking Reagent (Vector 
Laboratories, Burlingame, California, USA) according to manufacturer’s instructions. 
After blocking, primary antibody was added overnight at 4°C. Isotype-matched 
antibodies were used as negative controls on serial sections. The Vectastain ABC Elite 
System (Vector Laboratories) was used to visualize staining for immunohistochemistry. 
Proliferation was measured using anti-phospho-Histone H3 (pH3) Ser10 antibody 
(Millipore) that labels cells in the mitotic (M) phase of the cell cycle at 1:150 dilution. 
Enteroendocrine cells were assessed by Chromogranin A (CgA) staining using anti-CgA 
at 1:1000 (ImmunoStar Inc., Hudson, WI). Anti-lysozyme antibody (Dako, Carpentaria, 
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CA) at 1:500 was utilized to identify Paneth cells. Goblet cells were identified by 
Periodic Acid Schiff (PAS) staining. Identification of apoptotic cells was conducted using 
the ApopTag Plus Peroxidase In Situ Apoptosis Kit (Millipore) according to the 
manufacturer's protocol. For GFP immunofluorescence (IF) staining, anti-GFP (Novus, 
Littleton, CO) at 1:500 was utilized, and slides were counterstained and mounted with 
ProLong Gold antifade including 4′,6-diamidino-2-phenylindole (Invitrogen). Crypt 
proliferation, Paneth cell quantification, and GFP+ cell counts was generated by counting 
cells in 40 sequential, well-aligned crypts from the proximal small intestine. This is 
presented as the mean number of positive cells per crypt. Crypt apoptosis, 
enteroendocrine cell counts, and goblet cell counts were obtained by counting cells in 40 
sequential, well-aligned crypts and adjacent villi from the proximal small intestine. This 
is presented as the mean number of positive cells per crypt-villus unit.  
 
qRT-PCR analysis  
RNA from Bves–/– or WT proximal small intestine was isolated using the RNeasy 
Mini Kit (Qiagen, Valencia, Santa Clarita, California, USA). 20 µl of cDNA was 
synthesized using the iScript cDNA synthesis kit (Bio-rad, Hercules, California, USA) 
from 1 µg of total RNA. 1 µl of cDNA was used as a template in each subsequent PCR 
reaction. SYBR green qRT-PCR was performed using mouse Wnt signaling primer 
library I (Cat #: MWNT-I), as well as Lgr5, Ascl2, Axin2, and PCNA primers obtained 
from RealTimePrimers.com according to manufacturer’s instructions. Sequences for 
validated primers for Lrig1, Bmi1, Tert, Olfm4, Nanog, Muc2, and Bves were obtained 
from Harvard Primer Bank (Cambridge, MA) and SYBR green qRT-PCR was performed 
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according to manufacturer’s instructions (Invitrogen). Expression was analyzed using the 
delta-delta Ct method and normalized to Glyceraldehyde 3-phosphate dehydrogenase 
(Gapdh). 
 
Statistical Methods 
Analyses comparing two groups were analyzed using the Student’s t-test. One-
way ANOVA and Newman-Keuls post-test was used to compare multiple groups. Data is 
presented as the mean +/- the standard error of the mean (SEM) in bar graphs and a line 
identifying the mean is shown when all data points are plotted. All of these analyses were 
performed using GraphPad Prism®6.0c (San Diego, CA, USA). A P<0.05 was 
considered statistically significant. 
 
Results 
BVES regulates intestinal crypt homeostasis 
Previous studies have demonstrated that BVES regulates colonic epithelial 
phenotypes in vitro and Wnt signaling through alterations in β-catenin subcellular 
localization (Williams et al. 2011). However, its role in small intestinal biology and the 
impact of its deletion in vivo on SI homeostasis was not previously examined. To 
determine if BVES deletion alters crypt morphology, proliferation, or differentiation in 
the small intestine, we performed histological characterization of Bves–/– mice and 
examined the proximal small intestine. While villus height was comparable to that of WT 
mice, Bves–/– mice demonstrated significantly greater crypt depth (Figure 17A). Analysis 
of crypt dynamics revealed no differences in apoptosis (Figure 17B, 18); however 
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proliferation, as measured by phospho-histone H3 IHC, was increased in Bves–/– mice 
(Figure 17C, 18). Additionally, the number of PAS-labeled goblet cells was increased 
compared to WT mice (Figure 17D, 18), although there were no differences in numbers 
of Paneth (Figure 17E, 18) or enteroendocrine cells (Figure 17F, 18). These data 
demonstrate that BVES regulates proliferation, intestinal lineage allocation, and crypt 
morphology, indicating a previously unrecognized role for BVES in regulating intestinal 
homeostasis. 
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Figure 17. BVES regulates intestinal proliferation, lineage allocation, and crypt 
morphology. Small intestines were isolated and Swiss-rolled. (A) Representative H&E 
staining of sections of WT and Bves–/– small intestine. Images (left) and quantification 
(right) of WT and Bves–/– villus height (358 µm vs. 364 µm, P=0.76) and crypt depth 
(80.4 µm vs. 98.0 µm, **P<0.01, n=24). (B) Images (left) and quantification (right) of 
apoptotic cells per crypt/villus unit (1.2 vs. 1.0 TUNEL+ cells/crypt-villus unit, P=0.37, 
n=24). (C) Images (left) and quantification (right) of crypt proliferation (6.0 vs. 7.5 
phospho-Histone H3+ cells/crypt, **P<0.01, n=24). (D) Images (left) and quantification 
(right) of goblet cells/crypt-villus unit (13.1 vs. 20.2 PAS+ cells/crypt, **P<0.01, n=23). 
(E) Images (left) and quantification (right) of Paneth cells/crypt-villus unit (3.3 vs. 3.6 
Lysozyme+ cells/crypt, P=0.39, n=19). (F) Images (left) and quantification (right) of 
enteroendocrine cells/crypt-villus unit (1.4 vs. 1.1 CgA+ cells/crypt, P=0.10, n=24). All 
images were captured at 100x magnification. Black arrows indicate positively-stained 
cells. 
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Figure 18. Magnification of WT and Bves–/– small intestine. Left to Right: TUNEL 
staining for apoptotic cells, pH3 staining for proliferating cells, PAS staining for goblet 
cells, lysozyme staining for Paneth cells, and CgA staining for enteroendocrine cells. 
Black arrows indicate positively-stained cells. 
 
BVES modulates intestinal stem cell dynamics 
As stem cell programs and Wnt pathway activation are critical in regulating 
intestinal homeostasis, we investigated expression of Wnt targets and intestinal stem cell 
markers in the Bves–/– intestine. Transcript levels of Axin2 were significantly elevated at 
baseline in the Bves–/– SI (Figure 19A). Additionally, we found significant elevation in 
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expression of Lgr5, a marker of CBC stem cells and another well-defined Wnt target in 
the Bves–/– SI (Figure 19B). There were trending increases in expression of Lrig1 and 
Bmi1, markers of +4 more slow-cycling stem cell populations (Figure 19C). To confirm 
that BVES loss may be driving the expansion of crypt base columnar stem cell 
populations, we crossed WT and Bves–/– mice with a Lgr5-EGFP reporter line(Barker et 
al. 2007), which demonstrated an almost 2-fold increase in the number of GFP+ 
cells/+crypt in the Bves–/– cohort compared to WT (Figure 19D). 
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Figure 19. BVES regulates intestinal stem cell dynamics in vivo. (A) qRT-PCR 
analysis revealed increased expression of (A) Axin2 (*P<0.05, n=12) and (B) Lgr5 
(*P<0.05, n=12) but no significant difference in mRNA levels of (C) Lrig1 (P=0.21, 
n=12) and Bmi1 (P=0.41, n=12) in Bves–/– proximal small intestine compared to WT. (D) 
Intercross of WT and Bves–/– mice with Lgr5-EGFP-ires-CreERT2 mice revealed 
increased number of GFP+ cells/+crypt (3.5 vs. 5.2, **P<0.01, n=16) in the Bves–/– cohort. 
Images were captured at 400x magnification. 
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To further interrogate the role of BVES in SI stem cell behavior in an epithelial tissue-
autonomous manner, we decided to employ the enteroid modeling system using ex vivo 
cultures of WT and BVES null crypts. Enteroids derived from Bves–/– mice demonstrated 
increased proliferation as determined by PCNA expression when harvested 5 days after 
plating (Figure 20A). Bves–/– mice also demonstrated a 3-fold elevation in Muc2 
expression 96 hours after plating (Figure 20B). Thus, the enteroid platform accurately 
recapitulated some of the phenotypes observed in vivo.  
The enteroid platform is ideal for testing stem cell function (Durand et al. 2012; 
Farin, Van Es, and Clevers 2012; Sato et al. 2009). The “stemness” of an enteroid can be 
measured by several growth parameters. For instance, augmented stem cell survival can 
be measured by an increase in the number of crypts that survive plating when considering 
the total number of crypts plated and is represented as the plating efficiency. 
Additionally, percentages of cystic, stem-spheroid structures at specific time points can 
also serve as a marker for stemness. Bves–/– enteroids demonstrated higher plating 
efficiency (Figure 20C) and increased frequency of stem spheroids (Figure 20D) at 24 
and 48 hours post-plating. After repassaging and maintenance in culture, Bves–/– enteroids 
consistently retained a significantly higher proportion of peripheral cystic structures in 
comparison to WT enteroids 5 days after passaging (Figure 20E). Therefore, Bves–/– 
enteroids consistently demonstrated increased stemness when maintained in culture. 
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Figure 20. Bves–/– enteroids exhibit increased stemness ex vivo. Small intestinal crypts 
were isolated from WT or Bves–/– mice and embedded in Matrigel. (A) qRT-PCR analysis 
revealed increases in (A) PCNA (***P<0.001, n=6) and (B) Muc2 (**P<0.01, n=6) 
mRNA levels in Bves–/– enteroids compared to WT. Enteroid stem cell properties 
determined based on (C) plating efficiency ratio, as measured by percentage of surviving 
enteroids 24 and 48 hours post-plating compared to total crypts plated (24 hours, 
**P<0.01; 48 hours, **P<0.01; n=6); (D) ratio of stem spheroid proportions counted 24 
and 48 hours post-plating (24 hours, **P<0.01; 48 hours, **P<0.01; n=6) and (E) 
percentage of enteroids maintaining peripheral cystic structures 5 days after passaging 
(3.8 ± 1.0% vs. 10.2 ± 0.6%, **P<0.01, n=6). Images were captured at 40x magnification 
(20C) or 100x magnification (20D, 20E). 
 
To investigate if these stemness phenotypes corresponded to expansion of stem cell 
populations, we surveyed for expression of stem cell markers. Both CBC (Figure 21A) 
and +4 stem cell populations (Figure 21B) were significantly elevated in the Bves–/– 
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enteroids. Additionally, we observed a significant upregulation of Wnt ligands (Wnt2, 
Wnt2b, Wnt3, Wnt7a, Wnt8B), Frizzled receptors, which serve as cell-surface receptors of 
the Wnt pathway (Fzd1, Fzd2, Fzd5, Fzd6, Fzd7, Fzd9, Fzd10), and Wnt targets (Axin2, 
CCND1, CD44, and EGFR) in Bves–/– enteroids (Figure 21C-E), suggesting that 
amplified Wnt signaling may contribute to these stemness phenotypes. Collectively, these 
data identify a previously unrecognized role for BVES in regulating stem cell dynamics 
of the small intestine. 
 
Figure 21. BVES regulates intestinal stem cell dynamics and Wnt signaling ex vivo. 
qRT-PCR analysis revealed increases in expression of (A) CBC stem cell markers in 
Bves–/– enteroids compared to WT. Lgr5, Ascl2, Olfm4, Nanog, and Sox9 mRNA levels in 
Bves–/– enteroids compared to WT. qRT-PCR analysis also revealed increases in (B) +4 
stem cell markers Bmi1 and Lrig1 mRNA levels in Bves–/– enteroids compared to WT 
with no significant differences in TERT  expression (P=0.11). Expression of (C) Wnt 
ligands, (D) Wnt receptors, and (E) Wnt targets were significantly elevated in the Bves–/– 
enteroids. *P<0.05, **P<0.01 (n=6). 
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Intestinal Bves expression is downregulated after radiation and determines crypt viability 
Stem cell populations are critical to repopulating the intestinal epithelium after 
radiation injury to the small intestine (Metcalfe et al. 2014; Tian et al. 2011). As we 
observed that BVES regulates stem cell programs, we postulated that BVES would 
impact crypt regenerative dynamics after ionizing radiation (Barker 2014; Ottewell et al. 
2006). We first determined if Bves expression is altered in response to radiation, and 
observed that 96 hours after 12 Gy WBR that Bves messenger RNA was reduced more 
than 2.5-fold (Figure 22A). This time point is known to be one of intestinal crypt 
regeneration (Van Landeghem et al. 2012; Lund 2012). We then took advantage of the 
availability of the Bves–/– mice to test if the observed difference in Bves expression was 
functionally relevant to intestinal injury responses. WT and Bves–/– cohorts were exposed 
to 12 Gy radiation and sacrificed after 96 hours. Mice were injected with vincristine, a 
mitotic inhibitor, three hours prior to sacrifice to facilitate identification of regenerative 
crypts. Examination of hematoxylin and eosin (H&E) stained sections revealed that Bves–
/– mice exhibited significantly greater crypt viability in comparison to WT mice after 
radiation exposure (Figure 22B). Crypts were considered viable if three or more mitotic 
bodies were observed per crypt (Ottewell et al. 2006; Poindexter et al. 2015). Bves–/– mice 
also exhibited significantly greater proliferation (Figure 22C) but no differences in 
apoptosis (Figure 22D). Taken together, these data suggest that BVES modulates 
intestinal crypt viability after radiation and that its deletion promotes radioresistance. 
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Figure 22. BVES regulates intestinal crypt viability after radiation. (A) qRT-PCR 
analysis comparing Bves mRNA expression in WT proximal small intestine prior to 
radiation vs. 4 hours (P=0.30, n=12), and 96 hours after 12 Gy radiation (*P=0.05, n=12). 
(B) Representative H&E stained sections and quantification of viable intestinal crypts in 
WT and Bves–/– mice. Bves–/– mice exhibited significantly greater crypt viability 96 hours 
after 12 Gy radiation (42.5 ± 7.8% vs. 64.4 ± 3.7% *P<0.05, n=17). Crypts were 
considered viable if 3 or more mitotic bodies were observed per crypt. 40 sequential, 
well-aligned crypts in the proximal one-third of the small intestine were counted per data 
point. The percent of surviving crypts was calculated using the following equation: (# of 
viable crypts/total # of crypts counted) x 100. (C) Images (left) and quantification (right) 
of crypt proliferation 96 hours after 12 Gy radiation (14.4 vs. 20.0 phospho-Histone H3+ 
cells/crypt, *P<0.05, n=17). (D) Images (left) and quantification (right) of apoptotic cells 
per crypt/villus unit (4.1 vs. 4.3 TUNEL+ cells/crypt-villus unit, P=0.79, n=17). Images 
were captured at 10x magnification (22B, left) or 100x magnification (22B, right, 22C, 
22D). 
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BVES deletion results in amplified stem cell activity and Wnt signaling after radiation 
Surviving stem cells are critical to the repopulation of intestinal crypts after 
radiation, and we observed an expanded stem cell population in the Bves–/– mice at 
baseline. Therefore, we investigated if alterations in surviving stem cell populations after 
radiation may be contributing to the increased crypt viability in these mice. qRT-PCR 
analysis revealed increases in Bmi1 and TERT (Figure 23A) in Bves–/– mice, as well as 
Lgr5 and Ascl2 (Figure 23B). Therefore, unlike mice at baseline, we observed significant 
upregulation of markers of both +4 damage-responsive and CBC intestinal stem cell 
populations. Moreover, as Wnt signaling is a key signaling pathway that governs 
intestinal homeostasis and regeneration after injury, and given the amplified Wnt 
signaling present in the Bves–/– intestine at baseline and in ex vivo cultures, we assessed if 
alterations in the Wnt pathway were present after radiation. qRT-PCR analysis revealed 
significant upregulation of several Wnt ligands (Wnt1, Wnt2, Wnt2b, Wnt3, Wnt3a, Wnt6, 
Wnt7b, Wnt8b, Wnt9a, Wnt10b, and Wnt16), Frizzled receptors (Fzd3, Fzd8, Fzd9, and 
Fzd10), and Wnt targets genes (Lgr5, Ascl2, Sox2, VegfA) in the Bves–/– mice compared to 
WT (Figure 23C-E). Thus, amplified Wnt signaling may contribute to the increased 
proliferation and crypt viability observed in BVES knockout mice following radiation 
and supports stem cell survival and regeneration.  
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Figure 23. BVES modulates stem cell regenerative responses and Wnt signaling 
after radiation. Proximal small intestine was harvested from WT or Bves–/– mice after 12 
Gy WBR. qRT-PCR analysis revealed increases in mRNA expression of (A) +4 stem cell 
markers Bmi1 and TERT and (B) CBC stem cell markers Lgr5 and Ascl2 in Bves–/– 
proximal SI compared to WT. Expression of (C) Wnt ligands, (D) Wnt receptors, and (E) 
Wnt targets was significantly elevated in the Bves–/– proximal SI compared to WT. 
(*P<0.05, **P<0.01, n=12) 
 
Bves–/– enteroids demonstrate radioresistance 
As we observed increased crypt viability in vivo after radiation of Bves–/– 
intestine, we hypothesized that Bves–/– enteroid plating efficiency, a surrogate marker for 
crypt viability, would be similarly impacted after radiation. We dosed mice with 12 Gy 
WBR, isolated SI tissue, and plated crypts 4 hours later. Consistent with our observations 
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at the 96 hour time point, we observed no differences in apoptosis between the cohorts 
(Figure 24A). However, we observed a 2-fold increase in Bves–/– enteroid plating 
efficiency 24 hours after plating (Figure 24B). These data suggest an epithelial tissue-
autonomous role for BVES in regulating intestinal crypt viability after radiation. 
 
Figure 24. BVES deletion protects intestinal crypts after radiation. (A) 
Quantification of apoptotic cells per crypt/villus unit (10.5 vs. 10.5 TUNEL+ cells/crypt-
villus unit, P=0.97, n=19) in WT and Bves–/– proximal SI 4 hours after 12 Gy radiation. 
(B) Enteroids harvested from Bves–/– mice after 12 Gy radiation demonstrated increased 
plating efficiency when compared to WT (**P<0.01).  
 
 
Discussion 
In this study, we investigated the role of BVES in intestinal homeostasis, stem 
cell function, and response to injury after ionizing radiation. At baseline, Bves–/– mice 
demonstrated altered lineage allocation, increased crypt size, and higher intestinal 
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proliferation with an expanded intestinal stem cell population. Bves–/– enteroids exhibited 
increased stemness with increased plating efficiency, proportion of stem spheroids, and 
retention of cystic structures, as well as increased expression of both CBC and +4 stem 
cell populations. These ex vivo studies suggest that the altered stem cell dynamics in the 
Bves–/– intestine do not require stromal-epithelial crosstalk, thus identifying a previously 
unrecognized role for BVES in stem cell biology that is epithelial cell-autonomous. 
Moreover, we found that Bves expression was downregulated in WT SI after radiation, 
and Bves–/– mice displayed significantly greater crypt viability after radiation. 
Additionally, the Bves–/– cohort demonstrated increased populations of both CBC and 
damage-responsive +4 stem cell populations after radiation, along with significantly 
amplified Wnt signaling. Lastly, Bves–/– crypts isolated from mice 4 hours after 12 Gy 
radiation displayed increased plating efficiency, thus demonstrating increased viability in 
an ex vivo setting, as well. 
Peak apoptosis of the Lgr5+-CBC stem cell population is thought to occur 4-6 
hours after 12 Gy WBR (Hua et al. 2012; Lund 2012). After peak crypt loss between 48-
72 hours after 12 Gy WBR, crypt regeneration actively occurs at 96 hours (Hua et al. 
2012; Lund 2012). It is generally accepted that there are at least two subsets of stem cells: 
(1) a rapidly-cycling, CBC stem cell population at the base of the intestinal crypts, whose 
marker is Lgr5, a transmembrane receptor for R-spondin that amplifies Wnt tone, as well 
as Ascl2, Olfm4, Msi1, Smoc2, and Sox9; and (2) a damage-responsive, reserve stem cell 
population that is capable of repopulating the crypt and replacing Lgr5+-CBC stem cells 
in case of injury to the small intestinal epithelium (Barker 2014; Durand et al. 2012; Li 
and Clevers 2010; Potten et al. 2009; Tian et al. 2011). Markers for the latter subset of 
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stem cells include Bmi1, TERT, as well as Lrig1 and Hopx (Barker 2014; Van 
Landeghem et al. 2012). While the role of Lgr5+-CBC and +4 stem cell populations in 
repopulating intestinal crypts is under debate, studies have demonstrated that there is a 
role for each population in crypt regeneration (Hua et al. 2012; Metcalfe et al. 2014; Tian 
et al. 2011). While the +4 stem cell population is thought to be a more damage-
responsive population that is capable of repopulating the crypt after injury (Tian et al. 
2011), recent studies have shown that Lgr5+-CBC stem cell populations are radioresistant 
and are critical to crypt regeneration after injury (Hua et al. 2012; Metcalfe et al. 2014). 
Interestingly, markers for both the CBC and the putative +4 damage-responsive 
populations were elevated in the BVES knockout mice, suggestive of either higher 
proportions in survival of an already expanded stem cell population, or a more robust 
reparative mechanism driven by surviving stem cell populations.  
The Wnt signaling pathway is known to play a key role in the regulation of 
intestinal epithelial homeostasis as Wnt activation drives stem cell activity and maintains 
the intestinal stem cell niche (Fevr et al. 2007; Gregorieff and Clevers 2005; Pinto et al. 
2003). Multiple studies have demonstrated that Wnt signaling is essential to mediating 
the survival of stem/progenitor cell populations after radiation (Fevr et al. 2007; Kim et 
al. 2012; Woodward et al. 2007). We have previously demonstrated that BVES regulates 
Wnt signaling through E-cadherin stabilization and alterations in β-catenin distribution 
(Williams et al. 2011), but this is the first study to directly link BVES to intestinal stem 
cell regulation in vivo and ex vivo. In support of BVES deletion altering intestinal stem 
cell function, baseline characterization of Bves–/– mice demonstrated elevated expression 
of Lgr5 as well as an expanded stem cell compartment when crossed with the Lgr5-EGFP 
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reporter line. Bves–/– crypts in the enteroid culture system demonstrated increased plating 
efficiency, proportions of stem spheroids, and enteroids with peripheral cystic structures, 
along with elevations in stem cell markers and Wnt ligands, receptors, and targets. 
Correspondingly, amplified Wnt signaling was also present in the Bves–/– intestine after 
radiation-induced injury, and may contribute to the increased crypt proliferation and 
viability observed after BVES deletion.  
While we observed alterations in the Wnt pathway after BVES deletion, with 
impacts on intestinal stem cell dynamics and response to radiation injury, it is also 
possible that the observed phenotypes are being influenced by other signaling pathways 
that are known to be modulated by BVES. Indeed, studies have identified BVES as a 
regulator of a diverse group of pathways and cellular processes. We have previously 
shown that BVES alters cellular motility and cytoskeletal arrangement through its 
regulation of RhoA signaling (Russ et al. 2011; Williams et al. 2011). Additionally, 
BVES was recently found to impact vesicular trafficking through its interaction with 
VAMP3, a SNARE protein that recycles transferrin and β1-integrin receptors (Hager et 
al. 2010). Moreover, as a protein originally discovered to play a role in cardiac 
development, BVES has been shown to regulate a number of processes relevant to 
cardiac physiology. For example, BVES binds cAMP with high affinity, interacts with 
the potassium channel TREK-1, and regulates cardiac pacemaking (Froese et al. 2012). 
Additionally, BVES interacts with the caveolin Cav3 to regulate the structural and 
functional integrity of caveolae in cardiac myocytes (Alcalay et al. 2013). Thus, BVES 
impacts a number of cellular processes with broad physiological implications. Given the 
known prominent role of Wnt signaling in stem cell biology, however, we postulate that 
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the phenotype of radioresistance described in this report is due to loss of BVES 
repression of Wnt signaling.  
In conclusion, our findings demonstrate that BVES is critical for multiple aspects 
of small intestinal homeostasis and response to injury. Specifically, BVES regulates 
intestinal stem cell programs and is important in radiation-induced injury responses. This 
is the first study to identify that Bves is regulated in response to radiation, and that its 
underexpression has a clear biological impact on crypt regeneration, as the Bves–/– 
intestine is protected from radiation injury. This study offers promise in understanding 
the molecular mechanisms that regulate response to radiation therapy and a potentially 
attractive target for predicting radiation response in patients undergoing radiotherapy. 
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CHAPTER III 
 
BVES IS REQUIRED FOR MAINTENANCE OF COLONIC EPITHELIAL 
INTEGRITY IN EXPERIMENTAL COLITIS 
 
Abstract 
Blood Vessel Epicardial Substance (BVES/Popdc1) is a tight junction-associated 
transmembrane protein that regulates epithelial-to-mesenchymal transition (EMT) and is 
underexpressed in a number of malignancies, including colon cancer. We have previously 
identified that impaired BVES function promotes EMT, leads to abnormal junctional 
signaling, and increases epithelial permeability in vitro, all of which have been implicated 
in inflammatory bowel disease (IBD). However, there have been no in vivo studies 
investigating the role of BVES in intestinal biology. We hypothesized that BVES 
regulates colonic homeostasis and is critical to maintaining epithelial integrity after 
injury. At baseline, Bves–/– mice demonstrated increased proliferation, decreased 
apoptosis, altered intestinal lineage allocation, and increased permeability ex vivo. We 
employed the Citrobacter rodentium infectious colitis model to test if impaired 
permeability in the Bves–/– mice would impact severity of colitis. Bves–/– mice inoculated 
with C. rodentium exhibited significantly more edematous colons, with greater injury and 
colonic hyperplasia when assessed histologically. Bves–/– mice also demonstrated 
increased bacterial colonization and amplified immune responses after C. rodentium 
inoculation, both of which may be contributing to this worsened injury. Finally, BVES 
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mRNA levels were underexpressed in human ulcerative colitis biopsy specimens, 
suggesting relevance to human disease. These studies identify BVES as a key regulator of 
colonic mucosal integrity and suggest that it may play a protective role in IBD. 
 
Introduction 
Inflammatory bowel disease (IBD) affects over 1.4 million people in the United 
States, causing numerous and debilitating complications such as malnutrition, infection, 
severe pain, and an elevated risk of colorectal cancer (Baumgart and Carding 2007; 
Baumgart and Sandborn 2007). Despite concerted research efforts, the fundamental 
pathophysiology of IBD remains poorly understood. Intestinal mucosal homeostasis 
relies on continuous proliferation, differentiation, and repair of the epithelium in response 
to injury (Iizuka and Konno 2011; Maloy and Powrie 2011; Sturm and Dignass 2008). 
Maintenance of intestinal integrity requires competent epithelial barriers as well as intact 
repair programs to respond to intestinal challenges (Iizuka and Konno 2011; Maloy and 
Powrie 2011; Sturm and Dignass 2008). The epithelial barrier is known to be “leaky” in 
patients with IBD, with a number of studies demonstrating lower epithelial resistance and 
increased permeability of both inflamed and non-inflamed mucosa in Crohn’s disease and 
ulcerative colitis (Baumgart and Carding 2007; Shen, Su, and Turner 2009; Söderholm, 
Olaison, and Peterson 2002). Tight junctions are principal components of apical 
junctional complexes that are critical to the maintenance of epithelial barriers (Balda and 
Matter 1998; Balda et al. 1992). Disruption of tight-junctional integrity has been 
proposed as a contributing factor to epithelial barrier dysfunction present in IBD (Heller 
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et al. 2005; Ma et al. 2004; Shen, Su, and Turner 2009; Shen 2012; Söderholm, Olaison, 
and Peterson 2002; Turner 2009). 
Blood Vessel Epicardial Substance (BVES/Popdc1) is tight junction-associated, 
three-pass transmembrane protein originally discovered from a cDNA screen of the 
developing heart (Andrée et al. 2000; Reese et al. 1999). BVES is highly expressed in 
epithelial tissues, including the intestinal epithelium, and regulates epithelial-to-
mesenchymal transition (EMT) (Andrée et al. 2002; Han et al. 2014; Jayagopal et al. 
2011; Kawaguchi et al. 2008; Reese et al. 1999; Vasavada, DiAngelo, and Duncan 2004; 
Williams et al. 2011). We have previously demonstrated that BVES regulates colonic 
epithelial phenotypes in vitro (Williams et al. 2011) but its in vivo role in the maintenance 
of intestinal homeostasis remains unexplored. We hypothesized that BVES influences 
colonic homeostasis and is critical to maintaining colonic epithelial integrity after injury. 
In the present study, we have identified BVES as a key regulator of colonic 
mucosal integrity. At baseline, Bves–/– mice exhibit defects in intestinal secretory lineage 
allocation, along with higher cellular proliferation and decreased apoptosis. Ex vivo 
studies showed that Bves–/– colons have increased mucosal permeability. After 
inoculation with C. rodentium, Bves–/– mice demonstrated exacerbated colitis in 
comparison to their wildtype (WT) counterparts, along with significantly increased 
bacterial colonization and amplified immune responses. Lastly, analysis of human 
ulcerative colitis samples showed decreased BVES expression in comparison to normal 
biopsy specimens, suggesting relevance to human disease. Collectively, these findings 
indicate that BVES regulates colonic homeostasis, potentially protecting against intestinal 
epithelial injury, and may play a protective role in inflammatory bowel disease. 
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Methods 
Mouse Models 
Wildtype (C57BL/6 background) were obtained from the Jackson Laboratories. 
Bves–/– mice have been described in detail (Andrée et al. 2002). All experiments were 
performed with 8 to 10 week old male and female mice on C57BL/6 background under 
guidelines approved by the Vanderbilt Institutional Animal Care and Use Committee 
(IACUC). 
 
Permeability Analysis 
In order to compare the permeability of colons of WT mice with those of Bves–/– 
mice, we employed Ussing Chambers to measure the movement of FITC-Dextran across 
the mouse intestine. Sections of distal colons were placed in Ussing Chambers, and 100 
microliters of 80 mg/ml FITC-dextran solution used to measure movement of FITC-
dextran across tissues. 
 
Induction of Citrobacter rodentium colitis 
Mice were orally inoculated with C. rodentium as done previously (Coburn et al. 
2013; Gobert et al. 2004; Singh et al. 2011; Williams et al. 2013). Bacteria were grown 
overnight in Luria broth and mice were infected by oral gavage with 0.1 ml of broth 
containing 1x108 CFU of C. rodentium. Control mice received sterile broth. At 14 days 
post inoculation, the animals were sacrificed, and the colons were removed, cleaned, and 
Swiss-rolled for histology. Distal colon pieces were taken for colonization studies. For 
colonization, tissues were homogenized, serially diluted in Luria broth and plated on 
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MacConkey Agar plates. Colonies were counted after 24 hours and CFU/g of colon 
tissues were calculated. M. B. P. reviewed and scored the C. rodentium slides in a blinded 
fashion. Both acute (neutrophilic) and chronic (lymphocytic) inflammation, extent of 
inflammation, and epithelial damage were each scored on 0–3 scale (Gobert et al. 2004; 
Williams et al. 2013). The aggregate histological injury score was the sum of acute and 
chronic inflammation multiplied by the extent of inflammation, plus the epithelial injury 
(0 –21) (Gobert et al. 2004; Williams et al. 2013). 
 
Immunohistochemistry  
At time of sacrifice, colons were removed, rinsed with phosphate-buffered saline 
(PBS), and Swiss-rolled for histological assessment. The tissues were fixed in 10% 
formalin overnight and transferred to 70% ethanol. Tissues were submitted to Vanderbilt 
Tissue Processing Shared Resource (TPSR) core for processing and paraffin embedding. 
For immunohistochemistry (IHC), five micrometer sections were cut, dewaxed, hydrated, 
and endogenous peroxidase activity quenched with 0.03% hydrogen peroxide in MeOH 
(Barrett et al. 2011, 2012, 2013; Poindexter et al. 2015; Williams et al. 2013). Antigen 
retrieval was conducted using Antigen Unmasking Reagent (Vector Laboratories, 
Burlingame, California, USA) according to manufacturer’s instructions. After blocking, 
primary antibody was added overnight at 4°C. Isotype-matched antibodies were used as 
negative controls on serial sections. The Vectastain ABC Elite System (Vector 
Laboratories) was used to visualize staining for immunohistochemistry. Proliferation was 
measured using anti-phospho-Histone H3 (pH3) Ser10 antibody (Millipore) that labels 
cells in the mitotic (M) phase of the cell cycle at 1:150 dilution. Enteroendocrine cells 
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were assessed by Chromogranin A (CgA) staining using anti-CgA at 1:1000 
(ImmunoStar Inc., Hudson, WI). Goblet cells were identified by Periodic Acid Schiff 
(PAS) staining. Identification of apoptotic cells was conducted using the ApopTag Plus 
Peroxidase In Situ Apoptosis Kit (Millipore) according to the manufacturer's protocol. 
Counts were generated by counting cells in 100 sequential, well-aligned crypts from the 
distal colon. This is presented as the mean number of positive cells per crypt.  
 
qRT-PCR analysis  
RNA from Bves–/– or WT colons was isolated using the RNeasy Mini Kit (Qiagen, 
Valencia, Santa Clarita, California, USA). 20 µl of cDNA was synthesized using the 
iScript cDNA synthesis kit (Bio-rad, Hercules, California, USA) from 1 µg of total RNA. 
1 µl of cDNA was used as a template in each subsequent PCR reaction. SYBR green 
qRT-PCR was performed using mouse cytokine array libraries I (Cat #: MCA-I) and II 
(Cat #: MCA-II) purchased from RealTimePrimers.com (Elkins Park, Pennsylvania, 
USA) according to manufacturer’s instructions. Individual cytokines were analyzed using 
the delta-delta Ct method and normalized to Hypoxanthine-Guanine 
Phosphoribosyltransferase (Hprt). For analysis of BVES expression in human samples, 
BVES and GAPDH TaqMan probes were purchased from Applied Biosystems (Foster 
City, California, USA). Expression was normalized to GAPDH. 
 
Human Subjects 
Tissues were obtained during colonoscopies at the Vanderbilt University Medical 
Center, following a protocol approved by the Vanderbilt Institutional Review Board. 
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Statistical Methods 
Analyses comparing two groups were analyzed using the Student’s t-test. One-
way ANOVA and Newman-Keuls post-test was used to compare multiple groups. Data is 
presented as the mean +/- the standard error of the mean (SEM) in bar graphs and a line 
identifying the mean is shown when all data points are plotted. All of these analyses were 
performed using GraphPad Prism®6.0c (San Diego, CA, USA). A P<0.05 was 
considered statistically significant. 
 
Results 
BVES regulates colonic crypt homeostasis and contributes to epithelial barrier function 
Previous studies have demonstrated that BVES regulates colonic epithelial 
phenotypes in vitro (Williams et al. 2011). However, its role in intestinal biology and the 
impact of its deletion in vivo on colonic homeostasis were not previously examined. To 
determine if BVES deletion alters colonic proliferation, apoptosis, or lineage allocation, 
we performed histological characterization of Bves–/– mice and examined the distal colon. 
Proliferation, as measured by phospho-histone H3 IHC, was increased in Bves–/– mice 
(Figure 25A). Colons of Bves–/– mice demonstrated decreased apoptosis (Figure 25B). 
Additionally, the numbers of PAS-labeled goblet cells (Figure 25C) and enteroendocrine 
cells (Figure 25D) were increased compared to WT mice. Moreover, as we have 
previously identified that impaired BVES function leads to epithelial junctional 
compromise in vitro (Williams et al. 2011), we hypothesized that the Bves–/– intestine 
would be more permeable. We employed Ussing Chambers, an ex vivo physiologic 
system to measure the movement of FITC-Dextran across WT and Bves–/– colons and 
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found that the Bves–/– intestine was significantly more permeable (Figure 25E). These 
data demonstrate that BVES regulates intestinal proliferation, apoptosis, lineage 
allocation, and mucosal permeability, indicating a previously unrecognized role for 
BVES in regulating intestinal homeostasis. 
 
Figure 25. BVES regulates colonic proliferation, apoptosis, lineage allocation, and 
permeability. Colons were isolated and Swiss-rolled. (A) Images (left) and 
quantification (right) of crypt proliferation (0.6 vs. 1.5 phospho-Histone H3+ cells/crypt, 
**P<0.01, n=16). (B) Images (left) and quantification (right) of apoptotic cells per 
crypt/villus unit (0.3 vs. 0.2 TUNEL+ cells/crypt, *P=0.05, n=17). (C) Images (left) and 
quantification (right) of goblet cells/crypt (10.1 vs. 17.7 PAS+ cells/crypt, **P<0.01, 
n=12). (D) Images (left) and quantification (right) of enteroendocrine cells/crypt-villus 
unit (0.5 vs. 0.8 CgA+ cells/crypt, **P<0.01, n=10). (E) Ussing chamber ex vivo 
permeability studies revealed increased permeability of Bves–/– colons compared to WT 
(**P<0.01, n=8). All images were captured at 200x magnification. Black arrows indicate 
positively-stained cells. 
A) B) C) 
D) E) 
WT 
Bves-/- 
WT 
Bves-/- Bves-/- 
WT 
Bves-/- 
WT 
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BVES maintains colonic epithelial integrity after C. rodentium colitis 
Tight junction integrity has been proposed to be a key mediator of epithelial 
barrier integrity and is thought to be disrupted in IBD (Heller et al. 2005; Ma et al. 2004; 
Shen, Su, and Turner 2009; Shen 2012; Söderholm, Olaison, and Peterson 2002; Turner 
2009). Given the increased permeability at baseline of the Bves–/– intestine, we 
hypothesized that it would result in more severe colitis after inoculation with Citrobacter 
rodentium (Figure 26A). Both WT and Bves–/– mice lost weight after C. rodentium 
inoculation; however, by day 3 Bves–/– mice exhibited accelerated weight loss, and from 
day 4 to day 14, delayed recovery (Figure 26B). At necropsy, both genotypes had 
edematous appearing colons. However, the ratio of colon weight (% of body weight) as 
well as colon weight/colon length was significantly greater in the Bves–/– mice (Figure 
26C-D).  
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Figure 26. Bves–/– mice have more edematous colons after C. rodentium infection. (A) 
Schematic of C. rodentium inoculation protocol. WT and Bves–/– mice were sacrificed 14 
days after inoculation. (B) Bves–/– mice exhibited trending but not significant increases in 
weight loss but significantly more edematous colons after C. rodentium inoculation 
compared to WT when measured as (C) ratio of colon weight (% of body weight) as well 
as (D) colon weight/colon length. 
 
 
Histological review of H&E-stained Swiss-rolled colons (Figure 27A) by an expert 
gastrointestinal pathologist examining metrics such as epithelial ulceration, inflammatory 
infiltrate, submucosal edema, and impaired regeneration revealed significantly greater 
injury in Bves–/– mice (Figure 27B). These observations indicate that BVES contributes to 
the maintenance of epithelial integrity after colonic injury. 
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Figure 27. Bves–/– mice demonstrate exacerbated colitis after C. rodentium infection. 
(A) Representative H&E stained sections of WT and Bves–/– mice. (B) Bves–/– mice 
exhibited significantly greater injury after C. rodentium infection (Injury Score: 6.9 vs. 
11.0 **P<0.01, n=25). Histological injury score using a multi-point scale as described in 
the Methods section. Images were captured at 10x magnification (27A, left) or 100x 
magnification (27A, right). 
 
Bves–/– mice demonstrate increased bacterial colonization and amplified immune 
responses after C. rodentium infection 
As the BVES knockout mice demonstrated increased epithelial barrier 
permeability at baseline and worsened colitis, we hypothesized that they might sustain an 
increased bacterial load. Culturing of colonic mucosa indicated increased bacterial 
colonization in the Bves–/– cohort (Figure 28A). Moreover, cytokine profiling suggested 
increased expression of cytokines involved in Th1 and Th17 immune responses in the 
Bves–/– colon after C. rodentium-induced injury/inflammation (Figure 28B). 
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Figure 28. Bves–/– mice demonstrate increased bacterial colonization and amplified 
immune responses after C. rodentium infection. (A) Colonic bacterial colonization in 
WT and Bves–/– colons. (B) qRT-PCR analysis revealed increased mRNA expression of 
IFN-γ (*P<0.05, n=12), IL-6 (*P<0.05, n=12), IL-17F (*P<0.05, n=12), and IL-21 
(*P<0.05, n=12), in Bves–/– colons compared to WT.  
 
BVES is underexpressed in ulcerative colitis 
Based on our above observations, we hypothesized that patients with ulcerative 
colitis would have decreased BVES expression. We extracted RNA from colonic biopsies 
collected prospectively from normal controls or ulcerative colitis patients with varying 
degrees of disease activity based on histological analysis. There were no differences in 
use of 5-ASA, corticosteroids, immunomodulators or biologics between the colitis groups 
(data not shown). qRT-PCR was performed, and ddCt calculations between normal and 
disease samples revealed a 2.3-fold reduction of BVES mRNA levels in samples from 
patients with moderate/severe disease in comparison to normal controls (Figure 29). 
These data suggest that decreased BVES expression may be correlated with disease 
severity in IBD. 
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Figure 29. BVES is underexpressed in moderate to severe ulcerative colitis. BVES 
mRNA levels were determined using qRT-PCR on UC biopsy specimens. (A) BVES 
mRNA levels expressed as negative ddCt in normal (n=8), quiescent/mild UC (n=7), and 
moderate/severe UC (n=16). This represents a 2.3-fold decrease in expression in 
moderate/severe UC. 
 
Discussion 
In this study, we investigated the role of BVES in intestinal homeostasis and 
response to injury after experimental colitis. At baseline, Bves–/– mice demonstrated 
altered lineage allocation, higher intestinal proliferation, and decreased apoptosis. 
Additionally, Bves–/– colons exhibited increased permeability ex vivo, corresponding to 
prior findings that impairing BVES function alters transepithelilal resistance and 
junctional integrity in vitro. Moreover, we found that after C. rodentium-inoculation 
Bves–/– mice demonstrated exacerbated colitis. This was accompanied by an increased 
bacterial load in the Bves–/– colons. Lastly, we found that BVES expression was 
significantly downregulated in human biopsy specimens of patients with ulcerative 
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colitis, suggesting relevance to human disease and a potentially protective role for BVES 
in IBD. 
A number of studies have identified increased epithelial barrier permeability as a 
key factor in driving the pathogenesis of inflammatory bowel disease (Baumgart and 
Carding 2007; Henderson et al. 2011; Shen, Su, and Turner 2009; Turner 2009). This 
epithelial barrier dysfunction is thought to be at least in part due to compromised tight-
junctional integrity (Heller et al. 2005; Ma et al. 2004; Shen, Su, and Turner 2009; Shen 
2012; Söderholm, Olaison, and Peterson 2002; Turner 2009). Prior studies have 
demonstrated that impairing BVES function leads to alteration in tight junctional 
composition and failure to maintain tight junctional proteins such as ZO1 at the 
membrane (Osler, Chang, and Bader 2005; Russ et al. 2011; Williams et al. 2011). This 
study is the first to identify that BVES deletion increases epithelial permeability ex vivo 
and there is a biological significance to this epithelial barrier alteration as Bves–/– mice 
demonstrate increased colonization and worsened colitis after C. rodentium-inoculation.  
Citrobacter rodentium is an ideal pathogen for testing mucosal inflammation in 
the colon (Borenshtein, McBee, and Schauer 2008; Eckmann 2006). It induces superficial 
attaching/effacing lesions in the cecum and colon, with systemic infection much less 
likely when compared to other models of infectious colitis (Borenshtein, McBee, and 
Schauer 2008; Eckmann 2006). While C. rodentium infection has been known to induce 
Th1 adaptive immune responses, recent studies have identified a role for Th17 immune 
responses, as well (Chung et al. 2009; Harrington et al. 2005; Higgins et al. 1999; Maloy 
and Kullberg 2008; Mangan et al. 2006). Interferon gamma (IFN-γ) was significantly 
upregulated in the colons of Bves–/– mice relative to WT, suggestive of a polarization 
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towards Th1 immune responses (Eckmann 2006; Higgins et al. 1999; Simmons et al. 
2002). Moreover, we observed that the Bves–/– mice had increased transcript levels of IL-
17F and IL-21, cytokines produced by Th17 cells and known to have pro-inflammatory 
effects, as well as IL-6, a key driver of murine Th17 cell differentiation from naïve CD4+ 
T cells (Bettelli et al. 2006; Chung et al. 2009; Maloy and Kullberg 2008; Maloy and 
Powrie 2011). Thus, it is possible that amplified immune responses, potentially in 
response to the increased bacterial burden in the Bves–/– mice after C. rodentium 
infection, may be contributing to the worsened injury in this cohort. 
In conclusion, our findings demonstrate that BVES is critical for multiple aspects 
of intestinal homeostasis and response to injury. Specifically, BVES regulates colonic 
proliferation, apoptosis, lineage allocation, permeability, and is important to the 
maintenance of colonic epithelial integrity after colitis induction. This is the first study to 
identify that BVES is underexpressed in patients with inflammatory bowel disease and 
offers promise in better understanding mechanisms that underlie epithelial barrier 
dysfunction in IBD. 
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CHAPTER IV 
 
SUMMARY AND CONCLUSIONS 
 
Our findings from these studies have identified a previously-unrecognized role for 
BVES in maintaining intestinal epithelial integrity. While the directed aims of these 
studies have been to uncover the role of BVES in the maintenance of intestinal 
homeostasis and response to injury, these studies have broad implications beyond 
intestinal biology and specifically for the field of cancer biology. Upon initial survey, 
these findings appear to identify a differing role for BVES in the small intestine and 
colon: 1) While radiation injury modeling has uncovered a protective role for BVES 
deletion in the small intestine after radiation injury, given an expanded stem cell 
compartment at baseline and increased survival of stem cell populations supported by 
amplified Wnt signaling, 2) The deletion of BVES in the colon increases epithelial barrier 
permeability, as well as colonization and injury after inoculation with the pathogen 
Citrobacter rodentium. Nonetheless, a unifying principle of these underlying findings is 
their implications for the field of cancer biology. 
While our previous studies have identified a role for BVES in regulating Wnt 
signaling in vitro, our studies presented here demonstrate that BVES deletion in mice 
amplifies Wnt signaling in vivo at baseline and in response to injury in the small intestine, 
as well as in ex vivo cultures of intestinal crypts. While physiological Wnt signaling has 
been shown to play a critical role in the maintenance of crypt proliferation and stem cell 
maintenance, aberrant Wnt signaling is a prominent driver of a number of cancers, 
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including colorectal cancer (Clevers and Nusse 2012; Clevers 2013; J. H. van Es et al. 
2012; Pinto et al. 2003). Indeed, many studies identifying the mechanisms by which Wnt 
signaling regulates intestinal epithelial homeostasis were conducted in parallel with those 
that uncovered its role in driving colorectal carcinogenesis (Clevers and Nusse 2012; 
Clevers 2013). Additionally, given that BVES knockout mice demonstrate increased 
proliferation at baseline throughout the span of the lower gastrointestinal tract, the 
alterations in Wnt signaling may be a prominent contributor to this phenotype. Further 
investigation of how this altered Wnt signaling and increased proliferation may impact 
tumorigenesis in the intestine is certainly warranted given the known roles of each in 
driving intestinal cancers. 
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Figure 30. Putative mechanisms by which BVES regulates small intestinal integrity. 
BVES may participate in a repression circuit that attenuates Wnt signaling. Bves null 
crypts possess an expanded intestinal stem cell compartment in vivo and demonstrate 
increased stemness when cultured as miniguts ex vivo. Bves–/– mice demonstrate increased 
intestinal crypt viability after radiation injury. 
 
Additionally, our finding that BVES deletion results in an expansion of the stem 
cell compartment in the small intestine remains a potent observation. The role of stem 
cells in tumorigenesis and the existence of putative cancer cells functioning in a stem 
cell-like manner have been an intriguing and central aspect of cancer research for 
decades. Some of the earliest studies identifying the functional heterogeneity of cancer 
cells suggested the existence of a subset of cancer cells that exhibit a stem-like nature 
(Bruce and Van Der Gaag 1963; Hamburger and Salmon 1977). Recently, studies have 
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attempted to merge two competing ideas about the identity of cancer populations 
(Greaves and Maley 2012). Moreover, given the recent identification of intestinal stem 
cell markers such as Lgr5, significant advances have been made in our understanding of 
the contribution of various populations of intestinal stem cells to tumorigenesis. 
Specifically, studies have identified that Lgr5+ cells fuel the growth of established 
adenomas (Schepers et al. 2012). Identifying whether the expansion of the intestinal stem 
cell compartment is also present in the colon after BVES deletion and how such an 
expansion may affect intestinal tumorigenesis remain promising avenues of future 
investigation with concrete implications for the field of cancer biology. 
Moreover, our findings that BVES deletion protects the small intestine after 
radiation injury, given the increased crypt viability and surviving stem cell populations 
after ionizing radiation, also offers clear translational implications for cancer treatment. 
While ionizing radiation is commonly utilized to treat a number of malignancies of 
different origin and stage, it frequently presents serious side effects for rapidly 
proliferating tissues such as those of the gastrointestinal tract (Gudkov and Komarova 
2003; Shadad et al. 2013). With approximately seventy percent of patients with cancer 
receiving some form of radiation therapy, better understanding of the impact of radiation 
injury on normal tissues is an important aspect of cancer research. Radiation enteropathy, 
an intestinal injury process resulting from exposure to ionizing radiation, remains a major 
health concern in patients receiving radiation therapy for treatment of malignancies 
(Harb, Abou Fadel, and Sharara 2014). The incidence of radiation enteropathy is 
expected to continue to rise due to the unprecedented use of ionizing radiation for cancer 
treatment (Harb, Abou Fadel, and Sharara 2014; Shadad et al. 2013). The sensitivity of 
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various stem cell populations to damage from ionizing radiation is thought to have 
evolutionarily served as a protective mechanism to prevent initiation of tumorigenesis 
(Barker, van de Wetering, and Clevers 2008; Barker 2014). Studying radiation effects to 
the intestine is critical to develop better predictive biomarkers and therapeutics that 
address this radiation-related morbidity, and particularly because collateral damage to 
normal tissues frequently drives radiation dose limitations and thus represents a potential 
hurdle to effective cancer treatment (Harb, Abou Fadel, and Sharara 2014). Results from 
these studies suggest that BVES impacts intestinal crypt viability after radiation and 
could serve as a predictive biomarker of radiation response or as a potential therapeutic 
target. 
BVES was originally discovered to be a junctional-associated protein with a 
critical role in the regulation of tight and adherens junction integrity. Indeed, a number of 
studies have shown that manipulating BVES results in improper localization of a number 
of tight junction proteins such as ZO1, with other studies showing that its deletion results 
in failure to maintain adherens junction proteins such as E-cadherin at the membrane 
(Osler, Chang, and Bader 2005; Williams et al. 2011). Perturbations in junctional 
molecules, particularly adherens junction components such as E-cadherin and p120, have 
been shown by many groups to be associated with increased tumor invasiveness 
(Thoreson and Reynolds 2002; Yap 1998). Conversely, cancer cell lines that express E-
cadherin have been shown to demonstrate decreased invasiveness (Van Aken et al. 1993). 
Additionally, though less is known about tight junction regulation and cancer 
development, tight junction dysfunction has also been implicated in the development and 
progression of a number of carcinomas. A number of studies have identified that 
 81 
overexpression of claudin-1, -3, -4, and -7 is present in ovarian, colorectal, and gastric 
cancers (Dhawan et al. 2005; Hewitt, Agarwal, and Morin 2006), though other studies 
have suggested that claudin-1 functions as a tumor suppressor in gastric cancer (T. L. 
Chang et al. 2010). A common pathway by which each of these junctional proteins may 
influence tumorigenesis is through regulation of intracellular signaling pathways that 
contribute to or attenuate a protumorigenic phenotype. For example, while adherens 
junctions are known to regulate the WNT pathway, specifically through E-cadherin-
sequestration of β-catenin, tight junctions are known to regulate cytoskeletal networks 
(Rho/Rac) that are fundamental to modulation of migratory processes (Debruyne et al. 
2006; Williams et al. 2011). Moreover, both tight junctions and adherens junctions have 
been implicated in the regulation and modulation of epithelial-to-mesenchymal transition, 
a fundamental process in the metastatic progression of many cancers (Acloque et al. 
2009; Debruyne et al. 2006; Kalluri and Weinberg 2009; Williams et al. 2011; Zeisberg 
and Neilson 2009). 
Our studies have demonstrated that BVES regulates not only junctional integrity 
and epithelial permeability, but also wound healing processes and epithelial restitution in 
the intestine, which are key processes regulated by EMT. Indeed, while EMT is a critical 
feature in normal wound healing programs, there is considerable overlap between 
programs that regulate normal wound healing and those that underlie carcinogenesis and 
the metastatic progression of a number of cancers—basic processes such as proliferation, 
apoptosis, and cellular migration (Acloque et al. 2009; Kalluri and Weinberg 2009; 
Zeisberg and Neilson 2009). Some of the earliest parallels observed between wound 
healing programs and cancer programs resulted in the description of cancer as an 
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overhealing wound (Dvorak 2009; Kalluri and Weinberg 2009; Schäfer and Werner 
2008). Further investigation of the role of BVES in regulating epithelial-to-mesenchymal 
transition remains a promising avenue of research with important implications for both 
intestinal and cancer biology. 
Finally, given that BVES knockout mice have altered cytokine production at 
baseline, heightened susceptibility to inflammatory injury after C. rodentium inoculation, 
and that BVES is underexpressed in human ulcerative colitis biopsy specimens, our 
studies also carry broad implications for diseases that contribute to human cancers. 
Inflammatory injury is a key driver of many cancers, including colitis-associated 
carcinoma, with ulcerative colitis being a prominent risk factor for its development 
(Baumgart and Carding 2007; Clevers 2004; Itzkowitz and Yio 2004; Loftus and 
Sandborn 2002; Maloy and Powrie 2011).  
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Figure 31. Putative mechanisms by which BVES impacts colonic integrity. BVES 
contributes to junctional integrity in the colon. Bves–/– colons demonstrate increased 
permeability ex vivo, with increased injury and colonization after inoculation with the 
pathogen C. rodentium. Moreover, BVES is underexpressed in human ulcerative colitis 
biopsy specimens, suggesting relevance to human disease. 
 
Ultimately, these studies, which have identified a seemingly divergent role for 
BVES in regulating small intestinal and colonic integrity, are unifying in their 
implications for the field of cancer biology. As a junctional-associated protein that 
modulates Wnt signaling, small intestinal integrity after radiation injury, colonic 
inflammatory injury, as well as epithelial restitution processes and epithelial-to-
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mesenchymal transition, its continued study will have direct implications for our 
understanding of carcinogenesis and the field of cancer biology.  
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CHAPTER V 
 
FUTURE DIRECTIONS 
 
Since the discovery of BVES in 1999, much progress has been made in 
contributing to our understanding of its structure, function, and role in basic cellular 
processes. It has been shown to play a critical role in the maintenance of tight junctions 
and regulation of junctional signaling programs. Here, we demonstrate that BVES is a key 
regulator of intestinal epithelial integrity in vivo. We show that BVES regulates intestinal 
proliferation and stem cell programs, epithelial barrier integrity, and response to injury. 
However, much remains uninvestigated, and future studies of BVES and its contribution 
to intestinal homeostasis may expand our understanding of its role in basic intestinal 
biology and provide therapeutic advances for intestinal diseases. Future directions for 
these current projects can broadly be grouped into two categories: (1) further 
interrogation of the role of BVES in maintaining intestinal integrity utilizing 
complementary models of colitis, and (2) further investigation of the mechanisms by 
which BVES regulates junctional signaling. 
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Utilization of Complementary Models of Colitis and Colonic Injury 
While our current studies tested the role of BVES in the maintenance of colonic 
integrity using C. rodentium, it is one of many models that can be used to induce colitis. 
C. rodentium  is a pathogen that infects and colonizes the murine colonic epithelium in 
the same fashion that enteropathogenic Escherichia coli infects humans, and under 
histological examination, it mimics characteristics of Crohn’s disease: namely, thickening 
of the colon and transmural inflammation (Eckmann 2006). Another frequently-employed 
model of colitis is the dextran sodium sulfate (DSS) model, which induces colonic 
mucosal injury (Okayasu et al. 1990; Perše and Cerar 2012). DSS is a heparin-like 
polysaccharide that is thought to cause epithelial cytotoxicity and epithelial barrier 
disruption, resulting in weight loss, diarrhea, rectal bleeding, ulceration, and loss of 
epithelium, as well as leukocytic infiltration, and increased mucosal permeability 
(Dieleman et al. 1998; Okayasu et al. 1990; Perše and Cerar 2012). Interestingly, these 
changes are often accompanied by alterations in tight junctional components, including 
the loss or redistribution of occludin, ZO1, and various claudins (Mennigen et al. 2009; 
Poritz et al. 2007). 
Our preliminary data indicate that BVES knockout mice are more sensitive to 
DSS-induced colitis in multiple models of injury: an acute injury model in which mice 
are maintained on 4% DSS for 5 days prior to sacrifice and an injury-repair model in 
which mice are maintained on 4% DSS for 5 days and then water for 5 days prior to 
sacrifice (Figure 32). As the BVES knockout mice demonstrate increased permeability at 
baseline and worsened colitis in response to C. rodentium infection, the DSS model 
would be a complementary model with which to interrogate the role of BVES in 
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maintaining intestinal integrity after injury. Subsequent experiments would include 
employing DSS chronically, characterizing immune responses after DSS–injury, and 
determining the impact of BVES deletion on tight junction composition at baseline and 
after DSS injury. 
 
Figure 32. Bves–/– mice are more sensitive to DSS-induced colitis. (A) Hematoxylin 
and eosin (H&E) stained sections of WT and Bves–/– mice after DSS injury. (B) Acute 
injury trial with mice maintained on 4% DSS for 5 days prior to sacrifice. (C) Injury-
Repair trial with mice maintained on 4% DSS for 5 days and water for 5 days prior to 
sacrifice. *P < 0.05, **P < 0.01 
 
To understand why Bves–/– mice have increased permeability and are more 
susceptible to epithelial injury/damage in the C. rodentium model, we evaluated baseline 
chemokine/cytokine changes in Bves–/– colons as chemokines/cytokines can alter 
intestinal epithelial barrier function (Abraham and Medzhitov 2011; Matricon, Barnich, 
and Ardid 2010; Nishimura et al. 2009; Papadakis and Targan 2000; Strober and Fuss 
2011). Using RNA-seq, we identified a number of dysregulated cytokines in Bves–/– 
colons. Particularly interesting was a downregulation of IL-10ra, which has been 
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identified to have a critical, protective role in IBD (Amre et al. 2009; Glocker et al. 
2009). This finding is interesting as it has previously been shown that permeability 
deficits can exacerbate IL-10-mediated colitis (Arrieta et al. 2009; Madsen et al. 1999; 
Wang, Fang, and Hasselgren 2001). Utilization of the IL-10–/– model of enterocolitis 
would be ideal to further define the in vivo effects of BVES loss in immune-mediated 
intestinal inflammatory disease and allow for probing of epithelial-immune crosstalk 
which is heavily implicated in IBD etiology (Amre et al. 2009; Franke et al. 2008; 
Madsen et al. 1999). 
Moreover, while we show that after C. rodentium infection Bves–/– mice 
demonstrate worsened colitis, possibly in large part due to increased epithelial 
permeability, the contribution of adaptive and innate immune responses in driving this 
phenotype remains unexplored. Bves–/– mice displayed significantly elevated expression 
of IL-6 and as well as trending elevations in TNF-a, mediators of innate immunity 
(Eckmann 2006; Papadakis and Targan 2000). Bves–/– mice also demonstrated 
significantly elevated expression of IFN-γ, IL-21, and IL-17F compared to WT, 
suggestive of amplified adaptive immune responses of the Th1 and Th17 subtypes, which 
have been implicated in C. rodentium colitis (Chung et al. 2009; Maloy and Powrie 2011; 
Siegmund 2010). Multiple studies have demonstrated a key role for each in mediating 
protection from C. rodentium: innate immune responses mediate mucosal damage in C. 
rodentium infections while adaptive immunity develops to elicit bacterial clearance 
(Borenshtein, McBee, and Schauer 2008; Eckmann 2006; Khan, Ma, and Knodler 2006; 
Lebeis et al. 2007). Collectively, these data suggest that BVES loss dysregulates cytokine 
production and that BVES may modulate epithelial-immune crosstalk after C. rodentium-
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induced colitis. To further investigate the role of BVES in innate versus adaptive 
immunologic responses in inflammatory injury, utilization of a Rag2–/– mouse would be 
an ideal model and has previously been employed to interrogate the role of innate 
immunity specifically in C. rodentium-induced colitis (Satoh-Takayama et al. 2009) and 
other models of infectious colitis (Sun et al. 2013). As RAG2 deletion results in 
compromised adaptive immunity due to impaired lymphocyte development at the 
progenitor stage, the Rag2–/– model would allow us to investigate the role of BVES in 
innate immune responses during colitis (Akamatsu et al. 2003; Shinkai et al. 1992).  
Finally, given that BVES is known to regulate EMT, a critical mediator of 
physiological wound healing processes (Kalluri and Weinberg 2009; Williams et al. 
2011), investigation of the role of BVES in wound healing/epithelial restitution after 
intestinal injury would offer further insight into its role in maintaining intestinal 
homeostasis. Models of mechanical injury in which superficial biopsies are induced and 
monitored by endoscopy have been employed for probing intestinal wound healing 
processes (Seno et al. 2009). Our preliminary data indicates that the BVES knockout 
mice have impaired wound healing when compared to their WT counterparts (Figure 
33). When examining wound areas at multiple time points after injury, as well as 
parameters of morbidity, such as the presence of blood and exudate, Bves–/– mice suffer 
worse injury. Optimization of this injury model and histological assessment of colons 
post-biopsy remain future directions for this project. 
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Figure 33. Bves–/– mice demonstrate impaired wound healing. Endoscopic images of 
WT and Bves–/– colons immediately after and 4 hours following mechanical injury. 
 
Identification of Mechanisms by which BVES Regulates Junctional Signaling 
While a number of interacting proteins have been identified for BVES, the known 
interactions do not explain all of the BVES-dependent phenotypes observed. Osler et al. 
demonstrated that BVES could interact with ZO1, a tight junction protein (Osler, Chang, 
and Bader 2005). More recently, we demonstrated that BVES regulates RhoA signaling 
at least partially through its interaction with GEF-H1 and that this modulates EMT 
(Williams et al. 2011). Collectively, these data implicate BVES as a regulator of 
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junctional signaling programs that are fundamental to intestinal epithelial homeostasis 
and restitution after injury. It should be noted that these novel functions of BVES would 
not have been realized without using an unbiased approach such as the yeast-two-hybrid 
method, as examination of its primary structure reveals little information (Andrée et al. 
2000; Reese et al. 1999). It is highly likely that other BVES interacting proteins exist, and 
their identification is critical to understanding the role of BVES in normal and pathologic 
junctional biology. Because we have identified numerous BVES-dependent phenotypes 
that are not completely explained by known BVES-interacting proteins and pathways (i.e. 
WNT and RhoA signaling), we sought to identify other BVES binding partners via a 
yeast-two-hybrid (Y2H) screen. Twenty-six high probability BVES interactors were 
identified (Figure 34), including RSK1, a member of the RSK family of serine/threonine 
kinases that lie downstream of the Ras-MAPK cascade.  
 
Figure 34. PANTHER assignment of the BVES interactome. 
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RSK1 has been shown to regulate cellular proliferation, survival, and motility 
(Anjum and Blenis 2008; Larrea and Hong 2009; Romeo, Zhang, and Roux 2012), all 
cellular processes that are critical to epithelial injury recovery and influenced by BVES 
(Williams et al. 2011). This is particularly exciting as RSK1 specifically regulates RhoA 
activity (Larrea and Hong 2009), a BVES-regulated process (Smith et al. 2008; Williams 
et al. 2011), and has been identified as a key effector of Ras/ERK-mediated EMT (Doehn 
et al. 2009). Accumulating evidence indicates that Rho signaling is essential in restoring 
mucosal integrity (Cetin et al. 2004; Santos et al. 1997). We have confirmed the 
BVES:RSK1 interaction by directed Y2H. Refinement of this mapping, identification of 
the structural requirements for the BVES:RSK1 interaction, and testing the functional 
significance of this interaction would be next steps in determining if this interaction 
carries significance.  
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Appendix A 
 
SELENOPROTEIN P LOSS PROMOTES STEMNESS, OXIDATIVE DAMAGE 
AND INFLAMMATORY TUMORIGENESIS1 
 
Abstract 
Patients with Inflammatory Bowel Disease are at increased risk for colon cancer due to 
augmented oxidative stress and also have compromised antioxidant defenses secondary to 
nutritional deficiencies. Selenium, a micronutrient essential to selenoprotein production, 
is transported from the liver to target tissues via Selenoprotein P (SEPP1). Target tissues 
also produce SEPP1 where it is thought to possess an endogenous antioxidant function. 
We show that Sepp1 haploinsufficiency or mutation of either the selenium transport or 
enzymatic domain increases colitis-associated carcinogenesis with resulting increased 
genomic instability and promotion of a pro-tumorigenic microenvironment. This includes 
a marked increase in M2-polarized macrophages, indicating a role for SEPP1 in 
macrophage polarization and immune function. Furthermore, complete SEPP1 loss 
results in significantly fewer tumors, in part due to increased apoptosis. Sepp1-null “mini-
gut” cultures, in comparison to WT cultures, display increased stem cell characteristics 
coupled with increased ROS production, DNA damage, proliferation, decreased cell 
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Vallance, Wei Ning, Bobak Parang, Shenika V. Poindexter, Barbara Fingleton, Xi Chen, 
Mary K. Washington, Keith T. Wilson, Noah F. Shroyer, Kristina E. Hill, Raymond F. 
Burk, Christopher S. Williams. 2015. Selenoprotein P loss promotes stemness, oxidative 
damage and inflammatory tumorigenesis. *Co-first Authorship. 
 
 94 
survival, and modulation of WNT signaling in response to H2O2-mediated oxidative 
stress. These data demonstrate that SEPP1 influences inflammatory tumorigenesis by 
impacting genomic stability, the inflammatory microenvironment, and epithelial stem cell 
functions. 
 
Introduction 
Inflammatory Bowel Disease (IBD) primarily comprises two types of chronic 
inflammatory disorders of the intestine: Crohn’s disease (CD) and ulcerative colitis (UC). 
IBD affects approximately 1.4 million Americans, with typical onset occurring between 
15 and 30 years of age (Loftus and Sandborn 2002). While the etiology of IBD is 
incompletely understood, prevailing thought presents a model in which the interplay of 1) 
intestinal microbiota or other undefined environmental exposures; 2) genetic 
susceptibility; and 3) inappropriately sustained and severe autoimmune inflammatory 
responses leads to repetitive injury of the GI tract, resulting in a pro-tumorigenic 
microenvironment rich in reactive oxygen and nitrogen species that predisposes to colon 
cancer (Abraham and Cho 2009; Roessner et al. 2008). Colitis-associated cancer (CAC) 
risk in IBD is influenced by several factors including age of diagnosis, disease extent, and 
severity of inflammation (Herrinton et al. 2012; Jess et al. 2012; Neumann et al. 2011; 
Nguyen and Bressler 2012; Rubin et al. 2008). Importantly, as increased disease activity 
is associated with increased cancer risk, understanding modifiers of IBD severity and 
CAC risk factors are of paramount importance. 
Selenium is a trace element that is specifically incorporated into selenoproteins as 
selenocysteine through a specialized UGA codon encoded in the mRNA. Selenium 
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deficiency results in stimulation of the Wnt and Nrf2 pathways (Brigelius-Flohé and Kipp 
2013; Burk et al. 2008; Kipp et al. 2009), both heavily implicated in the pathogenesis of 
colon cancer (L.-C. Chang et al. 2013; Kim et al. 2011; Reya and Clevers 2005). 
Selenoproteins are enzymes that participate in oxidative defense and are thought to 
protect against colon cancer, especially in settings of high oxidant stress, such as chronic 
inflammatory states. Several epidemiological studies have inversely correlated nutritional 
selenium status and cancer risk, particularly in colon cancer (Shamberger and Willis 
1971). Recently, our laboratory has demonstrated that selenium deficiency in mice 
exacerbates intestinal injury in response to chemical models of colitis and increases 
tumorigenesis in CAC modeling (Barrett et al. 2013).   
SEPP1 is a major selenoprotein and is thought to serve two main roles: supplying 
tissues with selenium and acting in an antioxidant defense capacity. The transport role is 
carried out by the C-terminal domain of SEPP1, which contains nine selenocysteine 
residues (Hill et al. 2003; Schomburg et al. 2003). The antioxidant role is carried out by a 
single selenocysteine within a UxxC redox motif at amino terminal residues 40-43 (Burk 
and Hill 2005), a domain that has recently been shown to have peroxidase activity 
(Kurokawa et al. 2014). As selenoproteins are produced in a hierarchical manner based 
on selenium availability, the importance of SEPP1 is underscored by the fact that even 
under conditions of severe selenium deficiency, its production perseveres (Burk and Hill 
2005). Previous studies have shown that SEPP1 is downregulated in colorectal cancers 
(Al-Taie et al. 2004), and single nucleotide polymorphisms (SNPs) within the gene are 
associated with advanced adenoma risk (Peters et al. 2008). Because SEPP1 serves as the 
major selenium transport protein, the known effects of selenium on Wnt and Nrf2 
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signaling in target tissues may partially depend on SEPP1. The antioxidant function of 
SEPP1 also suggests that it could play a role in cancer prevention, particularly in the 
context of inflammatory cancers characterized by increased oxidative stress, such as CAC 
(Dincer et al. 2007). Indeed, the gastrointestinal tract is susceptible to oxidative damage 
resulting from direct contact of the colonic epithelium with microbial and food-derived 
reactive oxygen species (ROS), and the loss of SEPP1 might result in increased oxidative 
damage-induced tumor initiation in the colonic mucosa. This potential damage is 
augmented in the context of IBD, during which oxidative stress plays a major role 
(Dincer et al. 2007).  Thus, SEPP1 may regulate stem cell pathways and protect from 
CAC. 
In the present study, we investigated the role of SEPP1 in colonic epithelial biology 
and how its loss impacts colitis-associated carcinoma. We demonstrate that SEPP1 loss 
contributes to increases in colonic epithelial stem cell properties, decreased cell survival 
and increased oxidative DNA damage in response to oxidative stress, and modulation of 
Wnt tone in intestinal organoids. These SEPP1-dependent phenotypes ultimately 
contribute to an increase in inflammatory tumorigenesis in its complete absence or upon 
loss of either the redox active site or the selenium transport domain of SEPP1. SEPP1 
manipulation was found to alter the tumor microenvironment and genomic integrity. Our 
findings establish a critical role for SEPP1 in intestinal biology, homeostasis, injury 
response, preservation of genomic integrity, and inflammatory carcinogenesis.  
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Methods 
Ethics Statement 
This study was performed in strict accordance with the recommendations in the 
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. 
The protocol was approved by the Institute of Animal Care and Use Committee at 
Vanderbilt University (protocol number: M/10-355).  
 
Murine Carcinogenesis Protocols  
Sepp1-/- mice exhibit decreased survival on standard chow (Hill et al. 2004) and 
require selenium supplementation. Therefore, these mice were fed Torula yeast-based 
diets supplemented with 1.0 mg selenium as sodium selenite per kg. Accordingly, to 
properly control the experiment, WT and Sepp1+/- mice were also maintained on an 
identical diet. In a separate experiment, WT and Sepp1+/- mice were maintained on a 
normal selenium Torula yeast-based diet (0.25 mg per kg selenium as sodium selenite per 
kg). These diets were prepared and pelleted to our specifications (Hill et al. 2004) by 
Harlan-Teklad (Madison, WI, USA). For AOM only experiments (Figure 36A), eight- to 
twelve-week old C57Bl/6 wild type (WT) (n=4), Sepp1+/- (n=4), or Sepp1-/- (n=4) mice 
(Hill et al. 2003; Schomburg et al. 2003) were injected with 12.5 mg/kg of AOM (Sigma-
Aldrich, St. Louis, MO, USA) intraperitoneally. Mice were monitored for tumor burden 
by endoscopy once per month for 6 months and sacrificed 180 days post-AOM injection. 
For chronic DSS experiments, eight- to twelve-week old C57Bl/6 wild type (WT) (n=7), 
Sepp1+/- (n=10), or Sepp1-/- (n=10) mice (Hill et al. 2003; Schomburg et al. 2003) were 
subjected to three 5-day cycles of 3% DSS ad libitum with each cycle being followed by 
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a 16-day recovery period (Figure 36B). Mice were monitored for colonic injury by 
endoscopy 4 days into the recovery period after each DSS administration. Injury was 
evaluated based on the murine endoscopic index of colitis severity (MEICS) which 
grades mucosal thickening, vasculature pattern, granularity, exudate, and stool 
consistency (Becker, Fantini, and Neurath 2007). For AOM/DSS protocols, eight- to 
twelve-week old C57Bl/6 wild type (WT) (n=13), Sepp1+/- (n=9), or Sepp1-/- (n=11) mice 
(Hill et al. 2003; Schomburg et al. 2003) (constitutional knockout experiment with mice 
fed 1.0 mg selenium per kg diet), WT (n=16) or Sepp1+/- (n=17) (constitutional knockout 
experiment with mice fed 0.25 mg selenium per kg diet), WT (n=16) or Sepp1Δ240-361/Δ240-
361 (n=14) mice (Hill et al. 2007) (truncation experiments), WT (n=12) or Sepp1U40S/U40S 
(n=15) (Kurokawa et al. 2014) (redox motif mutant experiments) (Table 1) were injected 
with 12.5 mg/kg of AOM (Sigma-Aldrich, St. Louis, MO, USA) intraperitoneally. Three 
days post-injection, the animals were started on the first of three cycles of 3% DSS ad 
libitum. Each cycle lasted 5 days and was followed by a 16-day recovery period. During 
each cycle of recovery, colonoscopy was performed to assess injury, tumor multiplicity, 
and grade (Becker, Fantini, and Neurath 2007). All mice were sacrificed on day 70, with 
the exception of cohorts maintained on 0.25 mg selenium per kg diet, which were 
sacrificed on day 52 due to increased mortality following the third cycle of DSS. All 
tumor counts and measurements were performed in a blinded fashion under stereo-
dissecting microscopy. Histologic analysis was performed in a blinded fashion for 
severity of inflammation (Dieleman et al. 1998) and dysplasia on hematoxylin and eosin 
(H&E) stained “Swiss rolled” colons by a gastrointestinal pathologist (MKW).  
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Immunohistochemistry and immunofluorescence staining  
For SEPP1 and phalloidin staining, colons and small intestines were embedded in 
OCT media and flash frozen in liquid nitrogen. Five-micrometer sections were cut and 
SEPP1 staining was performed as described previously (Olson et al. 2008). For all other 
staining, standardized protocols were followed to ensure the integrity of the samples for 
IHC/IF applications. In brief, immediately upon sacrifice the colons were harvested, 
flushed with ice cold PBS, “Swiss rolled” without delay, and fixed in fresh neutral 
buffered 10% formalin, subsequently exchanged for 70% EtOH. Processing was 
performed at the Vanderbilt University Translational Pathology Shared Resource. Five-
micrometer sections of paraffin-embedded colons were cut and haematoxylin and eosin 
(H&E) staining was performed. For IHC cut sections were dewaxed, hydrated, and 
quenched of endogenous peroxidase activity with 0.03% hydrogen peroxide in methanol. 
Antigen retrieval was conducted using Antigen Unmasking Reagent (Vector 
Laboratories, Inc., Burlingame, California, USA) according to manufacturer’s 
instructions. After blocking, primary antibody was added [α-Ki67 (NeoMarkers), 
1:1,000; α-arginase I (ARG1, Santa Cruz), 1:500; α-IL-1β (R&D Systems), 1:40; α-F4/80 
(ABd Serotec) 1:1000; α-8-OHdG (Santa Cruz), 1:500] and incubated overnight at 4°C. 
Isotype-matched antibodies were included as negative controls. Identification of 
intratumoral apoptotic cells was conducted using the ApopTag Plus Peroxidase In Situ 
Apoptosis Kit (Chemicon, Temecula, California, USA) according to the manufacturer's 
protocol. Control slides were obtained by omitting the terminal transferase (TnT) 
enzyme. For immunofluorescence staining of proliferation, macrophages, and DNA 
damage, slides were counterstained and mounted with ProLong Gold antifade including 
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4′,6-diamidino-2-phenylindole (DAPI, Invitrogen, Grand Island, New York, USA). 
Apoptosis, proliferation, DNA damage, and M1 and M2 macrophage indices were 
generated by counting either the number of positive cells per high-powered field (HPF; 
40x objective) within each tumor or the number of positive cells per crypt in 20 crypts 
per mouse by a blinded observer. The average score was then calculated for each Swiss-
rolled colon. 
 
Colonic selenium measurements 
The determination of colonic selenium was carried out using a modification of the 
fluorometric assay of Koh and Benson (Koh and Benson 1983) developed by Sheehan 
and Gao (Sheehan and Gao 1990). Briefly, tissue was digested in nitric and perchloric 
acids and, after adjustment of pH, selenium (as selenite) was complexed with 
diaminonaphthalene. Selenium-diaminonaphthalene was extracted into cyclohexane and 
fluorescence was measured in a Perkin-Elmer LS 55 fluorometer as described previously 
(Burk et al. 2006). 
 
Western blot analysis of apoptosis and WNT pathway proteins  
Flash-frozen sections of colon (n=6 for each genotype) were lysed in RIPA buffer 
including 1x protease inhibitor cocktail (Sigma) using a rotor homogenizer (Janke & 
Kunkel IKA-Labortechnik Ultra-Turrax T25). Protein quantification was performed 
using a Pierce BCA Protein Assay Kit (Thermo) according to manufacturer’s 
instructions. Samples were suspended in loading buffer, boiled, and 40 µg was run on an 
SDS-PAGE gel for immunoblotting. The Apoptosis Antibody Sampler (mouse preferred, 
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#9930) and WNT signaling Antibody Sampler (#2915) kits (Cell Signaling Technology, 
Danvers, MA, USA) were used according to manufacturers’ protocol. Quantification was 
performed using Odyssey Imaging Software and normalized either to total caspase or β-
actin. 
 
Bone marrow macrophage polarization and analysis.  
Bone marrow macrophages were isolated and activated as has been previously 
published (Mosser and Zhang 2008; X. Zhang, Goncalves, and Mosser 2008). For the 
production of classically activated M1 macrophages, bone marrow macrophages were 
primed with 150 U/ml IFNγ for 6 hours and subsequently stimulated with 10 ng/ml LPS. 
For the production of alternatively activated M2 macrophages, bone marrow 
macrophages were treated with 20 U/ml IL13 for 12 hours. RNA was isolated using the 
RNEasy MiniKit (Qiagen, Valencia, CA, USA). 1 µg RNA was utilized to perform 
reverse transcription PCR using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA, 
USA). 1 µl of cDNA was used for qRT-PCR analysis of iNOS, IL-1β, and Ym1 using 
primers purchased from RealTimePrimers.com.  
 
Plasma SEPP1 protein determination 
Plasma SEPP1 was measured by ELISA (Hill et al. 2007). Plasma samples were 
diluted in PBST (PBS with 0.05% Tween-20) containing 2% rat plasma cleared of SEPP1 
by monoclonal antibody 8F11 as described in (Read et al. 1990). 
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Small intestinal organoid culturing 
Six centimeters of the distal small intestine were dissected, flushed with ice cold 
PBS, dissected into 1cm pieces, suspended in 5ml ice cold PBS and vortexed for 3 
seconds. PBS was removed with a pipettor and the wash repeated. Tissue was transferred 
to 5ml chelation buffer (1mM EDTA, made fresh in DPBS) and rocked for 10 minutes at 
4°C prior to washing twice with 10 ml PBS. 5 ml PBS was added and shaken gently for 2 
minutes. The supernatant from the first shake was poured off. 5 ml PBS was added and 
the shake was repeated for 2 minutes then supernatant was poured off. 5 ml fresh 
chelation buffer was added and chelation was performed for 10 minutes at 4°C with 
rocking. Crypts were filtered through a 70 µm filter into a pre-chilled 50 ml tube. The 
filter was rinsed with 5 ml cold shaking buffer (PBS with 43.3mM sucrose and 54.9mM 
Sorbitol). Complete crypts were counted and enough volume was transferred for 1200 
crypts to a pre-chilled 5 ml round-bottomed tube. Crypts were centrifuged at 150 x g for 
10 minutes at 4°C. Shaking buffer was aspirated and crypts were resuspended in 50 µl of 
Matrigel (BD Bioscience #356237, San Jose, CA, USA), per well, containing 50 ng/ml 
EGF (R&D Systems #2028-EG-200, Minneapolis, MN, USA), 100 ng/ml Noggin (R&D 
Systems #1967-NG-025/CF), 500 ng/ml R-Spondin (R&D Systems #3474-RS-050), and 
200 ng/ml Wnt3a (Millipore #GF-160, Billerica, MA, USA). Matrigel was overlayed 
with 500 µl Minigut culture media (Advanced DMEM/F12 (Invitrogen #12634-010, 
Carlsbad, CA, USA), L-Glutamine (Invitrogen #25030), Pen-Strep (Invitrogen #15140-
148), Hepes (Mediatech #25-060-CI), N2 Supplement (R&D Systems #390155), B27 
Supplement (Invitrogen #17504044). Every 4 days, media was replaced with fresh 
Minigut media plus growth factors. 
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Whole-mount 6-carboxy-2',7'-dichlorodihydrofluorescein diacetate (Carboxy-H2DCFDA) 
enteroid staining 
Enteroids were grown for 4 days post-plating. The morning of hydrogen peroxide 
treatment, enteroid media was replaced with fresh Minigut media. Either 0 µM, 400 µM, 
or 800 µM hydrogen peroxide was added directly to media. Two hours post-hydrogen 
peroxide treatment, growth media was removed from cells. Cells were treated with pre-
warmed DPBS containing either the probe carboxy-H2DCFDA (Invitrogen #mp-36103) 
or, as a negative control, carboxy-DCFDA to provide a final working concentration of 5 
mM. Enteroids were incubated at 37°C in a cell culture incubator for 1 hour. Loading 
buffer was removed and cells were returned to pre-warmed Minigut media. Cells were 
incubated at 37°C for 15 minutes. Media was removed and enteroids were fixed 
overnight at 4°C in 2% formaldehyde with gentle rocking. Fixative was removed and 
enteroids were washed twice with DPBS. Enteroids were imaged with a LSM 510 
Confocal microscope using the same specifications for imaging of all enteroids. ROS 
were quantified as staining intensity using ImageJ Image Analysis software. The graph 
represents the fold change intensity relative to WT enteroids treated with 0 µM hydrogen 
peroxide. Error bars represent the standard error of the mean for three separate 
experiments performed in duplicate. 
 
Whole-mount enteroid proliferation staining 
Proliferation was determined using the Click-iT EdU cell proliferation assay 
(Invitrogen #C-10337) according to manufacturers’ instructions. Enteroids were grown to 
4 days post-plating. Enteroid media was replaced with fresh Minigut media and either 0 
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µM or 800 µM hydrogen peroxide was added directly to media. Two hours post-
hydrogen peroxide treatment, media was replaced with fresh Minigut media and a 10 µM 
working solution of EdU was added to each well of the plate. Enteroids were incubated 
for 15 minutes under normal growth conditions. After incubation, media was removed 
and 1 ml of 2% formaldehyde in PBS was added to each well and incubated overnight at 
4°C. The fixative was removed and enteroids were washed twice with 1 ml 3% BSA in 
PBS. Wash buffer was removed and 1 ml of 0.5% Triton X-100 in PBS was added to 
each well and incubated at room temperature for 20 minutes. Click-iT reaction cocktail 
was prepared and 0.5 ml was added to each well. The wash solution was removed and 
enteroids were stained with TO-PRO-3 (1:500 in PBS for 15 minutes at room 
temperature). Enteroids were imaged with a LSM 510 Confocal microscope using the 
same specifications for imaging of all enteroids. Proliferation was quantified as EdU+ 
cells/crypt area where crypt area was determined using ImageJ Image Analysis software. 
The graph represents the fold change intensity relative to WT enteroids treated with 0 µM 
hydrogen peroxide. Error bars represent the standard error of the mean for three separate 
experiments performed in duplicate. 
 
RNAseq assay and analysis 
Tumors were dissected from WT and Sepp1-/- mice andRNA was isolated using 
the RNEasy MiniKit (Qiagen, Valencia, CA, USA). RNA integrity was determined using 
Experion RNA StdSens Analysis Kit (Bio-Rad, Hercules, CA, USA). All RNA samples 
had RNA integrity numbers (RINs) >8 and were deemed suitable for analysis. Initial raw 
sequencing data were aligned to reference mouse genome (mm10) using TopHat (version 
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2.0.8) software with default parameters (Trapnell, Pachter, and Salzberg 2009). The 
Cuffdiff software (version 2.1.1) was used to estimate read count for expression of each 
gene and to detect differentially expressed (DE) genes. For count based gene expression 
data, Cuffdiff uses the beta negative binomial model for each gene in each condition in 
order to estimate the null distribution of its log fold change under the null hypothesis 
(Trapnell et al. 2013). The p-values from Cuffdiff were adjusted by Benjamini and 
Hochberg’s method to control false discovery rate (FDR) (Benjamini et al. 2001).  
 
Statistical Methods 
Analyses comparing two groups were analyzed using the Student’s t-test, two-
tailed. One-way ANOVA and Newman-Keuls post-test was used to compare multiple 
groups. Data is presented as the mean +/- the standard error of the mean (SEM) in bar 
graphs and a line identifying the mean is shown when all data points are plotted. 
Percentages of mice displaying altered dysplasia grade were determined using Chi-square 
contingency analysis for each grade. All of these analyses were performed using 
GraphPad Prism®5.0c (San Diego, CA, USA). 
 
Results 
Loss of SEPP1 enhances both tumor promotion and initiation 
 Because SEPP1 mRNA expression is decreased as early as the adenoma stage in 
colorectal cancer (Figures 35A) (Smith et al. 2010) and in tumors of mice subjected to an 
inflammatory carcinogenesis protocol (Figures 35B), we predicted that SEPP1 loss 
would enhance tumorigenesis.  
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Figure 35. Sepp1 message is decreased in human cancer and tumors from mice 
subjected to the AOM/DSS protocol. (A) Human SEPP1 mRNA expression at various 
stages of colon tumorigenesis (10-normals, 6-adenomas, 33-Stage I, 76-Stage 2, 82-Stage 
3, 59-Stage 4 for combined total of 250 CRC samples, GSE17538). (B) Mouse Sepp1 
mRNA expression in tumors (n = 5) isolated from AOM/DSS mice relative to adjacent 
non-malignant mucosa (n = 5), normalized to GAPDH. ***P < 0.001, 2-tailed unpaired t 
test. 
 
In order to test the impact of SEPP1 loss on tumor initiation and promotion, 
respectively, we used both a six-month azoxymethane (AOM) protocol (Figure 36A) and 
a chronic dextran sodium sulfate (DSS) administration protocol (Figure 36B). AOM is a 
procarcinogen that is metabolically activated to a potent alkylating agent forming O6-
methyl-guanine (Pegg 1984). DSS serves as a tumor-promoting agent, and repeated DSS 
administration produces chronic colonic inflammation (Okayasu et al. 1996). To 
determine if SEPP1 deletion influences colonic tumorigenesis, we utilized Sepp1-/- mice. 
These mice are globally null for SEPP1, and a lack of expression can be seen in both the 
colon and small intestine as compared to WT mice (Figure 36C). Methylene blue 
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staining of colons 6 months post-AOM administration revealed an increase in aberrant 
crypt foci (ACF) in Sepp1-/- mice compared to WT mice (6.0 ± 0.6 vs 2.5 ± 0.3 
ACF/colon, P<0.001, Figure 36D), indicating a role for SEPP1 loss in tumor initiation. 
Endoscopic injury analysis of mice subjected to chronic DSS administration using the 
MEICS scoring system (Becker et al. 2005) revealed increased injury in response to DSS 
after three cycles (8.1 ± 0.4 vs 4.1 ± 0.5 MEICS score, P<0.0001, Figure 36E, left). 
Furthermore, chronic DSS treatment led to increased ACF formation in Sepp1-/- mice 
compared to both WT and Sepp1+/- mice (Sepp1-/-: 3.2 ± 0.4 vs Sepp1+/-: 2.1 ± 0.3 and 
WT: 1.9 ± 0.3 tumors/colon, P<0.05, Figure 36E, right), suggesting that complete 
SEPP1 loss exacerbates injury and tumorigenesis in response to DSS. Sepp1-/- mice also 
demonstrated decreased proliferation after chronic DSS treatment in comparison to 
Sepp1+/- and WT mice (Figure 36E, bottom) with no differences in apoptosis (data not 
shown) amongst the cohorts. 
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Figure 36: Absence of SEPP1 exacerbates tumorigenesis in response to AOM and 
injury after chronic DSS treatment. (A) Schematic of the AOM protocol utilized. Mice 
are injected with AOM and aged for 6 months before being sacrificed on day 180 post-
AOM treatment. (B) Schematic of the chronic DSS protocol utilized. Mice are subjected  
to three five-day cycles of 3% DSS ad libitum. There are 16 days of recovery between 
each DSS administration and mice are monitored for injury by endoscopy four days after 
each DSS cycle (black circles). (C) Immunofluorescent staining of SEPP1 (red) within 
the colon and small intestine of WT and Sepp1-/- mice (100x magnification). (D) Aberrant 
crypt foci counts (ACF/mouse) in WT (n = 4), Sepp1+/- (n = 4), and Sepp1-/- (n = 3) mice 
subjected to the AOM protocol. (E) Endoscopic colitis score (left), ACF counts 
(ACF/mouse, right), and Ki67 staining (bottom) in mice subjected to the chronic DSS 
protocol (7, WT; 10, Sepp1+/-; 10, Sepp1-/-). *P < 0.05, **P < 0.01, ***P < 0.001, 1-way 
ANOVA, Newman-Keuls Multiple Comparison Test.    
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Table 1: The genotypes of mice subjected to the AOM/DSS protocol and the symbols 
used for each genotype. 
  
 
SEPP1 is a haploinsufficient tumor suppressor in inflammatory carcinogenesis 
Based on the impact of SEPP1 loss on initiation in response to AOM and DSS as 
single modalities, we predicted that SEPP1 would play a critical role in ensuring tumor 
cell survival after inflammatory injury. We used the azoxymethane, repeated-dose 
dextran sodium sulfate (AOM/DSS) CAC model in WT, Sepp1+/-, and Sepp1-/- mice. As 
expected, complete loss of SEPP1 decreased colonic selenium content (Figure 37A), 
though we note that this decrease was modest, indicating that SEPP1 is not the only 
mechanism of selenium supply in the colon. Complete loss of SEPP1 led to a decrease in 
tumor multiplicity (2.7 ± 0.7 vs 5.2 ± 0.8 tumors/mouse, P=0.02, Figure 37B and Figure 
37C) and alteration in tumor size in Sepp1-/- mice compared to Sepp1+/- mice, but not WT 
mice (2.5 ± 0.4 vs 4.2 ± 0.5 mm2, P=0.01, Figure 35B and Figure 37D), suggesting that 
complete loss of SEPP1 impaired survival or proliferation of initiated epithelial cells. In 
contrast, partial loss of SEPP1 led to increased tumor multiplicity (8.3 ± 1.2 vs 5.2 ± 0.8 
tumors/mouse, P=0.03, Figure 37B, and Figure 37C) but no change in tumor size. 
However, histopathological examination suggested more advanced dysplasia in the 
Sepp1+/- mice (Figure 37E).  
Nomenclature Mouse Description 
WT Wild-type N10 C57Bl/6 
Sepp1+/- Heterozygous selenoprotein P knockout (C57Bl/6) 
Sepp1-/- Homozygous selenoprotein P knockout (C57Bl/6) 
Sepp1Δ240-361/Δ240-361 Homozygous deletion of Sepp1 amino acids 240-361 (C57Bl/6) 
Sepp1U40S/U40S Homozygous point mutation of position 40 selenocysteine to 
serine in Sepp1 (C57Bl/6) 
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Figure 37: Sepp1 haploinsufficiency augments inflammatory carcinogenesis. (A) 
Quantification of colonic selenium in WT (n = 8), Sepp1+/- (n = 5), and Sepp1-/- (n = 8) 
mice fed a selenium-supplemented (1.0 PPM) diet. (B) Representative gross colon 
images. (C) Tumor number (tumors/mouse, left) and (D) average tumor size (mm2, right) 
per mouse (17, WT; 15, Sepp1+/-; 20, Sepp1-/-). *P < 0.05, **P < 0.01, ***P < 0.001, 1-
way ANOVA, Newman-Keuls Multiple Comparison Test. (E) Representative images of 
Swiss rolled colons from each genotype (25x magnification). 
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The decrease in tumorigenesis in the Sepp1-/- mice was concomitant with 
increased apoptosis as measured by TUNEL staining (74.4 ± 10.9 vs 34.3 ± 3.1 TUNEL+ 
cells/tumor high-powered field (HPF) in WT, P<0.01, Figure 38A, left & Figures 39A 
& B, top) and western blotting for markers within the intrinsic apoptosis pathway (Figure 
38A, right & Figure 39B, bottom). Therefore, we hypothesized that decreased tumor 
multiplicity might be caused, in part, by clearance of initiated cells due to oxidative 
injury beyond that which total SEPP1 loss can compensate. This phenomenon has been 
hypothesized to play a role in the initiation process of many cancers and was recently 
demonstrated in the process of ferroptosis, a mechanism of cell death triggered via the 
production of iron-dependent ROS (Szatrowski and Nathan 1991; Yang et al. 2014). 
Moreover, proliferation was increased in Sepp1+/- tumors (85.9 ± 2.9 vs 55.6 ± 2.8 Ki67+ 
cells/tumor HPF in WT, P<0.0001, Figure 38B and Figure 39D) and decreased in 
Sepp1-/- tumors (19.0 ± 6.9 vs 55.6 ± 2.8 Ki67+ cells/tumor HPF, P<0.0001, Figure 38B 
and Figure 39D) and crypts (1.6 ± 0.2 vs 4.6 ± 0.2 Ki67+ cells/crypt, P<0.0001, Figure 
39C). These data support a role for clearance of initiated cells in Sepp1-/- tumors.   
 
Intratumoral DNA damage increases in a dose-dependent manner with decreased SEPP1 
levels 
Selenium has been identified as a potential contributor to the maintenance of 
genomic stability (Bera et al. 2013; Ferguson et al. 2012). However, the role of SEPP1 in 
DNA damage repair is unknown. We wanted to test the impact of SEPP1 deficiency on 
crypt and intratumoral DNA damage. 8-hydroxyguanine staining, a measure of oxidative 
DNA damage, demonstrated that intratumoral DNA damage increases with decreased 
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Sepp1 expression (WT: 8.1 ± 0.8, Sepp1+/-: 15.3 ± 1.5, P=0.002, Sepp1-/-: 23.3 ± 3.4 8-
hydroxyguanine+ cells/tumor HPF, P=0.0007, Figure 38C & Figure 39F), though crypt 
DNA damage was not altered when compared to WT mice in response to SEPP1 
deficiency (Figure 39E). These data suggest that, within the tumor microenvironment, 
decreasing Sepp1 expression leads to an increase in oxidative DNA damage. 
 
Figure 38: Intratumoral apoptosis and DNA damage are increased in response to 
complete Sepp1 knockout and proliferation is increased in Sepp1+/- tumors. (A) 
Quantification of intratumoral apoptosis as determined by TUNEL+ cells/tumor high-
powered field (left, HPF: 40x magnification; 6, WT; 10, Sepp1+/-; 4 Sepp1-/-). 
Quantification of cleaved caspase-3 protein normalized to caspase-3 (middle) and cleaved 
PARP protein normalized to β-actin (right). Quantification is shown as fold change 
relative to WT (n =  6 per group). (B) Quantification of intratumoral proliferation as 
determined by Ki67+ cells/tumor HPF (6, WT; 10, Sepp1+/-; 4 Sepp1-/-). (C) 
Quantification of intratumoral DNA damage as measured by 8-hydroxyguanine+ 
cells/tumor HPF (6, WT; 10, Sepp1+/-; 4 Sepp1-/-). *P < 0.05, **P < 0.01, ***P < 0.001, 
1-way ANOVA, Newman-Keuls Multiple Comparison Test. 
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Figure 39: Crypt apoptosis is increased and crypt proliferation is decreased in 
Sepp1-/- AOM/DSS-treated colons. (A) Quantification (left) and images (right) of crypt 
apoptosis (average TUNEL+/crypt; WT, 7; Sepp1+/-, 6; Sepp1-/-, 7). Intratumoral protein 
expression of cleaved caspase-3, caspase-3, cleaved PARP, and β-actin as a loading 
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control with three replicates within each genotype (bottom right). (B) Representative 
images of TUNEL staining within the tumor high-powered field. (C) Quantification (left) 
and representative images (right) of crypt proliferation (average ki67+/crypt; WT, 8; 
Sepp1+/-, 5; Sepp1-/-, 8). (D) Representative images of ki67 staining within the tumor 
high-powered field. (E) Quantification (left) and representative images (right) of DNA 
damage (average 8-OHdG+/crypt; WT, 8; Sepp1+/-, 5; Sepp1-/-, 8). (F) Representative 
image of 8-hydroxyguanine staining within the tumor high-powered field. All images 
were taken at 40x magnification. *P < 0.05, **P < 0.01, ***P < 0.001, 1-way ANOVA, 
Newman-Keuls Multiple Comparison Test. 
 
Pro-tumorigenic M2 macrophage polarization is increased in Sepp1+/- tumors 
 The most significantly-induced gene after polarization of macrophages to the M2 
phenotype is SEPP1 (Bosschaerts et al. 2008; Ghassabeh et al. 2006; Solinas et al. 2010). 
Moreover, proinflammatory cytokines induce iNOS, which results in down-regulation of 
SEPP1 (Speckmann et al. 2010). To determine if SEPP1 influences macrophage 
phenotypes and inflammation, we analyzed tumors from WT, Sepp1+/- and Sepp1-/- mice 
post-AOM/DSS for macrophage polarization. Immunohistochemistry of tumors for the 
pan-macrophage marker F4/80 and either the M1 macrophage marker IL-1β or the M2 
macrophage marker Arginase I (Arg1) revealed an increase of total macrophages in 
Sepp1+/- tumors (WT: 13.1 ± 1.3, Sepp1+/-: 23.2 ± 3.0, P<0.01, Sepp1-/-: 13.1 ± 0.8 F4/80+ 
cells/tumor HPF, Figure 40A), apparently resulting from an increased M2 macrophage 
presence (WT: 8.4 ± 0.8, Sepp1+/-: 18.0 ± 3.9, Sepp1-/-: 8.3 ± 1.1 F4/80+/ArgI+ cells/tumor 
HPF, Figure 40C) as M1 macrophage numbers remain unaltered (Figure 40B). 
Interestingly, Sepp1-/- tumors did not demonstrate increased M2 polarized macrophage 
infiltration. In order to determine whether this effect was due to recruitment or 
polarization, we isolated bone marrow macrophages from WT, Sepp1+/-, and Sepp1-/- 
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mice and treated with IFNγ and LPS to polarize to the M1 and IL-13 to polarize to the 
M2 phenotype. Analysis of M1 markers iNOS and IL-1β demonstrated decreased M1 
polarization in Sepp1+/- macrophages (iNOS: 19,494 ± 593.8 vs 14,961 ± 782.3 fold 
change, P<0.001, IL-1β: 337.6 ± 0.78 vs 225.1 ± 20.66 fold change, P<0.001, Figure 
40D), while the M2 marker Ym1 indicated increased polarization to M2 (13.1 ± 3.3 vs 
26.6 ± 0.3, P<0.001, Figure 40E). These data indicate that Sepp1 haploinsufficiency 
leads to altered macrophage polarization upon directed stimulation, a phenotype observed 
in vivo in the inflammatory infiltrates in Sepp1+/- tumors. Therefore, it is possible that 
altered immune responses may contribute to a pro-tumorigenic microenvironment in 
these mice.   
 
Figure 40: SEPP1 regulates pro-tumorigenic M2 macrophage polarization. 
Quantification of (A) intratumoral total macrophage staining as determined by F4/80+ 
cells/tumor HPF. (B) M1 macrophage staining as determined by F4/80+/IL-1β+ 
cells/tumor HPF. (C) M2 macrophage staining as determined by F4/80+/ArgI+ 
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cells/tumor HPF (8, WT; 12, Sepp1+/-; 8, Sepp1-/-). (D) iNOS (left, n = 5 per genotype) 
and IL-1β (right, n = 6 per genotype). (E) Ym1 mRNA expression (n = 6 per group) in 
WT, Sepp1+/-, and Sepp1-/- in vitro-activated bone marrow macrophages. Graphs 
demonstrate fold change in expression relative to unstimulated (US) WT macrophages 
normalized to Gapdh. *P < 0.05, **P < 0.01, ***P < 0.001, 1-way ANOVA, Newman-
Keuls Multiple Comparison Test.  
 
Loss of the selenium-rich C-terminal domain of SEPP1 promotes inflammatory 
tumorigenesis 
 SEPP1 is considered to be a selenium transport protein, and deletion of the 
selenium-rich C-terminal domain (Sepp1Δ240-361/Δ240-361) results in severe selenium 
deficiency in the brain and testes of mice (Hill et al. 2007). Colonic selenium levels were 
also decreased in Sepp1Δ240-361/Δ240-361 mice (394.5 ± 19.6 vs 260.2 ± 10.6 ng selenium/g 
colon, P=0.0001, Figure 41A), yet the presence of selenium suggests that while SEPP1 
contributes to selenium delivery to the colon, it is not the sole source. Because selenium 
has been implicated in DNA damage repair via regulation of p53 (Seo, Kelley, and Smith 
2002), WNT and Nrf2 signaling, and modification of several cancer types including 
colorectal, lung, laryngeal, hepatic, and prostate (Connelly-Frost et al. 2009; Jaworska et 
al. 2013; Kasaikina et al. 2013; Steinbrecher et al. 2010), we determined whether the loss 
of the selenium-rich domain of SEPP1 would contribute to tumorigenesis. We subjected 
WT and Sepp1Δ240-361/Δ240-361 mice to the AOM/DSS protocol and analyzed them for 
tumor burden. We found that SEPP1 truncation resulted in an increase in tumor number 
(7.9 ± 1.4 vs 3.9 ± 0.7 tumors/mouse, P=0.02, Figure 41B). We have previously 
determined that selenium deficiency results in increased dysplasia grade in this model 
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(Barrett et al. 2013). Similarly, tumor grade was more advanced in Sepp1Δ240-361/Δ240-361 
(P<0.05, Figure 41C) mice. 
Along with an increase in tumor number, we also observed an increase in 
intratumoral proliferation (20.3 ± 2.2 vs 13.4 ± 1.7 Ki67+ cells/tumor HPF, P=0.04, 
Figure 41D & Figure 42), but no change in crypt proliferation (Figure 44A) or crypt or 
tumor apoptosis (Figures 43B & C). Consistent with a role of selenium in DNA damage, 
there was an increase in crypt (1.0 ± 0.08 vs 0.7 ± 0.04 8-OHdG+ cells/crypt, P=0.02, 
Figure 41E & Figure 42B) and intratumoral (29.8 ± 2.8 vs 17.1 ± 2.7 8-OHdG+ 
cells/tumor HPF, P=0.01, Figure 41F & Figure 42C) DNA damage indices in mice 
lacking the selenium-rich C-terminal domain. These data suggest that the selenium-rich 
domain of SEPP1 may protect from tumor initiation by preserving genomic integrity. 
 
Mutation of the redox active selenocysteine in SEPP1 promotes inflammatory 
tumorigenesis 
 Residues 40-43 of the N-terminal domain of SEPP1 comprise a UXXC redox 
motif that acts as a peroxidase (Burk and Hill 2005; Kurokawa et al. 2014). As such, 
SEPP1 may contribute to antioxidant activity independent of its roles in selenium 
transport. In order to test whether loss of this antioxidant domain would modify 
tumorigenesis, we subjected mice in which the selenocysteine (U) at amino acid 40 was 
mutated to an enzymatically dead serine (S) (Sepp1U40S/U40S) to the AOM/DSS protocol. 
SEPP1-mutated mice displayed increased tumor number (7.3 ± 1.1 vs 3.8 ± 0.7 
tumors/mouse, P=0.02, Figure 41G) and tumor size (3.1 ± 0.3 vs 1.6 ± 0.2 mm2, 
P=0.002, Figure 41H). This increase in tumorigenesis was likely at least partially 
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dependent upon an increase in crypt proliferation (0.5 ± 0.04 vs 0.3 ± 0.02 Ki67+ 
cells/crypt, P=0.0009, Figure 41I & Figure 44A) and intratumoral proliferation (33.5 ± 
2.6 vs 15.2 ± 1.6 Ki67+ cells/tumor HPF, P<0.0001, Figure 41J & Figure 44B), despite 
no changes in apoptosis (Figure 45A & B). We did note an increase in crypt DNA 
damage (0.6 ± 0.02 vs 0.3 ± 0.03 8-OHdG+ cells/crypt, P<0.0001, Figure 41K & Figure 
44C) and intratumoral DNA damage (28.7 ± 2.6 vs 10.8 ± 1.2 8-OHdG+ cells/tumor HPF, 
P<0.0001, Figure 41L & Figure 44D) in the SEPP1-mutated mice, suggesting that the 
redox site of SEPP1 contributes to protection from DNA damage. 
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Figure 41: Both the selenium-rich region and putative antioxidant domain of SEPP1 
protect from inflammatory tumorigenesis. (A) Quantification of colonic selenium in 
WT (n = 6) and Sepp1Δ240-361/Δ240-361 (n = 6) mice. (B) Number of tumors per mouse (16, 
WT; 15, Sepp1Δ240-361/Δ240-361). *P < 0.05, ***P < 0.001, 2-tailed unpaired t test. (C) 
Percentage of total tumors per genotype with either high grade dysplasia (HGD, black) or 
low grade dysplasia (LGD, white) (top) (n = 15 per group, ***P < 0.001, Chi-square 
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contingency analysis) and representative images from tumors of the given genotypes (40x 
magnification, bottom). (D) Quantification of intratumoral proliferation as measured by 
Ki67+ cells/tumor HPF (12, WT; 17, Sepp1Δ240-361/Δ240-361). (E) Crypt DNA damage as 
measured by 8-hydroxyguanine+ cells/crypt averaged from 20 crypts within each mouse 
(8, WT; 9, Sepp1Δ240-361/Δ240-361). (F) Intratumoral DNA damage as measured by 8-
hydroxyguanine+ cells/tumor HPF (8, WT; 17, Sepp1Δ240-361/Δ240-361). (G) Number of 
tumors and (H) average tumor size within either WT (n = 12) or Sepp1U40S/U40S (n = 16) 
mice. (I) Quantification of crypt proliferation as measured by Ki67+ cells/crypt averaged 
from 20 crypts within each mouse (8, WT; 8, Sepp1U40S/U40S) (J) intratumoral proliferation 
as measured by Ki67+ cells/tumor HPF (11, WT; 19 , Sepp1U40S/U40S), (K) crypt DNA 
damage as measured by 8-hydroxyguanine+ cells/crypt averaged from 20 crypts within 
each mouse (8, WT; 8, Sepp1U40S/U40S), and (L) intratumoral DNA damage as measured 
by 8-hydroxyguanine+ cells/tumor HPF (9, WT; 8, Sepp1U40S/U40S). *P < 0.05, **P < 
0.01, ***P < 0.001, 2-tailed unpaired t test. 
 
 
 
Figure 42: Proliferation and DNA damage are increased in Sepp1Δ240-361/Δ240-361 
colons post-AOM/DSS administration. (A) Representative intratumoral proliferation 
staining as determined by ki67 positivity. (B) Crypt and (C) intratumoral DNA damage as 
measured by 8-hydroxyguanine staining. Images taken at 40x magnification. 
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Figure 43: Crypt proliferation and crypt and tumor apoptosis are unaltered in 
Sepp1Δ240-361/Δ240-361 colons. (A) Quantification of crypt proliferation (ki67+ cells/crypt; 
WT, 8; Sepp1Δ240-361/Δ240-361, 7). (B) Quantification of crypt (TUNEL+ cells/crypt; WT, 8; 
Sepp1Δ240-361/Δ240-361, 8) and (C) intratumoral (TUNEL+ cells/tumor HPF; WT, 5; 
Sepp1Δ240-361/Δ240-361, 13) apoptosis. 
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Figure 44: Proliferation and DNA damage are increased in colons of Sepp1U40S/U40S 
mice. (A) Representative images of proliferation in crypts (ki67+ cells/crypt) and (B) 
tumors (ki67+ cells/tumor HPF). (C) Representative images of DNA damage in crypts (8-
OHdG+ cells/crypt) and (D) tumors (8-OHdG+ cells/tumor HPF). HPF is 40x 
magnification. 
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Figure 45: Apoptosis is unaltered in colons of Sepp1U40S/U40S mice post-AOM/DSS 
protocol. (A) Quantification of crypt (TUNEL+ cells/crypt; WT, 7; Sepp1U40S/U40S, 7) and 
(B) intratumoral (TUNEL+ cells/tumor HPF; WT, 6; Sepp1U40S/U40S, 17) apoptosis in 
colons of mice treated with the AOM/DSS protocol. 
 
Sepp1 haploinsufficiency-driven CAC persists in mice fed normal selenium diets 
Sepp1-/- mice require selenium supplementation to survive (Hill et al. 2004); 
therefore all of the above experiments were conducted in the setting of supranutritional 
selenium levels. Our results indicate that Sepp1 haploinsufficiency augments 
tumorigenesis. We next determined whether Sepp1 heterozygosity would also augment 
tumorigenesis if mice were maintained on a normal selenium diet (0.25 PPM selenium). 
Sepp1+/- mice demonstrated an increase in tumor number when determined by both 
endoscopy (9.8 ± 1.2 vs 4.6 ± 0.8 tumors/mouse, P<0.01, Figure 46A, B) and analysis of 
tumor burden at sacrifice (11.6 ± 1.0 vs 5.5 ± 0.9 tumors/mouse, P<0.001, Figure 46C, 
D), and in general, these tumors were also larger than those observed in WT colons 
(P<0.05, Figure 46E). When comparing overall survival of cohorts maintained on a 
normal selenium diet (0.25 PPM selenium) versus selenium supplemented diet (1.0 PPM 
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selenium), cohorts maintained on selenium-supplemented diet demonstrated a significant 
survival benefit (P<0.001, Figure 46F). These results may have potential translational 
implications, as the 0.25 PPM diet more closely approximates selenium levels in the 
typical Western diet. 
 
Figure 46: Sepp1 haploinsufficiency-driven CAC persists in mice maintained on 
normal selenium diets. (A) Endoscopic images of WT and Sepp1+/- colons after the 
second cycle of DSS administration. (B) Endoscopic tumor burden quantitative 
assessment (11, WT; 13, Sepp1+/-). (C) Gross representative images of tumors (D) and 
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tumor counts at necropsy (11, WT; 13, Sepp1+/-). 2-tailed unpaired t test. (E) Tumor size 
distribution. Unpaired t test with Welch’s correction. *P < 0.05, **P < 0.01, ***P < 
0.001. (F) Survival analysis of AOM/DSS-treated mice maintained on the indicated diets. 
Unpaired t test with Welch’s correction, *P<0.05, **P<0.01, ***P<0.001. 
 
Absence of SEPP1 augments stem cell properties and reduces the ability of enteroids to 
survive in response to hydrogen peroxide 
 SEPP1 regulates oxidative stress and toxicity (Arteel et al.; Xiao et al. 2013), and 
consistent with a function in WNT signaling, has been shown to play a role in 
differentiation and stem cell properties (Sampson et al. 2011; Y. Zhang and Chen 2011). 
Recently, a model for epithelial crypt growth has been established based on the isolation 
of stem cells from the small intestinal crypt. From single crypts, complex structures can 
be grown in vitro that closely resemble their ex vivo counterparts (enteroids) (Sato and 
Clevers 2013). Using this model system, we sought to determine how SEPP1 influences 
intestinal epithelial biology. Importantly, Sepp1 expression in intestinal organoids was 
similar to expression in both the colon and the brain, a tissue known to produce high 
levels of SEPP1 (Steinbrenner and Sies 2013), indicating these cultures would accurately 
recapitulate an in vivo setting (Figure 47A).  
  Enteroids can be grown from a single stem cell or complete crypts (Fuller et al. 
2012), and the “stemness” of enteroids have been measured by several growth parameters 
(Durand et al. 2012; Farin, Van Es, and Clevers 2012; Sato, van Es, et al. 2011). For 
instance, augmented stem cell survival can be measured by an increase in the number of 
crypts that survive plating versus the total number of crypts plated (plating efficiency). 
Furthermore, the percentage of branching enteroids or stem spheroids present at certain 
time points can establish the differentiation capacity of the stem cells and the extent of 
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stem cell signaling, respectively. Finally, the number of branches within each enteroid 
indicates the ability of the stem cells to self-propagate and establish new crypts. To 
determine if Sepp1 contributes to epithelial cell growth and stem cell function at baseline, 
we analyzed Sepp1-/- enteroids for each of these properties (plating efficiency: 96.5 ± 2.4 
% enteroids of total crypts plated, branching enteroids: 61.5 ± 1.8 % branching enteroids, 
stem spheroids: 14.5 ± 0.2 % stem spheroids, number of branches: 3.2 ± 0.2 number of 
branches per branching enteroid, Figure 47B) and observed increased stem cell fitness 
and growth abilities compared to WT enteroids (plating efficiency: 65.5 ± 2.0 % 
enteroids of total crypts plated, P<0.0001, branching enteroids: 42.1 ± 2.4 % branching 
enteroids, P=0.02, stem spheroids: 7.6 ± 0.9 % stem spheroids, P=0.002, number of 
branches: 1.9 ± 0.1, P=0.003, Figure 47B).  
Because SEPP1 serves as a peroxidase in vitro (Kurokawa et al. 2014), we next 
determined the response of Sepp1-/- enteroids to hydrogen peroxide treatment. Analysis of 
ROS produced after treatment with hydrogen peroxide revealed a decreased ability of 
Sepp1-/- small intestine to respond to oxidative stress, as demonstrated by increased 
carboxy-H2DCFDA staining intensity (800 µM H2O2: 1.6 ± 0.4 vs 3.3 ± 0.4 fold-change 
intensity relative to 0 µM H2O2 WT, P=0.04, Figure 47C); however, there was no change 
in staining intensity of the oxidative-insensitive analogue carboxy-DCFDA. Moreover, 
baseline proliferation was increased in Sepp1-/- enteroids (1.0 ± 0.06 vs 1.4 ± 0.1 fold-
change EdU+ cells/crypt area relative to 0 µM H2O2 WT, P<0.05, Figure 47D) and while 
treatment with hydrogen peroxide resulted in decreased Sepp1-/- proliferation compared 
to untreated null enteroids (1.4 ± 0.1 vs 0.9 ± 0.09 fold-change EdU+ cells/crypt area 
relative to 0 µM H2O2 Sepp1-/-, P<0.01, Figure 47D), Sepp1-/- enteroids retained 
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increased proliferation compared to WT enteroids (0.4 ± 0.09 vs 0.9 ± 0.09 fold-change 
EdU+ cells/crypt area relative to 0 µM H2O2 WT, P<0.05, Figure 47D). Finally, Sepp1-/- 
enteroids demonstrated decreased survival in response to multiple daily administrations 
of hydrogen peroxide (P=0.005, Figure 47E). These data indicate that absence of SEPP1 
increases baseline stem phenotypes and proliferation and compromises the antioxidant 
potential of enteroids. These data are particularly compelling because they indicate an 
epithelial cell-autonomous role for SEPP1 in processes that would likely contribute to 
tumorigenesis in CAC, a cancer characterized by increased microenviromental oxidative 
stress. 
 
 
Figure 47: Sepp1-/- enteroids display increased stem cell characteristics and ROS 
production, proliferation, and decreased survival after oxidative stress. (A) Sepp1 
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mRNA expression in tissue isolated from WT mice (n = 3/group). Fold change 
expression normalized to Gapdh and relative to colonic Sepp1 expression. 1-way 
ANOVA, Newman-Keuls Multiple Comparison Test. (B) Percentage of surviving 
enteroids one day post-plating, percent of branching enteroids and stem spheroids 
counted three days post-plating, and average number of branches per branching enteroid 
at four days post-plating (n = 4/group /experiment). 2-tailed unpaired t test. (C) ROS 
quantification by carboxy-H2DCFDA staining intensity measured 2 hours post-treatment 
with H2O2. Fold change in intensity relative to WT enteroids treated with 0 µM H2O2 
(left, n = 4/group). Representative images of the single carboxy-H2DCFDA channel and 
merged carboxy-H2DCFDA and TO-PRO3 channels in WT and Sepp1-/- enteroids treated 
with either 0 µM or 800 µM H2O2 (100x magnification, right). (D) Proliferation as 
determined by EdU+ cells/crypt area within WT and Sepp1-/- enteroids after two hours of 
treatment with either 0 µM or 800 µM H2O2 (left, n = 4/group with analysis of 10 
enteroids/genotype) and representative images of EdU staining in WT and Sepp1-/- 
enteroids post-treatment with either 0 µM or 800 µM H2O2 (100x magnification, right). 1-
way ANOVA, Newman-Keuls Multiple Comparison Test. (E) Survival curves for WT 
(red), Sepp1+/- (blue), and Sepp1-/- (black) enteroids after daily treatment with 400 µM 
H2O2. *P < 0.05, **P < 0.01, ***P < 0.001. 
 
Wnt signaling and oxidative stress gene signatures are altered in Sepp1-/- epithelium 
 Enteroids rely on the addition of growth factors EGF, Noggin, and R-spondin for 
growth and differentiation (Sato and Clevers 2013). As Sepp1-/- enteroids demonstrate 
increased stem cell properties and fitness, we next determined growth factor dependency 
of Sepp1-/- enteroids. Depletion of EGF, Noggin, and R-spondin resulted in similar 
decreases in survival in all three genotypes, indicating that all three pathways are 
important for enteroid persistence (Figure 48A). 
In order to acquire an unbiased understanding of transcriptome changes within 
tumors of Sepp1-/- mice, we performed RNAseq analysis of tumors isolated from WT and 
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Sepp1-/- mice subjected to the AOM/DSS protocol. Ingenuity pathway analysis indicated 
that the Wnt pathway was among the most significantly-altered canonical pathways 
(Figure 49), as Sepp1-/- tumors demonstrated increases in TGFβR3, APPL2, SFRP-4 and 
-5, and Cdh2 expression, among other abnormalities (Table 2, Figure 50). As further 
validation of altered Wnt signaling in these tumors, protein analysis demonstrated 
increased expression of the Wnt targets LEF-1, Cyclin D1, and MMP-7 upon loss of 
Sepp1 expression (Figure 48B). We next determined whether SEPP1 loss influenced 
production of other oxidative defense genes. First, we tested for compensation by other 
selenoproteins at the RNA level and did not observe differences in their message between 
WT and Sepp1-/- tumors. We did, however, note significant alterations in several 
cytochrome P450 gene family members as well as beta-hydroxysteroid dehydrogenase 
genes (Figure 51), suggesting that other antioxidant genes are upregulated in an attempt 
to compensate for SEPP1 loss.  
	
 
Figure 48: WNT signaling plays a pivotal role in the Sepp1-/- phenotype. (A) Survival 
curves in response to growth factor depletion in WT, Sepp1+/-, and Sepp1-/- enteroids. (B) 
Quantification of WNT proteins LEF-1, Cyclin D1, and MMP-7 normalized to β-actin. 
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Quantification is shown as fold change relative to WT (left) and representative images of 
blots from three individual tumors from each genotype (right). 
 
   
Figure 49: Ingenuity pathway analysis of alterations in Canonical Signaling in 
Sepp1-/- tumor RNAseq data relative to WT data. The Wnt pathway was one of the 
most significantly altered pathways (highlighted in red). 
 
 
Table 2: Ingenuity Pathway Analysis of Sepp1-/- tumor RNAseq data relative to WT 
data. Select genes from the WNT signaling pathway that are overexpressed in Sepp1-/- 
tumors. 
Gene 
Symbol 
Gene Name Fold 
Change 
P-value 
TGFbR3 Transforming growth factor b-3 3.4 5.00E-
05 
APPL2 Adapter protein containing PH domain, PTB 
domain and leucine zipper motif 2 
2.4 0.0015 
SFRP4 Secreted frizzled-related protein 4 2.7 0.00015 
SFRP5 Secreted frizzled-related protein 5 2.9 5.00E-
05 
Cdh-2 Cadherin-2 2.1 0.00035 
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Figure 50: Ingenuity pathway analysis of Sepp1-/- tumor RNAseq data relative to 
WT data. WNT pathway alterations demonstrated in a pathway map. Genes highlighted 
with red are overexpressed and genes highlighted with green are suppressed. Intensity of 
color indicates extent of expression where darker color indicates a greater expression 
change. 
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Figure 51: Oxidoreductase proteins are alternatively regulated at the mRNA level in 
Sepp1-/- tumors, but expression of other selenoproteins is unaltered. (A) RNAseq 
analysis of significantly-altered antioxidant genes. 
 
Discussion 
 The efficacy of antioxidants as chemopreventive agents of malignancy in the 
general population has been disappointing. However, most studies have been conducted 
in the setting of relatively normal selenium levels, which ensures sufficient production of 
the majority of selenoproteins. Patients with inflammatory bowel disease are reported to 
be selenium deficient, potentially skewing selenoprotein production. Our findings suggest 
that modifying production of selenoproteins (i.e. SEPP1) in IBD patients may impact 
cancer risk. Here we show that reduced levels of a major selenoprotein, SEPP1, results in 
increased colonic epithelial stem cell properties, increased oxidative DNA damage, and 
increased Wnt signaling. These SEPP1-dependent phenotypes ultimately contribute to an 
increase in inflammatory tumorigenesis upon loss of either the redox active site or the 
selenium transport domain of SEPP1, via its effects on the tumor microenvironment and 
preservation of genomic integrity. These data establish a critical role for SEPP1 in 
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intestinal biology, homeostasis, injury response, preservation of genomic integrity, and 
inflammatory carcinogenesis. 
 Induction of several signaling pathways have been linked to selenium depletion, 
including Nrf2 (Burk et al. 2008) and Wnt (Brigelius-Flohé and Kipp 2013), and there is 
little known about the contribution of SEPP1 to the observed alterations in these 
pathways. We therefore performed an unbiased RNAseq analysis of tumors from WT and 
Sepp1-/- mice post-AOM/DSS protocol. Amongst the most severely-altered pathways in 
response to SEPP1 loss was the Wnt pathway. While genes were both up- and down-
regulated in this pathway, some of particular importance included modulators of Wnt 
signaling (SFRP4 & SFRP5), the transcriptional effector LEF/TCF, and the Wnt target 
MMP-7, which we also validated at the protein level. Genes that demonstrated increased 
expression included those coding for the TGF-β receptor, N-cadherin, and the liver 
receptor homologue-1 (LRH-1), which is important for maintaining stem cell 
pluripotence during development (Gu et al. 2005). Importantly, Ingenuity Pathway 
Analysis (IPA) identified the Wnt/β-catenin signaling pathway as being stimulated in 
Sepp1-/- tumors. This is of particular importance because SEPP1 is a selenium transporter, 
and selenium deficiency leads to an increase in Wnt signaling, suggesting that the 
selenium transport function of SEPP1 may contribute to Wnt modulation. 
 An extensive literature has implicated selenium in the modulation of immune 
processes, particularly in relation to macrophage activity (Carlson et al. 2009, 2010; 
Vunta et al. 2008). We noted an increase in M2 polarized macrophages in tumors of 
AOM/DSS treated Sepp1+/- mice and hypothesized that this was due to an effect of 
SEPP1 on macrophage polarization. Isolation of bone marrow macrophages from 
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Sepp1+/- mice and subsequent polarization with either IFNγ and LPS (M1) or IL-13 (M2) 
resulted in deficits in expression of the M1 markers iNOS and IL-1β and increased 
expression of the M2 marker Ym1. This altered polarization may contribute to 
tumorigenesis by altering the tumor microenvironment in Sepp1+/- mice. As such, SEPP1 
may reduce inflammatory tumorigenesis by attenuating pro-inflammatory immune cell 
activation. This is especially important to note when considering the potential positive 
impact of selenium supplementation on patients with nutritional deficiencies due to 
diseases such as IBD. 
The influence of plasma SEPP1 on delivery of selenium to target tissues has been 
extensively studied (Burk et al. 2006; Hill et al. 2007). Our enteroid studies demonstrate 
a role for tissue-produced SEPP1 in intestinal biology, as loss of intestinal epithelial cell-
autonomous Sepp1 impacts cellular growth, differentiation, and response to ROS. 
Because it is a secreted protein, we hypothesize that SEPP1 provides localized 
antioxidant benefit to the proximate epithelial microenvironment. It was recently shown 
that SEPP1 antioxidant capacity is due, at least in part, to its ability to act as a substrate 
for thioredoxin reductase-1, which catalyzes NADPH oxidation (Kurokawa et al. 2014). 
From these studies, we postulate that extracellular SEPP1 within the near-cell 
environment may be cooperating with intracellular selenoproteins such as thioredoxin 
reductase-1, Gpx2, and Gpx4 to protect the epithelium from oxidative damage. 
 Whether selenium supplementation is of potential value in reducing cancer risk 
has been studied. The U.S. case-control SELECT study did not demonstrate any clear 
association between serum selenium levels and the risk of recurrent CRC (Lippman et al. 
2009), and a meta-analysis of intervention trials concluded that oral administration of 
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antioxidants including selenium were not effective in preventing colorectal neoplasia in 
the general population (Papaioannou et al. 2011). A major limitation of these studies, 
however, was patient selection, as patients in both studies had near-normal selenium 
levels. Our data suggest that targeted supplementation in populations known to be 
selenium deficient might be an effective prevention strategy. IBD patients are selenium 
deficient as measured by both plasma selenium and SEPP1 levels (Ojuawo and Keith 
2002). Furthermore, the plasma concentration of SEPP1 is reduced 53% in patients with 
CD compared to healthy controls (Andoh et al. 2005). This suggests that patients with 
IBD are selenium deficient to such an extent that selenium supplementation might 
increase SEPP1 levels and subsequently reduce risk of CAC arising from IBD. Indeed, in 
line with the idea of a protective role for selenium supplementation, our study 
demonstrated a significant survival benefit in cohorts of mice that were on high selenium 
diet in comparison to those on normal selenium diet when subjected to an AOM/DSS 
inflammatory carcinogenesis protocol. 
 Importantly, several SNPs have been identified in SEPP1 that might contribute to 
decreased expression in tumors. For instance, SNPs in SEPP1 are associated with 
decreased plasma SEPP1 in men and increased prostate cancer risk (Cooper et al. 2008; 
Steinbrecher et al. 2010). Furthermore, four SEPP1 variants have been significantly 
associated with advanced colorectal adenoma risk including the variant SEPP1 -4166G 
which exists within the promoter region, two loci in the 3’ region of SEPP1, and a third 
locus in the 3’ region of SEPP1 which is inversely associated with risk of colorectal 
adenoma (Peters et al. 2008). Additionally, genetic instability has been observed within 
the (T)17 repeat motif within the SEPP1 promoter in CRC to the mutator phenotype. 
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Thus, this SEPP1 repeat structure may be of functional relevance to SEPP1 gene 
expression and thus modify tumorigenesis (Al-Taie et al. 2002). A mechanism by which 
some of these polymorphisms may alter SEPP1 status is by either altering expression or 
proportions of SEPP1 isoforms. Several functional polymorphisms in the SEPP1 gene 
have been shown to influence isoform expression, and it is thought that increased 
expression of the 60 kDa isoform of SEPP1 may increase selenoprotein synthesis and 
decrease CRC risk (Méplan et al. 2009). Thus, genotyping of SEPP1 in patients with 
CAC may indicate increased responsiveness to selenium supplementation. 
In conclusion, we demonstrate a cell-autonomous role for SEPP1 in the intestinal 
epithelium and that its reduction, in vivo, augments inflammatory carcinogenesis. These 
in vivo effects occur via independent enzymatic and transport activities. Our studies 
establish a critical role for SEPP1 in intestinal biology, homeostasis, injury response, 
preservation of genomic integrity, and inflammatory carcinogenesis and suggest that 
SEPP1 could serve as a therapeutic target in the prevention of CAC.  
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Appendix B 
 
TRANSCRIPTIONAL CO-REPRESSOR MTG16 REGULATES SMALL 
INTESTINAL CRYPT PROLIFERATION AND CRYPT REGENERATION 
AFTER RADIATION-INDUCED INJURY2	
	
Abstract	
Myeloid translocation genes (MTGs) are transcriptional co-repressors implicated in 
development, malignancy, differentiation, and stem cell function. While MTG16 loss 
renders mice sensitive to chemical colitis, the role of MTG16 in the small intestine is 
unknown. Histological examination revealed that Mtg16-/- mice have increased enterocyte 
proliferation and goblet cell deficiency. After exposure to radiation, Mtg16-/- mice 
exhibited increased crypt viability and decreased apoptosis in comparison to WT mice. 
Flow cytometric and immunofluorescence analysis of intestinal epithelial cells for 
phospho-Histone H2A.X also indicated decreased DNA damage and apoptosis in Mtg16-/- 
intestines. To determine if Mtg16 deletion affected epithelial cells in a cell-autonomous 
fashion, intestinal crypts were isolated from Mtg16-/- mice. Mtg16-/- and WT intestinal 
crypts showed similar enterosphere forming efficiencies when cultured in the presence of 
EGF, Noggin, and R-spondin. However, when Mtg16-/- crypts were cultured in the 
presence of Wnt3a, they demonstrated higher enterosphere forming efficiencies and 
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delayed progression to mature enteroids. Mtg16-/- intestinal crypts isolated from irradiated 
mice exhibited increased survival in comparison to WT intestinal crypts. Interestingly, 
Mtg16 expression was reduced in a stem cell-enriched population at the time of crypt 
regeneration. This is consistent with MTG16 negatively regulating regeneration in vivo. 
Taken together, our data demonstrates that MTG16 loss promotes radioresistance and 
impacts intestinal stem cell function, possibly due to shifting cellular response away from 
DNA damage-induced apoptosis and towards DNA repair after injury.  
 
Introduction 
Radiation enteritis is a pathological condition in which the small intestine is 
injured following exposure to ionizing radiation (Harb, Abou Fadel, and Sharara 2014). 
Risk factors associated with radiation enteritis include mutations in DNA repair genes 
such as BRCA1 and BRCA2 (Ernestos et al. 2010; Nieuwenhuis 2002) or in DNA damage 
response genes such as Tp53 (Mazzatti et al. 2005) and B-Cell Lymphoma 6 Protein 
(BCL6) (Margalit et al. 2006). Sensitivity to intestinal radiation-induced injury may be 
further influenced by changes in cell cycle kinetics, synchronization of replicating cell 
populations, or inhibition of effective DNA repair (Brown and Rzucidlo 2011; Shadad et 
al. 2013). Typically, DNA repair of radiation-induced DNA double-strand breaks 
depends on the activation of DNA damage response programs that induce 
phosphorylation of histone H2A.X and activation of a number of mediators that 
phosphorylate Tp53. Together, the actions of these proteins ultimately lead to DNA repair 
or apoptosis if DNA repair is insufficient (Sulli, Micco, and Fagagna 2012).  
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Myeloid translocation genes (MTGs) were discovered in acute myeloid leukemia 
(AML) (Miyoshi et al. 1993). The MTGs—MTG8, MTGR1, and MTG16—serve as 
scaffold proteins and facilitate the formation of transcriptional repression complexes 
containing histone deacetylases (HDACs), nuclear receptor co-repressor 1 (NcoR), and 
mammalian switch-independent 3A (mSin3A) (Amann et al. 2001; Davis, McGhee, and 
Meyers 2003; Lutterbach et al. 1998; Wang et al. 1998). Because MTGs are unable to 
bind DNA directly, association with transcription factors such as B-Cell Lymphoma 6 
(BCL6), promyelocytic leukemia zinc finger (PLZF), and T-cell factor 4 (TCF4) dictate 
target specificity (Moore et al. 2008). We have recently shown that MTGs compete with 
β-catenin for TCF4 occupancy, and MTG binding attenuates TCF4-mediated 
transcriptional activation (Moore et al. 2008). Given that TCF4 is critical for stem cell 
renewal in the adult intestine (V. Es et al. 2012), MTGs may regulate key stem cell 
signaling pathways necessary for homeostasis and injury repair (Davis, McGhee, and 
Meyers 2003; Moore et al. 2008). In support of this concept, Mtg16-/- mice have stress-
induced hematopoietic stem cell defects (Chyla et al. 2008), as well as abnormal crypt 
regeneration in the colon after injury-induced inflammation (Williams et al. 2013). 
However, the effect of Mtg16 deletion on small intestine injury responses has yet to be 
determined. 
Given that MTG16 impacts colonic responses to chemically-induced colitis, we 
hypothesized that MTG16 may alter radiation-induced small intestinal regenerative 
responses. In the present study, we link MTG16 to epithelial regeneration after radiation-
induced injury. At baseline, Mtg16-/- mice exhibited decreased goblet cell numbers and 
higher proliferation. Furthermore, after 12 Gy whole-body radiation, Mtg16-/- mice 
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showed protection from radiation-induced DNA damage and p53 activation. Ex vivo 
culturing of Mtg16-/- enteroids revealed increased Wnt responsiveness and delayed 
maturation. Complementary to in vivo findings, Mtg16-/- enteroids were more 
radioresistant than WT counterparts, indicating an epithelial cell-autonomous role for 
Mtg16 in radiation-induced epithelial responses. Lastly, examination of a post-irradiation 
gene expression array dataset indicated that during the proliferative recovery phase, 
Mtg16 expression was reduced in stem cell populations.  
 
Methods 
Mouse Models 
WT (C57BL/6 background) mice were obtained from the Jackson Laboratories. 
Mtg16-/- mice were obtained from S.W. Hiebert (Vanderbilt University) and have been 
described in detail (Chyla et al. 2008). All experiments were performed with 8 to 12 
week old WT and Mtg16-/- male and female mice on C57BL/6 background. All in vivo 
experimental procedures were performed under guidelines approved by the Vanderbilt 
Institutional Animal Care and Use Committee (IACUC). 
 
Gamma Irradiation 
WT and Mtg16-/- mice were placed in a plexiglass-partitioning device and onto a 
turntable delivery platform, ensuring uniform radiation dosing of all mice. Mice received 
12 Gy whole-body radiation from a Mark I 137Cs source delivered at 1.58 Gy/min. To 
assess early injury responses, mice were sacrificed four hours after irradiation, a time 
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known in WT mice to be associated with maximal induction of p53-mediated apoptosis 
(Leibowitz et al. 2011).  
To assess regenerative response, WT and Mtg16-/- mice were dosed with 12 Gy 
irradiation as described above. Ninety-three hours after irradiation, mice were injected 
with 0.02 mg/kg of vincristine sulfate (Sigma-Aldrich, St. Louis, MO) to arrest cells in 
metaphase, facilitating identification of crypt cells entering mitosis over the three-hour 
period between administration and tissue harvest (Alferez and Goodlad 2007; Ottewell et 
al. 2006). Mice were euthanized three hours later (Figure 55A) at the ninety-six hour 
time point. The ninety-six hour post-irradiation time point was chosen as it is a time point 
of crypt regeneration (Lund 2012; Potten et al. 1995; Tian et al. 2011).  
 
Immunohistochemistry and Immunofluorescence 
Baseline Characterization 
Following sacrifice, small intestines were removed, rinsed with Phosphate 
Buffered Saline (PBS), and Swiss-rolled for histological examination. The tissues were 
fixed in 10% formalin overnight and transferred to 70% ethanol. Tissues were submitted 
to the Vanderbilt University Translational Pathology Shared Resource (TPSR) core for 
processing and paraffin-embedding. Five micron sections were cut for histology. The 
distal one-third of small intestinal sections from WT and Mtg16-/- mice was evaluated for 
crypt morphology, crypt depth, villus height, and biomarkers of proliferation and 
secretory lineages. Goblet cells were identified by Periodic Acid-Schiff (PAS) staining. 
Enteroendocrine cells (EECs) were assessed by Chromogranin A (CgA) staining using 
anti-CgA (ImmunoStar Inc., Hudson, WI) at 1:1000 dilution. Paneth cells were identified 
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using anti-lysozyme antibody (Dako, Carpentaria, CA) at 1:500 dilution. Proliferation 
was measured using anti-phospho-Histone H3 (pH3) Ser10 antibody (Millipore/Upstate 
Bedford, MA) that labels cells in the mitotic (M) phase of the cell cycle at 1:150 dilution. 
Vectastain Elite ABC Kit (Vector Laboratories, Burlingame, CA) was used for secondary 
antibody and visualization. 
 
Four Hours Post-Irradiation Analyses 
Small intestines were harvested 4 hours post-irradiation and ~3-4 cm segments of 
the distal small intestine were excised and further dissected prior to snap freezing in 
liquid nitrogen for use in subsequent flow cytometric analysis (Chaturvedi et al. 2011, 
2014). The remaining section of the distal small intestine was Swiss-rolled, fixed and 
submitted to the Vanderbilt TPSR core for processing and sectioning. For phospho-
Histone H2A.X immunofluorescence, antigen retrieval was performed by using 500mL 
of 1M sodium citrate buffer (pH=6.0). Slides were placed in a pressure cooker and heated 
for 15 minutes on high pressure. Slides were then rinsed with deionized H2O to remove 
excess citrate buffer. Tissue sections were permeabilized by adding 50µL of 0.1% Tween 
20 to each section and allowed to incubate for 30 minutes in a covered chamber. Slides 
were washed twice to remove permeabilization buffer. Tissue sections were blocked in 
5% goat serum in Tris-Buffered Saline (TBS). Anti-phospho-Histone H2A.X (Ser139) 
from Millipore (EMD Millipore, Billerica, MA) was used at 1:100 dilution and slides 
incubated overnight at 4°C. Isotype-matched antibodies were included as negative 
controls. Sections were then washed in 1X PBS and incubated for one hour at room 
temperature in Alexa Fluor 488 goat anti-mouse-IgG (Invitrogen, Grand Island, NY) at 
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1:100 dilution. Slides were counterstained and mounted with ProLong Gold Antifade 
with 4′,6-diamidino-2-phenylindole (DAPI, Invitrogen, Grand Island, NY).  
 
Ninety-Six Hours Post-Irradiation Analyses 
At 96 hours post-irradiation, small intestines were harvested and Swiss-rolled as 
described above. Crypt regeneration was assessed by examination of H&E stained 
sections for the number of mitotic figures present per crypt in the distal one-third of the 
small intestine. 
 
Flow Cytometric Analysis of Epithelial Cell Isolates 
Flow cytometric analysis of epithelial cell isolates including both crypt and villus 
populations was performed as previously described (Chaturvedi et al. 2011). Frozen 
tissue segments were thawed in calcium and magnesium free 1X Dulbecco’s Phosphate 
Buffered Saline (DPBS). DPBS was decanted and samples were resuspended in cold 
Hanks’ Balanced Salt Solution (HBSS) containing 3mM ethylenediaminetetraacetic acid 
(EDTA) and dithiothreitol (DTT) for 1 hour with gentle shaking every 15 minutes. 
HBSS/EDTA/DTT solution was decanted and epithelial cells from crypts and villi were 
resuspended three times in 25mL of 1X DPBS. After each resuspension, conical tubes 
were shaken vigorously for a minimum of 30 seconds. The cell suspension was passed 
through a 70-µm cell strainer to remove clumps. Epithelial cells were pelleted, 
centrifuged at 1500 rpm for 10 min, and resuspended in 1 mL of 1X DPBS. Cells were 
manually counted using a hemocytometer. 1x106 cells were resuspended in 1 mL of 37% 
formaldehyde (Ted Pella Inc., Redding, CA) diluted to a final concentration of 4% and 
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incubated at room temperature for 10 minutes. Epithelial cell isolates were stained 
according to manufacturer’s instructions for expression of the following antibodies: 
Biotinylated E-cadherin (ABCAM, Cambridge, MA) and Streptavidin-Peridinin 
chlorophyll protein (PerCP)-Cy5.5 tagged antibody (BD Bioscience, San Jose, CA) were 
used to identify epithelial cells. Phospho-Histone H2A.X (Ser139) PE conjugated 
antibody (Cell Signaling, USA, MA) was used to identify DNA damage in epithelial 
cells. p53 antibody conjugated to Alexa Fluor 488 (Cell Signaling, Danvers, MA) was 
used as a marker to detect p53 induction since this is a critical mediator of radiation-
induced apoptosis or DNA repair. All cells were analyzed by flow cytometry on a Becton 
Dickinson LSR II and first gated for E-cadherin expression. At least 10,000 events were 
collected. The percentage of epithelial cells positive for phospho-Histone H2A.X or p53 
was calculated using FlowJo software (TreeStar Inc., Ashland, OR).  
 
Apoptosis Assays 
Apoptosis in epithelial cell isolates was quantified using the Cell Death Detection 
ELISAPLUS kit (Roche Applied Sciences, Indianapolis, IN) following the manufacturer’s 
protocol. TUNEL staining on tissue sections was conducted with ApopTag Plus 
Peroxidase In Situ Apoptosis Detection Kit (EMD Millipore, Billerica, MA) according to 
the manufacturer's protocol. Control stains were obtained by omitting the terminal 
deoxynucleotide transferase (TdT) enzyme. Crypt apoptotic indices were generated by 
averaging the number of apoptotic cells in 40 sequential, well-aligned crypts per mouse 
in the distal one-third of the small intestine. This is presented as the mean number of 
TUNEL+ cells per crypt in each animal.  
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Enteroid Cultures  
The crypt-enteroid culture method was modified from Sato et al (Mahe et al. 
2013; Sato et al. 2009). Briefly, mouse proximal small intestine (~10 cm) was excised, 
opened longitudinally, and washed with ice-cold 1X DPBS. The intestine was cut into 
small pieces and incubated in ice-cold 1X DPBS containing 1mM EDTA on a rocking 
platform for 30 minutes. After being rinsed once with ice-cold PBS to remove EDTA, the 
intestinal fragments were resuspended 3 times by gentle shaking in 5mL of ice-cold 1X 
DPBS. After each resuspension, supernatant was collected and passed through a 70-µm 
cell strainer (Fisher Scientific, USA, MA) to remove villus fragments. The cell strainer 
was cleared using 5mL of dissociation buffer. 400 crypts were resuspended in Matrigel 
(BD Bioscience) containing growth factors all obtained from R&D Systems (R&D 
Systems, Minneapolis, MN): 50ng/mL EGF, 100ng/mL Noggin, and 500ng/mL R-
spondin (ENR media) or 100ng/mL Wnt3A+ENR (WENR media). Neither media nor 
growth factors were replaced throughout the course of the experiment. Plating 
efficiencies were calculated by dividing the total number of enterospheres formed by the 
original number of crypts plated at Day 0 and multiplying by 100. Enterospheres were 
visualized and counted at 24, 48, and 72 hours after plating. Experiments were performed 
in duplicate and repeated three times.  
 
Statistical Analysis  
Statistical analysis and graphs were generated using GraphPad Prism 6.0. All data 
are represented as the standard deviation, unless stated otherwise. Student t-test was 
performed to compare two groups. One-way analysis of variance with Tukey’s multiple 
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comparison tests was performed to compare more than two groups. A P<0.05 was 
considered statistically significant. 
 
Results 
MTG16 regulates crypt proliferation and goblet cell numbers in vivo 
Previous studies have demonstrated that MTGs regulate lineage specification and 
proliferation in a number of tissues (Chyla et al. 2008; Lindberg et al. 2005) 
hematopoiesis; (Williams et al. 2013) colon). In the small intestine, Mtgr1 knockout mice 
exhibited defects in secretory lineage allocation (Amann et al. 2005), while loss of Mtg16 
has been reported to promote colonocyte proliferation and exacerbate colonic response to 
injury (Williams et al. 2013). The role of MTG16 in small intestinal biology is unknown. 
To define whether MTG16 deletion alters morphology, proliferation, or secretory cell 
lineage allocation in the small intestine, we performed a histological characterization of 
Mtg16-/- mice. Mtg16-/- mice had normal crypt architecture with both villus height and 
crypt depth being comparable to WT mice (Figure 52A). In contrast, pH3+ cells/crypt-
villus unit were increased in Mtg16-/- intestine (Figure 52B), indicating increased 
enterocyte proliferation. There were no significant differences in numbers of 
enteroendocrine or Paneth cells (Figure 52C). However, PAS-labeled goblet cells per 
crypt villus unit were significantly reduced in Mtg16-/- mice (Figure 52C). Thus, MTG16 
regulates proliferation in the small intestinal crypts and is required for efficient goblet 
cell production. 
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Figure 52. MTG16 regulates epithelial progenitor cell lineage allocation and 
proliferation. Small intestines were isolated and Swiss-rolled. (A) Representative H&E 
demonstrating normal crypt morphology in WT and Mtg16-/- small intestine.  
Measurement of villus height and crypt depth of 100 crypts from the distal small intestine 
demonstrating no differences between Mtg16-/- and WT mice (n=17 mice). (B) pH3+ cells 
demonstrate increased proliferation in Mtg16-/- small intestine (n=5) when compared to 
WT (n=8, *P=0.01). (C) (i) Period Acid Schiff (PAS) stain demonstrated reduced number 
of goblet cells in Mtg16-/- small intestine when compared to WT (n=7 each, *P<0.05). (ii) 
Chromogranin A (CgA) staining demonstrated no difference in the number of 
enteroendocrine cells between Mtg16-/- (n=8) and WT (n=9, P=0.75). (iii) Lysozyme 
staining demonstrated no differences in number of Paneth cells between WT and Mtg16-/- 
mice (n=7 in each group, P=0.16). All images were captured at 10x magnification. 
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MTG16 is critical for radiation-induced DNA damage response 
To assess intestinal injury responses, WT and Mtg16-/- mice were exposed to 12 
Gy of ionizing radiation. DNA damage and apoptosis were quantified 4 hours post-
irradiation (Figure 53A), the peak time for detection of p53-induced apoptosis in the 
small intestine in response to irradiation (Leibowitz et al. 2011). Flow cytometric analysis 
for phospho-histone H2A.X on epithelial isolates from irradiated WT and Mtg16-/- mice 
revealed significantly decreased levels in Mtg16-/- intestine when compared to WT 
(Figure 53B). This was confirmed by immunofluorescence staining of WT and Mtg16-/- 
intestine for phospho-Histone H2A.X (Figure 53C).  
 
Figure 53. MTG16 is required for proper response to radiation-induced DNA 
damage. (A) Schematic of 4-hour irradiation protocol. (B) Detection of phospho-Histone 
H2A.X by flow cytometry in epithelial cells isolated from WT (n=7) and Mtg16-/- (n=9) 
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mice (**P=0.003). (C) Top panels: Representative immunofluorescent staining of WT 
and Mtg16-/-  small intestine for phospho-γH2A.X with DAPI 4 hours after 12 Gy 
irradiation (10x magnification). The areas in white boxes are shown at higher 
magnification (40x magnification) in the bottom panels. 
 
In addition, while analysis of p53 positive epithelial cells by flow cytometry 
revealed no significant differences between the cohorts (Figure 54A), analysis of 
phospho-Histone H2A.X/p53 double positive epithelial cells indicated a significant 
reduction in the percentage of double positive cells in epithelial isolates from Mtg16-/- 
mice at 4 hours post-irradiation (Figure 54B). Further, apoptosis assessed by cell death 
ELISA was also reduced in Mtg16-/- intestine (Figure 54C). Taken together, these data 
suggest that Mtg16 deletion protects from injury via decreased triggering of apoptosis 
after radiation-induced injury.    
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Figure 54. MTG16 is critical for p53-mediated apoptosis.  (A) Flow cytometry 
detection of P53 in epithelial isolates from irradiated WT (n=4) and Mtg16-/- (n=5) mice 
(B) Flow cytometry detection of phospho-Histone H2A.X and P53 in epithelial isolates 
from irradiated WT (n=4) and Mtg16-/- (n=5) mice (*P=0.02). (C) Apoptosis was 
measured by Cell Death ELISA (*P=0.03, n=10 in each group). 
 
MTG16 loss promotes crypt regeneration 
Since we observed decreases in DNA damage and apoptosis, we postulated that 
MTG16 would impact crypt regenerative dynamics in response to ionizing radiation 
(Barker, van de Wetering, and Clevers 2008; Leibowitz et al. 2011; Martin et al. 1998; 
Ottewell et al. 2006). Therefore, we exposed WT and Mtg16-/- mice to 12 Gy irradiation 
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followed by a 93-hour recovery period (Figure 55A). Three hours prior to sacrifice, mice 
were injected with vincristine, a mitotic inhibitor, facilitating identification of 
regenerative crypts. At the 96-hour time point, proliferation of stem cells leads to crypt 
regeneration (Van Landeghem et al. 2012; Martin et al. 1998; Potten and Chadwick 1994; 
Potten et al. 1995). Mtg16-/- mice had 20% increased crypt viability in comparison to WT 
mice (Figure 55B) with a concurrent reduction in TUNEL positive intestinal epithelial 
cells (Figure 55C). Taken together, these data indicate that the absence of MTG16 
protects the epithelium from radiation-induced apoptosis during the regenerative phase, 
as well. 
 
Figure 55. Mtg16-/- mice are protected from radiation-induced injury. (A) Schematic 
diagram of 96-hour irradiation protocol. (B) Representative H&E demonstrating small 
intestinal crypt survival in WT and Mtg16-/- mice. The letter “V” denotes viable crypts 
and the letter “S” denotes sterile crypts. Mtg16-/- (n=8) mice have a higher percentage of 
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surviving crypts than WT (n=6) (***P=0.0002). Crypts were considered viable if 3 or 
more mitotic bodies were observed per crypt. 40 sequential, well-aligned crypts in the 
distal one-third of the small intestine were counted per data point. The percent of 
surviving crypts was calculated using the following equation: (# of viable crypts/total # 
of crypts counted) x 100. (C) TUNEL staining demonstrated a reduction in the number of 
TUNEL+ cells in Mtg16-/- (n=6) vs. WT (n=5) (**P=0.001). All images were captured at 
10x magnification. 
 
MTG16 impacts stem cell growth, maturation and Wnt3A response 
To investigate the mechanisms by which MTG16 might contribute to stem cell 
survival we examined growth patterns of three-dimensional enteroid cultures of crypts 
isolated from WT and Mtg16-/- mice. Specifically, we calculated the enterosphere forming 
efficiency. We considered enterospheres to be “spherical structures composed of several 
small intestinal epithelial cells that appear as a rounded-off epithelial cysts” when 
evaluated 24 hours post-plating (Stelzner et al. 2012). There were no differences in 
plating efficiencies between the two groups when cultured in Matrigel containing EGF, 
Noggin, and R-spondin (ENR) (Figure 56A). Because MTG16 is a negative regulator of 
Wnt signaling, as it can competitively bind to TCF4 and oppose β-catenin-dependent 
transcriptional activation (Moore et al. 2008), we postulated that Mtg16-/- enteroids may 
be hyper-responsive to Wnt activation. Therefore we added Wnt3A+ENR (WENR) to the 
Matrigel and plated freshly isolated crypts. In WENR supplemented crypt cultures, there 
was a 50% higher plating efficiency of Mtg16-/- crypts (Figure 56B). Interestingly, 
Mtg16-/- enteroids also showed reduced progression to budding enteroids compared to 
WT enteroids at 72 hours post-plating (Figure 56C). These observations suggest that 
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MTG16 affects stem cell growth and maturation in a Wnt-dependent manner, such that 
loss of Mtg16 promotes increases in Wnt responsiveness. 
 
Figure 56. MTG16 regulates enteroid growth and Wnt3A response. Small intestinal 
crypts were isolated from WT or Mtg16-/- mice and plated at 400 crypts/well for all 
experiments. (A) Plating efficiency was calculated for crypts embedded in Matrigel 
containing EGF, Noggin and R-spondin (ENR). There was no significant difference in 
plating efficiency between Mtg16-/- and WT intestinal crypts (P=0.14). Plating efficiency 
was calculated using the following equation: (Total # of crypts that formed enterospheres 
at 24 hours /total # of crypts plated at 0 hours). (B) Plating efficiency was calculated for 
crypts embedded in Matrigel containing Wnt3A+ENR (WENR). Mtg16-/- enteroids 
exhibited higher plating efficiency than WT Enteroids (*P=0.03) (C) (i) Enteroid 
morphology at 24, 48, and 72 hours (10x magnification). (ii) Mtg16-/- enteroids exhibited 
delayed enterosphere progression to budding enteroids at 72 hours (Enterosphere: 
***P<0.0001; Budding Enteroids: **P<0.001) E= enterosphere and B= budding 
enteroid. Experiments were performed in duplicate and repeated three times. 
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MTG16 modulates intestinal stem cell regenerative response after irradiation 
Because increased crypt regeneration was observed in vivo after irradiation of 
Mtg16-/- mice, we hypothesized that Mtg16-/- enteroid plating efficiency, a surrogate 
marker for stem cell survival or growth, would be similarly impacted. To test this, mice 
were dosed with 12 Gy radiation and crypts were isolated and plated in Matrigel 
containing ENR 4 hours later. We observed a 70% increase plating efficiency in Mtg16-/- 
enteroids 24 hours after plating (Figure 57A).  
 Given that specific gene expression programs are modified after intestinal injury 
and during regenerative phases, we sought to determine if Mtg16 was regulated in 
response to radiation-induced injury. Using a well-characterized Sox9 transgenic model 
(Gracz, Ramalingam, and Magness 2010; Van Landeghem et al. 2012), we assessed 
Mtg16 RNA levels in different populations of Sox9-EGFP sorted cells. Prior studies have 
demonstrated that Sox9, a Wnt target gene, is a marker for self-renewing small intestinal 
epithelial stem cells (Formeister et al. 2009; Furuyama et al. 2011; Gracz, Ramalingam, 
and Magness 2010). Studies using Sox9-EGFP reporter mice have demonstrated that 
FACS for different levels of Sox9-EGFP expression yields Sox9-EGFPNegative cells 
enriched for enterocyte markers, Sox9-EGFPSublow cells enriched for progenitors, Sox9-
EGFPLow cells enriched for Lgr5+ and other intestinal stem cell markers, and Sox9-
EGFPHigh cells enriched for enteroendocrine cells (Van Landeghem et al. 2012). In the 
present study, qRT-PCR on these populations for Mtg16 indicated no significant 
difference in Mtg16 levels across populations; however, after irradiation, Mtg16 was 
specifically downregulated in the Sox9-EGFPLow stem cell-enriched compartment and 
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increased in the Sox9-EGFPNegative cells (Figure 57B). Thus, these data suggest that 
MTG16 levels are regulated during the regenerative phase after radiation-induced injury. 
 
Figure 57. MTG16 decreases stem cell regenerative response after radiation-induced 
injury. (A) Plating efficiency of intestinal crypts isolated from WT and Mtg16-/- mice 
dosed with 12 Gy irradiation. Higher plating efficiencies were observed in crypts isolated 
from Mtg16-/- mice when compared to crypt isolation from WT mice (*P=0.01) (White 
arrows indicate live and black arrows indicate dead enterospheres, 10x magnification). 
Experiments were performed in duplicate and repeated three times. (B) Quantitative PCR 
of Mtg16 expression in Sox9-EGFPNegative, Sox9-EGFPSublow, Sox9-EGFPLow, and Sox9-
EGFPHigh cells from the intestines of both nonirradiated and irradiated mice. No 
significant differences were observed in Mtg16 mRNA levels across populations. Mtg16 
mRNA expression is lower in intestinal epithelial stem cell (IESC) enriched Sox9-
EGFPLow and higher in terminally differentiated Sox9-EGFPNegative cells 5 days post-
irradiation (IESCs: *P<0.05 and Enterocytes: *P<0.05, n=5 per group). Black bars 
represent non-irradiated (NI) and white bars represents irradiated (Irr). 
 
Discussion 
The goal of the present study was to investigate the role of MTG16 in the small 
intestine by examining the effect of Mtg16 deletion on baseline mucosal homeostasis and 
response to injury after ionizing radiation. At baseline, Mtg16-/- mice demonstrate higher 
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intestinal proliferation and altered lineage allocation. Mtg16-/- enteroids were hyper-
responsive to Wnt activation and exhibited delayed progression to mature enteroids, 
suggesting altered stem cell activity in the Mtg16-/- intestine. After irradiation, Mtg16-/- 
mice were protected from DNA damage and had decreased p53 activation. Additionally, 
Mtg16-/- crypts isolated from mice at 4 hours after 12 Gy radiation had increased plating 
efficiency, indicating an epithelial cell-autonomous role for MTG16 in protecting crypt 
stem cells. Lastly, examination of Mtg16 expression in isolated stem cells at the time of 
crypt regeneration demonstrated that Mtg16 expression was reduced in stem cell 
populations.  
 Despite an increase in proliferation in the Mtg16-/- mice, we did not observe a 
difference in gross morphology or morphometry. There are multiple factors that influence 
crypt morphometry, with apoptosis and proliferation each partially contributing to overall 
crypt depth or villus height. We suspect that the rather subtle, but significant increase in 
proliferation may be insufficient to influence mucosal morphometry in the Mtg16-/- mice. 
Mtg16-/- mice exhibit hematopoietic lineage allocation defects with skewing of early 
myeloid progenitor cells toward granulocytic/macrophage lineages and a reduction in 
megakaryocyte-erythroid progenitor cells (Chyla et al. 2008). We report that these 
lineage allocation differences are not limited to hematopoiesis, as Mtg16-/- small intestine 
also has decreased goblet cell numbers. While the functional role of goblet cells in 
radiation injury is unclear (Becciolini and Fabbrica 1985; van Dongen, Kooyman, and 
Visser 1976; Kanter and Akpolat 2008), it is possible that decreased goblet cells in 
Mtg16-/- mice might impact crypt viability after radiation injury.  
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 While we report higher crypt viability after radiation than what others have 
previously reported (Ottewell et al. 2006), we believe that differences in technique may 
account for this apparent discrepancy. With a Swiss-rolling technique and examination of 
40 sequential, well-aligned crypts in the distal one-third of the small intestine at this time 
point and radiation dose, we reproducibly observe crypt viability in the 60-80% range in 
WT mice. We observed significantly higher crypt viability in the Mtg16-/- mice, 
suggesting either greater viability and survival post-irradiation or faster crypt 
regeneration. Other methods of assessment, such as evaluating cross-sections of small 
intestine often score lower indices of viability (Ottewell et al. 2006). Given our 
experimental design, we may also have higher crypt viability indices because 
regeneration occurs at 96 hours post-radiation, and it is possible that dead crypts may 
have already been cleared by this point and thus, would not be factored into our 
assessment.  
While decreased phosphorylation of H2A.X in the Mtg16-/- mice suggests 
accelerated repair and decreased DNA damage in this cohort, an alternative consideration 
is that MTG16 regulates the phosphorylation of H2A.X in response to irradiation and 
triggers activation of DNA repair machinery. Thus Mtg16 deletion may result in a failure 
to recognize damage after radiation due to compromised phosphorylation of H2A.X, and 
Mtg16-/- mice may suffer DNA damage and have defective initiation of repair 
mechanisms. Another important consideration for these studies is that while Mtg16-/- mice 
exhibit decreased apoptosis after radiation compared to WT mice, there is a possibility 
that intestinal cells that escape apoptosis may later undergo mitotic catastrophe, an 
indication of failed DNA repair. This phenomenon has been observed in p53-/- mice 
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(Gudkov and Komarova 2003). We did not test this as Mtg16-/-  mice do not survive, 
secondary to marrow failure, even at lower doses of radiation. This experiment may be 
performed when Mtg16 floxed mice become available. 
 After irradiation, and at time of crypt regeneration, Mtg16 expression is reduced 
in Sox9-EGFPLow stem cell-enriched compartments. Microarray analysis of Sox9-
EGFPLow stem cell has shown that genes involved in differentiation, crypt repair, and 
radiation-induced apoptosis are repressed in Sox9-EGFPLow cells (Van Landeghem et al. 
2012). Given this evidence, we postulate that lower MTG16 levels may permit activation 
of stem cell programs promoting epithelial reconstitution. We also observed that Mtg16 
expression is increased in Sox9-EGFPNegative  populations. As previously reported by 
Landeghem et al, Sox9-EGFPNegative  cells are enriched for differentiated lineages. Thus, 
MTG16 might repress stem cell programs and allow differentiation to progress after 
injury in this population of cells. 
The Wnt signaling pathway plays an important role in regulating intestinal 
epithelial stem cell function (Fevr et al. 2007; Gregorieff and Clevers 2005; Pinto et al. 
2003). We have previously shown that MTG16 competes with β-catenin for TCF4 
occupancy and that the absence of MTG16 results in increased epithelial proliferation 
(Davis, McGhee, and Meyers 2003; Moore et al. 2008). In support of enhanced TCF4 
activity in response to Wnt, baseline characterization of Mtg16-/- crypts in the enteroid 
culture system showed increased plating efficiency and delayed maturation in the 
presence of Wnt3A. Furthermore, several lines of evidence support a role for WNT/β-
catenin signaling in survival of stem/progenitor cell populations after radiation (Kim et 
al. 2012; Woodward et al. 2007). Ex vivo studies presented here show that enteroids 
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isolated from irradiated Mtg16-/- mice have increased survival in comparison to WT 
enteroids. Together, these data suggest that MTG16 may be important in modifying 
survival programs in stem cell populations after radiation. 
Our findings indicate that MTG16 is critical for multiple aspects of small 
intestinal homeostasis and response to injury. Specifically, MTG16 controls goblet cell 
allocation, enterocyte proliferation, and is important in radiation-induced injury 
responses. Importantly, because current treatment modalities are aimed at targeting the 
symptoms of radiation enteritis (Carr and Holden 1986; Schembri, Azzopardi, and Ellul 
2014), this study offers promise in understanding the underlying molecular mechanisms 
that regulate responses to radiation therapy.   
  
 160 
REFERENCES 
Abraham, Clara, and Judy H Cho. 2009. “Inflammatory Bowel Disease.” The New 
England Journal of Medicine 361(21): 2066–78. 
Abraham, Clara, and Ruslan Medzhitov. 2011. “Interactions between the Host Innate 
Immune System and Microbes in Inflammatory Bowel Disease.” Gastroenterology 
140(6): 1729–37. 
Acloque, Hervé et al. 2009. “Epithelial-Mesenchymal Transitions : The Importance of 
Changing Cell State in Development and Disease.” The Journal of Clinical 
Investigation 119(6): 1438–49. 
Aigner, K et al. 2007. “The Transcription Factor ZEB1 (deltaEF1) Promotes Tumour Cell 
Dedifferentiation by Repressing Master Regulators of Epithelial Polarity.” 
Oncogene 26(49): 6979–88.  
Akamatsu, Yoshiko et al. 2003. “Deletion of the RAG2 C Terminus Leads to Impaired 
Lymphoid Development in Mice.” Proceedings of the National Academy of Sciences 
of the United States of America 100(3): 1209–14.  
Van Aken, J et al. 1993. “Immunohistochemical Analysis of E-Cadherin Expression in 
Human Colorectal Tumours.” Pathology, research and practice 189(9): 975–78. 
Al-Taie OH, Uceyler N, Eubner U, Jakob F, Mörk H, Scheurlen M, Brigelius-Flohe R, 
Schöttker K, Abel J, Thalheimer A, Katzenberger T, Illert B, Melcher R, Köhrle J. 
2004. “Expression Profiling and Genetic Alterations of the Selenoproteins GI-GPx 
and SePP in Colorectal Carcinogenesis.” Nutr Cancer 48(August 2013): 37–41. 
Al-Taie, Oliver H et al. 2002. “A Complex DNA-Repeat Structure within the 
Selenoprotein P Promoter Contains a Functionally Relevant Polymorphism and Is 
Genetically Unstable under Conditions of Mismatch Repair Deficiency.” European 
journal of human genetics : EJHG 10(9): 499–504. 
Alcalay, Yifat et al. 2013. “Popeye Domain Containing 1 (Popdc1/Bves) Is a Caveolae-
Associated Protein Involved in Ischemia Tolerance.” PLoS ONE 8(9): e71100. 
Alferez, D, and R A Goodlad. 2007. “To Best Measure Cell Proliferation in Samples 
from the Intestine.” Cell Proliferation 40(2): 231–40. 
Amann, Joseph M et al. 2001. “ETO , a Target of T (8;21) in Acute Leukemia , Makes 
Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its 
Oligomerization Domain.” Molecular and cellular biology 21(19): 6470–83. 
 161 
Amann, Joseph M et al. 2005. “Mtgr1 Is a Transcriptional Corepressor That Is Required 
for Maintenance of the Secretory Cell Lineage in the Small Intestine.” Molecular 
and cellular biology. 
Amre, D K et al. 2009. “Interleukin 10 (IL-10) Gene Variants and Susceptibility for 
Paediatric Onset Crohn’s Disease.” Alimentary pharmacology & therapeutics 29(9): 
1025–31. 
Andoh, Akira et al. 2005. “Serum Selenoprotein-P Levels in Patients with Inflammatory 
Bowel Disease.” Nutrition 21(5): 574–79. 
Andrée, B et al. 2000. “Isolation and Characterization of the Novel Popeye Gene Family 
Expressed in Skeletal Muscle and Heart.” Developmental biology 223(2): 371–82. 
Andrée, Anne Fleige, Hans-henning Arnold, and Thomas Brand. 2002. “Mouse Pop1 Is 
Required for Muscle Regeneration in Adult Skeletal Muscle.” Molecular and 
cellular biology 22(5): 1504–12. 
Anjum, Rana, and John Blenis. 2008. “The RSK Family of Kinases: Emerging Roles in 
Cellular Signalling.” Nature reviews. Molecular cell biology 9(10): 747–58.  
Arrieta, M C, K Madsen, J Doyle, and J Meddings. 2009. “Reducing Small Intestinal 
Permeability Attenuates Colitis in the IL10 Gene-Deficient Mouse.” Gut 58(1): 41–
48. 
Arteel, G E et al. “Protection by Selenoprotein P in Human Plasma against Peroxynitrite-
Mediated Oxidation and Nitration.” Biological chemistry 379(8-9): 1201–5.  
Artis, David. 2008. “Epithelial-Cell Recognition of Commensal Bacteria and 
Maintenance of Immune Homeostasis in the Gut.” Nature reviews. Immunology 
8(6): 411–20.  
Balda, M. B. Fallon, C. M. Van Itallie, and J. M. Anderson. 1992. “Structure, Regulation, 
and Pathophysiology of Tight Junctions in the Gastrointestinal Tract.” Yale Journal 
of Biology and Medicine 65(6): 725–35. 
Balda, and K Matter. 1998. “Tight Junctions.” Journal of cell science 111 (Pt 5: 541–47. 
Barker, Nick et al. 2007. “Identification of Stem Cells in Small Intestine and Colon by 
Marker Gene Lgr5.” Nature 449(7165): 1003–7.  
Barker, Nick et al. 2014. “Adult Intestinal Stem Cells: Critical Drivers of Epithelial 
Homeostasis and Regeneration.” Nature reviews. Molecular cell biology 15(1): 19–
33.  
 162 
Barker, Nick, Marc van de Wetering, and Hans Clevers. 2008. “The Intestinal Stem 
Cell.” Genes & development 22(14): 1856–64.  
Barrett et al. 2011. “MTGR1 Is Required for Tumorigenesis in the Murine AOM/DSS 
Colitis-Associated Carcinoma Model.” Cancer research 71(4): 1302–12.  
Barrett et al. 2012. “Tumor Suppressor Function of the Plasma Glutathione Peroxidase 
Gpx3 in Colitis-Associated Carcinoma.” Cancer Research 73(3): 1245–55. 
Barrett, Caitlyn W et al. 2013. “Dietary Selenium Deficiency Exacerbates DSS-Induced 
Epithelial Injury and AOM/DSS-Induced Tumorigenesis.” PloS one 8(7): e67845.  
Barthold, S W et al. 1976. “The Etiology of Transmissible Murine Colonic Hyperplasia.” 
Laboratory animal science 26(6 Pt 1): 889–94.  
Barthold, S W et al. 1978. “Transmissible Murine Colonic Hyperplasia.” Veterinary 
pathology 15(2): 223–36. 
Bataille, Frauke, and Christian Rohrmeier. 2008. “Evidence for a Role of Epithelial 
Mesenchymal Transition during Pathogenesis of Fistulae in Crohn’s Disease.” 
Inflammatory bowel diseases 14(11): 1514–27.  
Baumgart, and Simon R Carding. 2007. “Inflammatory Bowel Disease: Cause and 
Immunobiology.” The Lancet 369: 1627–40. 
Baumgart, and WJ Sandborn. 2007. “Inflammatory Bowel Disease: Clinical Aspects and 
Established and Evolving Therapies.” The Lancet 369(9573): 1641–57. 
Beachy, P, S S Karhadkar, and D M Berman. 2004. “Tissue Repair and Stem Cell 
Renewal in Carcinogenesis.” Nature 432(7015): 324–31. 
Becciolini, A, and D Fabbrica. 1985. “Quantitative Changes in the Goblet Cells of the 
Rat Small Intestine after Irradiation.” Acta radiologica. Oncology 24(October 1984). 
Becker, C et al. 2005. “In Vivo Imaging of Colitis and Colon Cancer Development in 
Mice Using High Resolution Chromoendoscopy.” Gut 54(7): 950–54. 
Becker, C, M C Fantini, and M F Neurath. 2007. “High Resolution Colonoscopy in Live 
Mice.” Nature Protocols 1(6): 2900–2904. 
Benjamini, Y et al. 2001. “Controlling the False Discovery Rate in Behavior Genetics 
Research.” Behavioural brain research 125(1-2): 279–84. 
Bera, Soumen, Viviana De Rosa, Walid Rachidi, and Alan M. Diamond. 2013. “Does a 
Role for Selenium in DNA Damage Repair Explain Apparent Controversies in Its 
Use in Chemoprevention?” Mutagenesis 28(2): 127–34. 
 163 
Bettelli, Estelle et al. 2006. “Reciprocal Developmental Pathways for the Generation of 
Pathogenic Effector TH17 and Regulatory T Cells.” Nature 441(7090): 235–38. 
Bjerknes, M, and H Cheng. 1981a. “The Stem-Cell Zone of the Small Intestinal 
Epithelium. I. Evidence from Paneth Cells in the Adult Mouse.” The American 
journal of anatomy 160(1): 51–63. 
Bjerknes, M, and H Cheng. 1981b. “The Stem-Cell Zone of the Small Intestinal 
Epithelium. III. Evidence from Columnar, Enteroendocrine, and Mucous Cells in the 
Adult Mouse.” The American journal of anatomy 160(1): 77–91.  
Booth, C, and C S Potten. 2000. “Gut Instincts: Thoughts on Intestinal Epithelial Stem 
Cells.” The Journal of clinical investigation 105(11): 1493–99. 
Borenshtein, Diana, Megan E McBee, and David B Schauer. 2008. “Utility of the 
Citrobacter Rodentium Infection Model in Laboratory Mice.” Current opinion in 
gastroenterology 24(1): 32–37.  
Bosschaerts, Tom et al. 2008. “Associated with African Trypanosomiasis through the IL-
10.” The Journal of Immunology 180(7): 6168–75. 
Brand, Thomas. 2005. “The Popeye Domain-Containing Gene Family.” Cell 
biochemistry and biophysics 43(1): 95–103.  
Brigelius-Flohé, Regina, and Anna Patricia Kipp. 2013. 527 Methods in Enzymology 
Selenium in the Redox Regulation of the Nrf2 and the Wnt Pathway. 1st ed. Elsevier 
Inc. 
Brown, Kellie R, and Eva Rzucidlo. 2011. “Acute and Chronic Radiation Injury.” 
Journal of Vascular Surgery: 15–21. 
Bruce, W R, and H Van Der Gaag. 1963. “A Quantitative Assay For the Number of 
Murine Lymphoma Cells Capable of Proliferation in Vivo.” Nature 199: 79–80.  
Bry, Lynn, and Michael B Brenner. 2004. “Critical Role of T Cell-Dependent Serum 
Antibody, but Not the Gut-Associated Lymphoid Tissue, for Surviving Acute 
Mucosal Infection with Citrobacter Rodentium, an Attaching and Effacing 
Pathogen.” Journal of immunology (Baltimore, Md. : 1950) 172(1): 433–41. 
Buczacki, Simon J a et al. 2013. “Intestinal Label-Retaining Cells Are Secretory 
Precursors Expressing Lgr5.” Nature 495(7439): 65–69.  
Burk, Raymond F, and Kristina E Hill. 2005. “Selenoprotein P: An Extracellular Protein 
with Unique Physical Characteristics and a Role in Selenium Homeostasis.” Annual 
review of nutrition 25: 215–35. 
 164 
Burk, Raymond F. et al. 2006. “Deletion of Selenoprotein P Upregulates Urinary 
Selenium Excretion and Depresses Whole-Body Selenium Content.” Biochimica et 
Biophysica Acta - General Subjects 1760(12): 1789–93. 
Burk, Raymond F. et al. 2008. “Selenium Deficiency Activates Mouse Liver Nrf2-ARE 
but Vitamin E Deficiency Does Not.” Free Radical Biology and Medicine 44(8): 
1617–23. 
Carlson, Bradley a et al. 2009. “Selenoproteins Regulate Macrophage Invasiveness and 
Extracellular Matrix-Related Gene Expression.” BMC immunology 10: 57. 
Carlson, Bradley a et al. 2010. “Role of Selenium-Containing Proteins in T-Cell and 
Macrophage Function.” The Proceedings of the Nutrition Society 69(3): 300–310. 
Carr, N D, and D Holden. 1986. “Pathogenesis and Treatment of Radiation Bowel 
Disease: Discussion Paper.” Journal of the Royal Society of Medicine: 1–4. 
Cetin, Selma et al. 2004. “Endotoxin Inhibits Intestinal Epithelial Restitution through 
Activation of Rho-GTPase and Increased Focal Adhesions.” The Journal of 
biological chemistry 279(23): 24592–600.  
Chang, Liang-Che et al. 2013. “Immunohistochemical Study of the Nrf2 Pathway in 
Colorectal Cancer: Nrf2 Expression Is Closely Correlated to Keap1 in the Tumor 
and Bach1 in the Normal Tissue.” Applied immunohistochemistry & molecular 
morphology : AIMM / official publication of the Society for Applied 
Immunohistochemistry 21(6): 511–17.  
Chang, Ti Ling et al. 2010. “Claudin-1 Has Tumor Suppressive Activity and Is a Direct 
Target of RUNX3 in Gastric Epithelial Cells.” Gastroenterology 138(1): 255–65. 
Chaturvedi, Rupesh et al. 2011. “Spermine Oxidase Mediates the Gastric Cancer Risk 
Associated with Helicobacter Pylori CagA.” Gastroenterology 141(5): 1696–1708.  
Chaturvedi, Rupesh et al. 2014. “Activation of EGFR and ERBB2 by Helicobacter Pylori 
Results in Survival of Gastric Epithelial Cells with DNA Damage.” 
Gastroenterology 146(7): 1739–51.e14. 
Cheng, H, and C P Leblond. 1974a. “Origin, Differentiation and Renewal of the Four 
Main Epithelial Cell Types in the Mouse Small Intestine. I. Columnar Cell.” The 
American journal of anatomy 141(4): 461–79.  
Cheng, H, and C P Leblond. 1974b. “Origin, Differentiation and Renewal of the Four 
Main Epithelial Cell Types in the Mouse Small Intestine. V. Unitarian Theory of the 
Origin of the Four Epithelial Cell Types.” The American journal of anatomy 141(4): 
537–61.  
 165 
Chung, Yeonseok et al. 2009. “Critical Regulation of Early Th17 Cell Differentiation by 
Interleukin-1 Signaling.” Immunity 30(4): 576–87.  
Chyla, Brenda J et al. 2008. “Deletion of Mtg16, a Target of t(16;21), Alters 
Hematopoietic Progenitor Cell Proliferation and Lineage Allocation.” Molecular 
and cellular biology 28(20): 6234–47. 
Clevers, Hans. 2004. “At the Crossroads of Inflammation and Cancer.” Cell 118(6): 671–
74.  
Clevers, Hans. 2013. “The Intestinal Crypt, a Prototype Stem Cell Compartment.” Cell 
154(2): 274–84. 
Clevers, Hans, and Roel Nusse. 2012. “Wnt/β-Catenin Signaling and Disease.” Cell 
149(6): 1192–1205. 
Coburn, Lori a. et al. 2013. “High-Throughput Multi-Analyte Luminex Profiling 
Implicates Eotaxin-1 in Ulcerative Colitis.” PLoS ONE 8(12). 
Connelly-Frost, Alexandra et al. 2009. “Selenium, Folate, and Colon Cancer.” Nutrition 
and cancer 61(2): 165–78. 
Cooper, Matthew L et al. 2008. “Interaction between Single Nucleotide Polymorphisms 
in Selenoprotein P and Mitochondrial Superoxide Dismutase Determines Prostate 
Cancer Risk.” Cancer research 68(24): 10171–77. 
Davis, J.Nathan, Laura McGhee, and Shari Meyers. 2003. “The ETO (MTG8) Gene 
Family.” Gene 303: 1–10. 
Debruyne, Delphine et al. 2006. “Colon Cancer Cells: Pro-Invasive Signalling.” The 
International Journal of Biochemistry & Cell Biology 38(8): 1231–36.  
Dhawan, Punita et al. 2005. “Claudin-1 Regulates Cellular Transformation and 
Metastatic Behavior in Colon Cancer.” The Journal of Clinical Investigation 115(7): 
1765–76. 
Dieleman, L a et al. 1998. “Chronic Experimental Colitis Induced by Dextran Sulphate 
Sodium (DSS) Is Characterized by Th1 and Th2 Cytokines.” Clinical and 
experimental immunology 114(3): 385–91. 
Dincer, Yildiz et al. 2007. “Oxidative DNA Damage and Antioxidant Activity in Patients 
with Inflammatory Bowel Disease.” Digestive Diseases and Sciences 52(7): 1636–
41. 
 166 
Doehn, Ulrik et al. 2009. “RSK Is a Principal Effector of the RAS-ERK Pathway for 
Eliciting a Coordinate Promotile/invasive Gene Program and Phenotype in 
Epithelial Cells.” Molecular cell 35(4): 511–22. 
Van Dongen, J M, J Kooyman, and W J Visser. 1976. “The Influence of 400 R X-
Irradiation on the Number and the Localization of Mature and Immature Goblet 
Cells and Paneth Cells in Intestinal Crypt and Villus.” Cell and tissue kinetics 9: 65–
75. 
Durand, A. et al. 2012. “Functional Intestinal Stem Cells after Paneth Cell Ablation 
Induced by the Loss of Transcription Factor Math1 (Atoh1).” Proceedings of the 
National Academy of Sciences 109(23): 8965–70. 
Dvorak, Harold. 2009. “Tumors: Wounds That Do Not Heal. Similarities between Tumor 
Stroma Generation and Wound Healing.” The New England Journal of Medicine 
315(26): 1650–59. 
Eckmann, Lars. 2006. “Animal Models of Inflammatory Bowel Disease: Lessons from 
Enteric Infections.” Annals of the New York Academy of Sciences 1072: 28–38.  
Ernestos, Beroukas et al. 2010. “Increased Chromosomal Radiosensitivity in Women 
Carrying BRCA1/BRCA2 Mutations Assessed with the G2 Assay.” International 
journal of radiation oncology, biology, physics 76(4): 1199–1205. 
Van Es, Johan H et al. 2012. “A Critical Role for the Wnt Effector Tcf4 in Adult 
Intestinal Homeostatic Self-Renewal.” Molecular and cellular biology 32(10): 
1918–27. 
Es, Van et al. 2012. “A Critical Role for the Wnt Effector Tcf4 in Adult Intestinal 
Homeostatic Self-Renewal.” Molecular and Cellular Biology 32(10): 1918–27. 
Farin, Henner F., Johan H. Van Es, and Hans Clevers. 2012. “Redundant Sources of Wnt 
Regulate Intestinal Stem Cells and Promote Formation of Paneth Cells.” 
Gastroenterology 143(6): 1518–29.e7.  
Ferguson, Lynnette R., Nishi Karunasinghe, Shuotun Zhu, and Alice H. Wang. 2012. 
“Selenium and Its’ Role in the Maintenance of Genomic Stability.” Mutation 
Research - Fundamental and Molecular Mechanisms of Mutagenesis 733(1-2): 100–
110.  
Fevr, Tea, Sylvie Robine, Daniel Louvard, and Joerg Huelsken. 2007. “Wnt/beta-Catenin 
Is Essential for Intestinal Homeostasis and Maintenance of Intestinal Stem Cells.” 
Molecular and cellular biology 27(21): 7551–59. 
Fordham, Robert P. et al. 2013. “Transplantation of Expanded Fetal Intestinal Progenitors 
Contributes to Colon Regeneration after Injury.” Cell Stem Cell 13(6): 734–44. 
 167 
Formeister, Eric J et al. 2009. “Distinct SOX9 Levels Differentially Mark 
Stem/progenitor Populations and Enteroendocrine Cells of the Small Intestine 
Epithelium.” American journal of physiology. Gastrointestinal and liver physiology 
296(5): G1108–18.  
Franke, Andre et al. 2008. “Sequence Variants in IL10, ARPC2 and Multiple Other Loci 
Contribute to Ulcerative Colitis Susceptibility.” Nature genetics 40(11): 1319–23. 
Froese, Alexander et al. 2012. “Popeye Domain Containing Proteins Are Essential for 
Stress-Mediated Modulation of Cardiac Pacemaking in Mice.” Journal of Clinical 
Investigation 122(3): 1119–30. 
Fuller, Megan K. et al. 2012. “Intestinal Crypts Reproducibly Expand in Culture.” 
Journal of Surgical Research 178(1): 48–54.  
Furuyama, Kenichiro et al. 2011. “Continuous Cell Supply from a Sox9-Expressing 
Progenitor Zone in Adult Liver, Exocrine Pancreas and Intestine.” Nature genetics 
43(1): 34–41.  
Ghassabeh, Gholamreza Hassanzadeh et al. 2006. “Identification of a Common Gene 
Signature for Type II Cytokine – Associated Myeloid Cells Elicited in Vivo in 
Different Pathologic Conditions.” In Vivo 108(2): 575–83. 
Glocker, Erik-Oliver et al. 2009. “Inflammatory Bowel Disease and Mutations Affecting 
the Interleukin-10 Receptor.” The New England journal of medicine 361(21): 2033–
45. 
Gobert, Alain P et al. 2004. “Protective Role of Arginase in a Mouse Model of Colitis.” 
Journal of immunology (Baltimore, Md. : 1950) 173(3): 2109–17.  
Gracz, Adam D, Sendhilnathan Ramalingam, and Scott T Magness. 2010. “Sox9 
Expression Marks a Subset of CD24-Expressing Small Intestine Epithelial Stem 
Cells That Form Organoids in Vitro.” American journal of physiology. 
Gastrointestinal and liver physiology 298(5): G590–600.  
Greaves, Mel, and Carlo C. Maley. 2012. “Clonal Evolution in Cancer.” Nature 
481(7381): 306–13. 
Gregorieff, Alex, and Hans Clevers. 2005. “Wnt Signaling in the Intestinal Epithelium: 
From Endoderm to Cancer.” Genes & development 19(8): 877–90. 
Groschwitz, Katherine R., and Simon P. Hogan. 2009. “Intestinal Barrier Function: 
Molecular Regulation and Disease Pathogenesis.” Journal of Allergy and Clinical 
Immunology 124(1): 3–20.  
 168 
Gu, Peili et al. 2005. “Orphan Nuclear Receptor LRH-1 Is Required To Maintain Oct4 
Expression at the Epiblast Stage of Embryonic Development Orphan Nuclear 
Receptor LRH-1 Is Required To Maintain Oct4 Expression at the Epiblast Stage of 
Embryonic Development.” Molecular and cellular biology 25(9): 3492–3505. 
Gudkov, Andrei V, and Elena a Komarova. 2003. “The Role of p53 in Determining 
Sensitivity to Radiotherapy.” Nature reviews. Cancer 3(2): 117–29.  
Guo, Xiangrong et al. 2003. “A Rac/Cdc42-Specific Exchange Factor, GEFT, Induces 
Cell Proliferation, Transformation, and Migration.” The Journal of biological 
chemistry 278(15): 13207–15.  
Hager, and D M Bader. 2009. “Bves: Ten Years After.” Histology and Histopathology 
24(6): 777–87.  
Hager, Hillary et al. 2010. “Identification of a Novel Bves Function: Regulation of 
Vesicular Transport.” The EMBO journal 29(3): 532–45. 
Hamburger, A, and S E Salmon. 1977. “Primary Bioassay of Human Myeloma Stem 
Cells.” The Journal of Clinical Investigation 60(4): 846–54.  
Han, Ping et al. 2014. “BVES Inhibition Triggers Epithelial-Mesenchymal Transition in 
Human Hepatocellular Carcinoma.” Digestive diseases and sciences 59(5): 992–
1000.  
Harb, Ali H, Carla Abou Fadel, and Ala I Sharara. 2014. “Radiation Enteritis.” Current 
gastroenterology reports 16(5): 383.  
Harrington, Laurie E et al. 2005. “Interleukin 17-Producing CD4+ Effector T Cells 
Develop via a Lineage Distinct from the T Helper Type 1 and 2 Lineages.” Nature 
immunology 6(11): 1123–32. 
Hauer-Jensen, Martin, James W. Denham, and H. Jervoise N. Andreyev. 2014. 
“Radiation Enteropathy—pathogenesis, Treatment and Prevention.” Nature reviews. 
Gastroenterology & Hepatology 11(8): 470–79.  
Heller, Frank et al. 2005. “Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative 
Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell Restitution.” 
Gastroenterology 129(2): 550–64.  
Henderson, Paul, Johan E. Van Limbergen, Jürgen Schwarze, and David C. Wilson. 
2011. “Function of the Intestinal Epithelium and Its Dysregulation in Inflammatory 
Bowel Disease.” Inflammatory Bowel Diseases 17(1): 382–95. 
Hermiston, M L, and J I Gordon. 1995. “In Vivo Analysis of Cadherin Function in the 
Mouse Intestinal Epithelium: Essential Roles in Adhesion, Maintenace of 
 169 
Differentiation, and Regulation of Programmed Cell Death.” Journal of Cell Biology 
129(2): 489–506. 
Herrinton, Lisa J. et al. 2012. “Incidence and Mortality of Colorectal Adenocarcinoma in 
Persons with Inflammatory Bowel Disease from 1998 to 2010.” Gastroenterology 
143(2): 382–89.  
Hewitt, Kyle J, Rachana Agarwal, and Patrice J Morin. 2006. “The Claudin Gene Family: 
Expression in Normal and Neoplastic Tissues.” BMC cancer 6: 186. 
Higgins, Lisa M. et al. 1999. “Citrobacter Rodentium Infection in Mice Elicits a Mucosal 
Th1 Cytokine Response and Lesions Similar to Those in Murine Inflammatory 
Bowel Disease.” Infection and Immunity 67(6): 3031–39. 
Hill, Kristina E et al. 2004. “Neurological Dysfunction Occurs in Mice with Targeted 
Deletion of the Selenoprotein P Gene.” The Journal of nutrition 134(1): 157–61. 
Hill, Kristina E. et al. 2003. “Deletion of Selenoprotein P Alters Distribution of Selenium 
in the Mouse.” Journal of Biological Chemistry 278(16): 13640–46. 
Hill, Kristina E. et al. 2007. “The Selenium-Rich C-Terminal Domain of Mouse 
Selenoprotein P Is Necessary for the Supply of Selenium to Brain and Testis but Not 
for the Maintenance of Whole Body Selenium.” Journal of Biological Chemistry 
282(15): 10972–80. 
Hooper, Lora V, and Andrew J Macpherson. 2010. “Immune Adaptations That Maintain 
Homeostasis with the Intestinal Microbiota.” Nature reviews. Immunology 10(3): 
159–69.  
Hossain, Zakir, and Takashi Hirata. 2008. “Molecular Mechanism of Intestinal 
Permeability: Interaction at Tight Junctions.” Molecular bioSystems 4(12): 1181–85. 
Hua, Guoqiang et al. 2012. “Crypt Base Columnar Stem Cells in Small Intestines of Mice 
Are Radioresistant.” Gastroenterology 143(5): 1266–76.  
Hynds, Robert E., and Adam Giangreco. 2013. “Concise Review: The Relevance of 
Human Stem Cell-Derived Organoid Models for Epithelial Translational Medicine.” 
Stem Cells 31(3): 417–22. 
Iizuka, Masahiro, and Shiho Konno. 2011. “Wound Healing of Intestinal Epithelial 
Cells.” World journal of gastroenterology : WJG 17(17): 2161–71.  
Itzkowitz, Steven H, and Xianyang Yio. 2004. “Inflammation and Cancer IV . Colorectal 
Cancer in Inflammatory Bowel Disease : The Role of Inflammation.” American 
Journal of Physiology - Gastrointestinal and Liver Physiology 287: G7–17. 
 170 
Jaworska, Katrzyna et al. 2013. “A Low Selenium Level Is Associated with Lung and 
Laryngeal Cancers.” PLoS ONE 8(3): 1–6. 
Jayagopal, Ashwath, Jin Long Yang, Frederick R. Haselton, and Min S. Chang. 2011. 
“Tight Junction-Associated Signaling Pathways Modulate Cell Proliferation in 
Uveal Melanoma.” Investigative Ophthalmology and Visual Science 52(1): 588–93. 
Jess, Tine et al. 2012. “Decreasing Risk of Colorectal Cancer in Patients with 
Inflammatory Bowel Disease over 30 Years.” Gastroenterology 143(2): 375–81.e1; 
quiz e13–14.  
Kalluri, R, and RA Weinberg. 2009. “The Basics of Epithelial-Mesenchymal Transition.” 
The Journal of Clinical Investigation 119(6): 1420–28.  
Kanter, Mehmet, and Meryem Akpolat. 2008. “Vitamin C Protects against Ionizing 
Radiation Damage to Goblet Cells of the Ileum in Rats.” Acta histochemica 110(6): 
481–90. 
Kaper, James B, James P Nataro, and Harry L Mobley. 2004. “Pathogenic Escherichia 
Coli.” Nature reviews. Microbiology 2(2): 123–40. 
Kasaikina, Marina V. et al. 2013. “Contrasting Roles of Dietary Selenium and 
Selenoproteins in Chemically Induced Hepatocarcinogenesis.” Carcinogenesis 
34(5): 1089–95. 
Kawaguchi, Michiya et al. 2008. “Identification of a Novel Intracellular Interaction 
Domain Essential for Bves Function.” PLoS ONE 3(5): e2261. 
Khan, MA, Caixia Ma, and LA Knodler. 2006. “Toll-Like Receptor 4 Contributes to 
Colitis Development but Not to Host Defense during Citrobacter Rodentium 
Infection in Mice.” Infection and immunity 74(5): 2522–36. 
Kim et al. 2010. “Frequent Silencing of Popeye Domain-Containing Genes, BVES and 
POPDC3, Is Associated with Promoter Hypermethylation in Gastric Cancer.” 
Carcinogenesis 31(9): 1685–93. 
Kim et al. 2011. “NRF2 Blockade Suppresses Colon Tumor Angiogenesis by Inhibiting 
Hypoxia-Induced Activation of HIF-1??” Cancer Research 71(6): 2260–75. 
Kim, Yonghyun et al. 2012. “Wnt Activation Is Implicated in Glioblastoma 
Radioresistance.” Laboratory investigation; a journal of technical methods and 
pathology 92(3): 466–73. 
Kipp, Anna et al. 2009. “Four Selenoproteins, Protein Biosynthesis, and Wnt Signalling 
Are Particularly Sensitive to Limited Selenium Intake in Mouse Colon.” Molecular 
Nutrition and Food Research 53(12): 1561–72. 
 171 
Kitamura, Kazuya, Yasunari Nakamoto, Shuichi Kaneko, and Naofumi Mukaida. 2004. 
“Pivotal Roles of Interleukin-6 in Transmural Inflammation in Murine T Cell 
Transfer Colitis.” Journal of leukocyte biology 76(6): 1111–17. 
Knight, Ruth F, David M Bader, and Jon R Backstrom. 2003. “Membrane Topology of 
Bves/Pop1A, a Cell Adhesion Molecule That Displays Dynamic Changes in Cellular 
Distribution during Development.” The Journal of biological chemistry 278(35): 
32872–79. 
Koh, T S, and T H Benson. 1983. “Critical Re-Appraisal of Fluorometric Method for 
Determination of Selenium in Biological Materials.” Journal - Association of 
Official Analytical Chemists 66(4): 918–26.  
Koo, Bon-Kyoung et al. 2012. “Controlled Gene Expression in Primary Lgr5 Organoid 
Cultures.” Nature methods 9(1): 81–83. 
Korinek, V et al. 1998. “Depletion of Epithelial Stem-Cell Compartments in the Small 
Intestine of Mice Lacking Tcf-4.” Nature genetics 19(4): 379–83. 
Kucharzik, T et al. 2001. “Neutrophil Transmigration in Inflammatory Bowel Disease Is 
Associated with Differential Expression of Epithelial Intercellular Junction 
Proteins.” The American journal of pathology 159(6): 2001–9.  
Kühn, R et al. 1993. “Interleukin-10-Deficient Mice Develop Chronic Enterocolitis.” Cell 
75(2): 263–74. 
Kurokawa, Suguru et al. 2014. “Sepp1UF Forms Are N-Terminal Selenoprotein P 
Truncations That Have Peroxidase Activity When Coupled with Thioredoxin 
Reductase-1.” Free Radical Biology and Medicine 69: 67–76. 
Van Landeghem, Laurianne et al. 2012. “Activation of Two Distinct Sox9-EGFP-
Expressing Intestinal Stem Cell Populations during Crypt Regeneration after 
Irradiation.” American journal of physiology. Gastrointestinal and liver physiology 
302(10): G1111–32.  
Lander, E S et al. 2001. “Initial Sequencing and Analysis of the Human Genome.” Nature 
409(6822): 860–921. 
Larrea, MD, and Feng Hong. 2009. “RSK1 Drives p27Kip1 Phosphorylation at T198 to 
Promote RhoA Inhibition and Increase Cell Motility.” Proceedings of the National 
Academy of Sciences of the United States of America 106(23): 9268–73. 
Lebeis, Sarah L et al. 2007. “TLR Signaling Mediated by MyD88 Is Required for a 
Protective Innate Immune Response by Neutrophils to Citrobacter Rodentium.” 
Journal of immunology (Baltimore, Md. : 1950) 179(1): 566–77.  
 172 
Leibowitz, Brian J et al. 2011. “Uncoupling p53 Functions in Radiation-Induced 
Intestinal Damage via PUMA and p21.” Molecular cancer research : MCR 9(5): 
616–25. 
Li, and Hans Clevers. 2010. “Coexistence of Quiescent and Active Adult Stem Cells in 
Mammals.” Science (New York, N.Y.) 327(5965): 542–45. 
Li, Vivian S W, and Hans Clevers. 2012. “In Vitro Expansion and Transplantation of 
Intestinal Crypt Stem Cells.” Gastroenterology 143(1): 30–34. 
Lindberg, Sofia Rondin, André Olsson, Ann-Maj Persson, and Inge Olsson. 2005. “The 
Leukemia-Associated ETO Homologues Are Differently Expressed during 
Hematopoietic Differentiation.” Experimental hematology 33(2): 189–98. 
Lippman, Scott M et al. 2009. “Effect of Selenium and Vitamin E on Risk of Prostate 
Cancer and Other Cancers.” JAMA 301: 39–51. 
Loftus, Edward V, and William J Sandborn. 2002. “Epidemiology of Inflammatory 
Bowel Disease.” Gastroenterology clinics of North America 31(1): 1–20.  
Lund, Pauline Kay. 2012. “Fixing the Breaks in Intestinal Stem Cells after Radiation: A 
Matter of DNA Damage and Death or DNA Repair and Regeneration.” 
Gastroenterology 143(5): 1144–47. 
Luperchio, Steven a., and David B. Schauer. 2001. “Molecular Pathogenesis of 
Citrobacter Rodentium and Transmissible Murine Colonic Hyperplasia.” Microbes 
and Infection 3(4): 333–40. 
Lutterbach, B et al. 1998. “ETO, a Target of t(8;21) in Acute Leukemia, Interacts with 
the N-CoR and mSin3 Corepressors.” Molecular and cellular biology 18(12): 7176–
84. 
Ma, Thomas Y et al. 2004. “TNF-Alpha-Induced Increase in Intestinal Epithelial Tight 
Junction Permeability Requires NF-Kappa B Activation.” American journal of 
physiology. Gastrointestinal and liver physiology 286(3): G367–76.  
Maaser, Christian et al. 2004. “Clearance of Citrobacter Rodentium Requires B Cells but 
Not Secretory Immunoglobulin A ( IgA ) or IgM Antibodies.” Infection and 
Immunity 72(6): 3315–24. 
Machen, T. E., D. Erlij, and F. B. Wooding. 1972. “Permeable Junctional Complexes. 
The Movement of Lanthanum across Rabbit Gallbladder and Intestine.” Journal of 
Cell Biology 54(2): 302–12. 
 173 
Madsen, K L et al. 1999. “Interleukin-10 Gene-Deficient Mice Develop a Primary 
Intestinal Permeability Defect in Response to Enteric Microflora.” Inflammatory 
bowel diseases 5(4): 262–70. 
Mahe, Maxime M et al. 2013. “Establishment of Gastrointestinal Epithelial Organoids.” 
Curr Protoc Mouse Biol. 3(December): 217–40. 
Maloy, K J, and M C Kullberg. 2008. “IL-23 and Th17 Cytokines in Intestinal 
Homeostasis.” Mucosal immunology 1(5): 339–49. 
Maloy, and Fiona Powrie. 2011. “Intestinal Homeostasis and Its Breakdown in 
Inflammatory Bowel Disease.” Nature 474(7351): 298–306.  
Mangan, Paul R et al. 2006. “Transforming Growth Factor-Beta Induces Development of 
the T(H)17 Lineage.” Nature 441(7090): 231–34. 
Margalit, Ofer et al. 2006. “BCL6 Is Regulated by p53 through a Response Element 
Frequently Disrupted in B-Cell Non-Hodgkin Lymphoma.” Blood 107(4): 1599–
1607. 
Marshman, Emma, Catherine Booth, and Christopher S. Potten. 2002. “The Intestinal 
Epithelial Stem Cell.” BioEssays 24(1): 91–98. 
Martin, K, C S Potten, S a Roberts, and T B Kirkwood. 1998. “Altered Stem Cell 
Regeneration in Irradiated Intestinal Crypts of Senescent Mice.” Journal of cell 
science 111 (Pt 1): 2297–2303. 
Matricon, Julien, Nicolas Barnich, and Denis Ardid. 2010. “Immunopathogenesis of 
Inflammatory Bowel Disease.” Self/nonself 1(4): 299–309. 
Mazzatti, Dawn J. et al. 2005. “p53 Modulates Radiation Sensitivity Independent of p21 
Transcriptional Activation.” American Journal of Clinical Oncology 28(1): 43–50. 
Mennigen, Rudolf et al. 2009. “Probiotic Mixture VSL#3 Protects the Epithelial Barrier 
by Maintaining Tight Junction Protein Expression and Preventing Apoptosis in a 
Murine Model of Colitis.” American journal of physiology. Gastrointestinal and 
liver physiology 296(5): G1140–49. 
Méplan, Catherine et al. 2009. “Relative Abundance of Selenoprotein P Isoforms in 
Human Plasma Depends on Genotype, Se Intake, and Cancer Status.” Antioxidants 
& redox signaling 11(11): 2631–40.  
Metcalfe, Ciara, Noelyn M. Kljavin, Ryan Ybarra, and Frederic J. De Sauvage. 2014. 
“Lgr5+ Stem Cells Are Indispensable for Radiation-Induced Intestinal 
Regeneration.” Cell Stem Cell 14(2): 149–59.  
 174 
Mills, Stacey E. 2012. Histology for Pathologists, 4th Edition. 4th ed. Philadelphia, 
Pennsylvania: Lippincott Williams & Wilkins. 
Miyoshi, H et al. 1993. “The t(8;21) Translocation in Acute Myeloid Leukemia Results in 
Production of an AML1-MTG8 Fusion Transcript.” The EMBO journal 12(7): 
2715–21. 
Moore, Amy C et al. 2008. “Myeloid Translocation Gene Family Members Associate 
with T-Cell Factors (TCFs) and Influence TCF-Dependent Transcription.” 
Molecular and cellular biology 28(3): 977–87.  
Moore, Arthur Dalley, and Anne Agur. 2009. Clinically Oriented Anatomy, 6th Edition. 
6th ed. Philadelphia, Pennsylvania. 
Mosser, David M., and Xia Zhang. 2008. “Activation of Murine Macrophages.” Current 
Protocols in Immunology (SUPPL. 83): 8–15. 
Neumann, Helmut et al. 2011. “Cancer Risk in IBD: How to Diagnose and How to 
Manage DALM and ALM.” World Journal of Gastroenterology 17(27): 3184–91. 
Neurath, M, I Fuss, and W Strober. 2000. “TNBS-Colitis.” International reviews of 
immunology 19(1): 51–62.  
Nguyen, Geoffrey C., and Brian Bressler. 2012. “A Tale of Two Cohorts: Are We 
Overestimating the Risk of Colorectal Cancer in Inflammatory Bowel Disease?” 
Gastroenterology 143(2): 288–90.  
Nieuwenhuis, B. 2002. “BRCA1 and BRCA2 Heterozygosity and Repair of X-Ray-
Induced DNA Damage.” International Journal of Radiation Biology 78(4). 
Nishimura, Miyuki et al. 2009. “Chemokines as Novel Therapeutic Targets for 
Inflammatory Bowel Disease.” Annals of the New York Academy of Sciences 1173: 
350–56. 
Ojuawo, A, and L Keith. 2002. “The Serum Concentrations of Zinc, Copper and 
Selenium in Children with Inflammatory Bowel Disease.” The Central African 
journal of medicine 48(9-10): 116–19. 
Okayasu, I et al. 1990. “A Novel Method in the Induction of Reliable Experimental 
Acute and Chronic Ulcerative Colitis in Mice.” Gastroenterology 98(3): 694–702. 
Okayasu, I et al. 1996. “Promotion of Colorectal Neoplasia in Experimental Murine 
Ulcerative Colitis.” Gut 39(1): 87–92. 
 175 
Olson, Gary E., Virginia P. Winfrey, Kristina E. Hill, and Raymond F. Burk. 2008. 
“Megalin Mediates Selenoprotein P Uptake by Kidney Proximal Tubule Epithelial 
Cells.” Journal of Biological Chemistry 283(11): 6854–60. 
Osler, and David M Bader. 2004. “Bves Expression during Avian Embryogenesis.” 
Developmental dynamics : an official publication of the American Association of 
Anatomists 229(3): 658–67. 
Osler, M Chang, and D Bader. 2005. “Bves Modulates Epithelial Integrity through an 
Interaction at the Tight Junction.” Journal of cell science 118(Pt 20): 4667–78. 
Osler, Travis K Smith, and David M Bader. 2006. “Bves, a Member of the Popeye 
Domain-Containing Gene Family.” Developmental dynamics : an official 
publication of the American Association of Anatomists 235(3): 586–93.  
Ottewell, Penelope D et al. 2006. “Gastrin Increases Murine Intestinal Crypt 
Regeneration Following Injury.” Gastroenterology 130(4): 1169–80.  
Papadakis, KA, and SR Targan. 2000. “Role of Cytokines in the Pathogenesis of 
Inflammatory Bowel Disease.” Annual review of medicine 51: 289–98. 
Papaioannou, D et al. 2011. “Antioxidants in the Chemoprevention of Colorectal Cancer 
and Colorectal Adenomas in the General Population: A Systematic Review and 
Meta-Analysis.” Colorectal disease 13(10): 1085–99.  
Paris, F et al. 2001. “Endothelial Apoptosis as the Primary Lesion Initiating Intestinal 
Radiation Damage in Mice.” Science (New York, N.Y.) 293(5528): 293–97.  
Pearson, a D et al. 1982. “Intestinal Permeability in Children with Crohn’s Disease and 
Coeliac Disease.” British medical journal (Clinical research ed.) 285(6334): 20–21. 
Pegg, A E. 1984. “Methylation of the O6 Position of Guanine in DNA Is the Most Likely 
Initiating Event in Carcinogenesis by Methylating Agents.” Cancer investigation 
2(3): 223–31.  
Perše, Martina, and Anton Cerar. 2012. “Dextran Sodium Sulphate Colitis Mouse Model: 
Traps and Tricks.” Journal of biomedicine & biotechnology 2012: 718617.  
Peters, Ulrike et al. 2008. “Variation in the Selenoenzyme Genes and Risk of Advanced 
Distal Colorectal Adenoma.” Cancer Epidemiology Biomarkers and Prevention 
17(5): 1144–54. 
Pinto, Daniel, Alex Gregorieff, Harry Begthel, and Hans Clevers. 2003. “Canonical Wnt 
Signals Are Essential for Homeostasis of the Intestinal Epithelium.” Genes Dev.: 
1709–13. 
 176 
Poindexter, Shenika V et al. 2015. “Transcriptional Co-Repressor MTG16 Regulates 
Small Intestinal Crypt Proliferation and Crypt Regeneration after Radiation-Induced 
Injury.” American Journal of Physiology - Gastrointestinal and Liver Physiology. 
Poritz, Lisa S. et al. 2007. “Loss of the Tight Junction Protein ZO-1 in Dextran Sulfate 
Sodium Induced Colitis.” Journal of Surgical Research 140(1): 12–19. 
Porras, Monica et al. 2006. “Correlation between Cyclical Epithelial Barrier Dysfunction 
and Bacterial Translocation in the Relapses of Intestinal Inflammation.” 
Inflammatory bowel diseases 12(9): 843–52.  
Potten. 1977. “Extreme Sensitivity of Some Intestinal Crypt Cells to X and Gamma 
Irradiation.” Nature 269(5628): 518–21.  
Potten. 1990. “A Comprehensive Study of the Radiobiological Response of the Murine 
(BDF1) Small Intestine.” International journal of radiation biology 58(6): 925–73.  
Potten. 2009. “The Stem Cells of Small Intestinal Crypts: Where Are They?” Cell 
proliferation 42(6): 731–50.  
Potten, Catherine Booth, and D Mark Pritchard. 1997. “Stem Cell Review The Intestinal 
Epithelial Stem Cell : The Mucosal Governor.” : 219–43. 
Potten, C S et al. 1995. “Stimulation and Inhibition of Proliferation in the Small Intestinal 
Crypts of the Mouse after in Vivo Administration of Growth Factors.” Gut 36(6): 
864–73. 
Potten, C S, and CA Chadwick. 1994. “Small Intestinal Growth Regulatory Factors 
Extracted by Simple Diffusion from Intact Irradiated Intestine and Tested in Vivo.” 
Growth factors (Chur, Switzerland) 10(1): 63–75. 
Potten, and J H Hendry. 1975. “Differential Regeneration of Intestinal Proliferative Cells 
and Cryptogenic Cells after Irradiation.” International journal of radiation biology 
and related studies in physics, chemistry, and medicine 27(5): 413–24.  
Potten, William J. Hume, Peter Reid, and John Cairns. 1978. “The Segregation of DNA 
in Epithelial Stem Cells.” Cell 15(November): 899–906. 
Potten, Gary Owen, and Dawn Booth. 2002. “Intestinal Stem Cells Protect Their Genome 
by Selective Segregation of Template DNA Strands.” Journal of cell science 115(Pt 
11): 2381–88. 
Read R, Bellew T, Yang J-G, Hill KE, Palmer IS, Burk RF. 1990. “Selenium and Amino 
Acid Composition of Selenoprotein P, the Major Selenoprotein in Rat Serum.” 
Journal of Biological Chemistry 265(October 15): 17899–905. 
 177 
Reese, DE, M Zavaljevski, NL Streiff, and D Bader. 1999. “Bves: A Novel Gene 
Expressed during Coronary Blood Vessel Development.” Developmental biology 
209(1): 159–71.  
Reya, Tannishtha, and Hans Clevers. 2005. “Wnt Signalling in Stem Cells and Cancer.” 
Nature 434(7035): 843–50. 
Ripley, Anna N, Megan E Osler, Christopher V E Wright, and David Bader. 2006. 
“Xbves Is a Regulator of Epithelial Movement during Early Xenopus Laevis 
Development.” Proceedings of the National Academy of Sciences of the United 
States of America 103(3): 614–19. 
Roessner, a., D. Kuester, P. Malfertheiner, and R. Schneider-Stock. 2008. “Oxidative 
Stress in Ulcerative Colitis-Associated Carcinogenesis.” Pathology Research and 
Practice 204(7): 511–24. 
Romeo, Yves, Xiaocui Zhang, and Philippe P Roux. 2012. “Regulation and Function of 
the RSK Family of Protein Kinases.” The Biochemical journal 441(2): 553–69.  
Rubin, David T et al. 2008. “Colorectal Cancer Prevention in Inflammatory Bowel 
Disease and the Role of 5-Aminosalicylic Acid: A Clinical Review and Update.” 
Inflammatory bowel diseases 14(2): 265–74.  
Russ, Patricia K et al. 2011. “Bves Modulates Tight Junction Associated Signaling.” 
PLoS ONE 6(1): e14563.  
Sampson, Natalie et al. 2011. “ROS Signaling by NOX4 Drives Fibroblast-to-
Myofibroblast Differentiation in the Diseased Prostatic Stroma.” Molecular 
endocrinology (Baltimore, Md.) 25(3): 503–15. 
Santos, M F et al. 1997. “Rho Proteins Play a Critical Role in Cell Migration during the 
Early Phase of Mucosal Restitution.” The Journal of clinical investigation 100(1): 
216–25.  
Sato, and Hans Clevers. 2013. “Growing Self-Organizing Mini-Guts from a Single 
Intestinal Stem Cell: Mechanism and Applications.” Science (New York, N.Y.) 
340(6137): 1190–94. 
Sato, Toshiro et al. 2009. “Single Lgr5 Stem Cells Build Crypt-Villus Structures in Vitro 
without a Mesenchymal Niche.” Nature 459(7244): 262–65. 
Sato, Toshiro, Daniel E. Stange, et al. 2011. “Long-Term Expansion of Epithelial 
Organoids from Human Colon, Adenoma, Adenocarcinoma, and Barrett’s 
Epithelium.” Gastroenterology 141(5): 1762–72.  
 178 
Sato, Toshiro, Johan H van Es, et al. 2011. “Paneth Cells Constitute the Niche for Lgr5 
Stem Cells in Intestinal Crypts.” Nature 469(7330): 415–18.  
Satoh-Takayama, Naoko et al. 2009. “The Natural Cytotoxicity Receptor NKp46 Is 
Dispensable for IL-22-Mediated Innate Intestinal Immune Defense against 
Citrobacter Rodentium.” Journal of immunology (Baltimore, Md. : 1950) 183(10): 
6579–87. 
Schäfer, Matthias, and Sabine Werner. 2008. “Cancer as an Overhealing Wound: An Old 
Hypothesis Revisited.” Nature reviews. Molecular cell biology 9(8): 628–38. 
Schauer, D. B., and S. Falkow. 1993. “Attaching and Effacing Locus of a Citrobacter 
Freundii Biotype That Causes Transmissible Murine Colonic Hyperplasia.” 
Infection and Immunity 61(6): 2486–92. 
Schembri, John, Matthias Azzopardi, and Pierre Ellul. 2014. “Small Bowel Radiation 
Enteritis Diagnosed by Capsule Endoscopy.” BMJ case reports 2014: 2013–14. 
Schepers, Arnout G et al. 2012. “Lineage Tracing Reveals Lgr5+ Stem Cell Activity in 
Mouse Intestinal Adenomas.” Science 337(6095): 730–35.  
Schomburg, Lutz et al. 2003. “Gene Disruption Discloses Role of Selenoprotein P in 
Selenium Delivery to Target Tissues.” The Biochemical journal 370(Pt 2): 397–402. 
Seno, Hiroshi et al. 2009. “Efficient Colonic Mucosal Wound Repair Requires Trem2 
Signaling.” Proceedings of the National Academy of Sciences of the United States of 
America 106(1): 256–61.  
Seo, Young R, Mark R Kelley, and Martin L Smith. 2002. “Selenomethionine Regulation 
of p53 by a ref1-Dependent Redox Mechanism.” Proceedings of the National 
Academy of Sciences of the United States of America 99(22): 14548–53. 
Shadad, Abobakr K, Frank J Sullivan, Joseph D Martin, and Laurence J Egan. 2013. 
“Gastrointestinal Radiation Injury: Symptoms, Risk Factors and Mechanisms.” 
World journal of gastroenterology : WJG 19(2): 185–98. 
Shaker, Anisa, and Deborah C. Rubin. 2012. “Stem Cells: One Step Closer to Gut 
Repair.” Nature 485(7397): 181–82. 
Shamberger, R J, and C E Willis. 1971. “Selenium Distribution and Human Cancer 
Mortality.” CRC critical reviews in clinical laboratory sciences 2(2): 211–21. 
Sheehan, T. M T, and M. Gao. 1990. “Simplified Fluorometric Assay of Total Selenium 
in Plasma and Urine.” Clinical Chemistry 36(12): 2124–26. 
 179 
Shen, Le. 2012. “Tight Juntions on the Pove: Molecular Mechanisms for Epithelial 
Barrier Regulation.” Annals of the New York Academy of Sciences (1258): 9–18. 
Shen, Le, Liping Su, and Jerrold R. Turner. 2009. “Mechanisms and Functional 
Implications of Intestinal Barrier Defects.” Digestive Diseases 27(4): 443–49. 
Shinkai, Y et al. 1992. “RAG-2-Deficient Mice Lack Mature Lymphocytes Owing to 
Inability to Initiate V(D)J Rearrangement.” Cell 68(5): 855–67.  
Siegmund, Britta. 2010. “Interleukin-18 in Intestinal Inflammation: Friend and Foe?” 
Immunity 32(3): 300–302.  
Simmons, Cameron P et al. 2002. “Impaired Resistance and Enhanced Pathology during 
Infection with a Noninvasive, Attaching-Effacing Enteric Bacterial Pathogen, 
Citrobacter Rodentium, in Mice Lacking IL-12 or IFN-Gamma.” Journal of 
immunology (Baltimore, Md. : 1950) 168(4): 1804–12. 
Simmons, Cameron P et al. 2003. “Central Role for B Lymphocytes and CD4 + T Cells 
in Immunity to Infection by the Attaching and Effacing Pathogen Citrobacter 
Rodentium.”  Infection and Immunity: 71(9): 5077–86. 
Singh, Kshipra et al. 2011. “The Apolipoprotein E-Mimetic Peptide COG112 Inhibits 
NF-kappaB Signaling, Proinflammatory Cytokine Expression, and Disease Activity 
in Murine Models of Colitis.” The Journal of biological chemistry 286(5): 3839–50. 
Smith et al. 2008. “Bves Directly Interacts with GEFT, and Controls Cell Shape and 
Movement through Regulation of Rac1/Cdc42 Activity.” Proceedings of the 
National Academy of Sciences of the United States of America 105(24): 8298–8303.  
Smith, and David M Bader. 2006. “Characterization of Bves Expression during Mouse 
Development Using Newly Generated Immunoreagents.” Developmental dynamics : 
an official publication of the American Association of Anatomists 235(6): 1701–8.  
Smith, J. Joshua et al. 2010. “Experimentally Derived Metastasis Gene Expression 
Profile Predicts Recurrence and Death in Patients With Colon Cancer.” 
Gastroenterology 138(3): 958–68.  
Söderholm, JD, G Olaison, and KH Peterson. 2002. “Augmented Increase in Tight 
Junction Permeability by Luminal Stimuli in the Non-Inflamed Ileum of Crohn’s 
Disease.” Gut 50: 307–13.  
Solinas, Graziella et al. 2010. “Tumor-Conditioned Macrophages Secrete Migration-
Stimulating Factor: A New Marker for M2-Polarization, Influencing Tumor Cell 
Motility.” Journal of immunology (Baltimore, Md. : 1950) 185(1): 642–52. 
 180 
Speckmann, Bodo et al. 2010. “Proinflammatory Cytokines down-Regulate Intestinal 
Selenoprotein P Biosynthesis via NOS2 Induction.” Free Radical Biology and 
Medicine 49(5): 777–85.  
Steinbrecher, Astrid et al. 2010. “Effects of Selenium Status and Polymorphisms in 
Selenoprotein Genes on Prostate Cancer Risk in a Prospective Study of European 
Men.” Cancer Epidemiology Biomarkers and Prevention 19(11): 2958–68. 
Steinbrenner, Holger, and Helmut Sies. 2013. “Selenium Homeostasis and Antioxidant 
Selenoproteins in Brain: Implications for Disorders in the Central Nervous System.” 
Archives of Biochemistry and Biophysics 536(2): 152–57.  
Stelzner, Matthias et al. 2012. “A Nomenclature for Intestinal in Vitro Cultures.” 
American journal of physiology. Gastrointestinal and liver physiology 302(12): 
G1359–63. 
Strober, Warren, and Ivan J Fuss. 2011. “Proinflammatory Cytokines in the Pathogenesis 
of Inflammatory Bowel Diseases.” Gastroenterology 140(6): 1756–67. 
Sturm, Andreas, and Axel U Dignass. 2008. “Epithelial Restitution and Wound Healing 
in Inflammatory Bowel Disease.” World journal of gastroenterology : WJG 14(3): 
348–53. 
Sulli, Gabriele, R Di Micco, and FA di Fagagna. 2012. “Crosstalk between Chromatin 
State and DNA Damage Response in Cellular Senescence and Cancer.” Nature 
Reviews Cancer 12(10): 709–20. 
Sun, Xiaolun, Bo Liu, Ryan Balfour Sartor, and Christian Jobin. 2013. 
“Phosphatidylinositol 3-Kinase-Γ Signaling Promotes Campylobacter Jejuni-
Induced Colitis through Neutrophil Recruitment in Mice.” Journal of immunology 
(Baltimore, Md. : 1950) 190(1): 357–65.  
Szatrowski, Ted P., and Carl F. Nathan. 1991. “Production of Large Amounts of 
Hydrogen Peroxide by Human Tumor Cells.” Cancer Res. 51(3): 794–98.  
Thoreson, Molly, and Albert B. Reynolds. 2002. “Altered Expression of the Catenin p120 
in Human Cancer: Implications for Tumor Progression.” Differentiation 70(9-10): 
583–89.  
Tian, Hua et al. 2011. “A Reserve Stem Cell Population in Small Intestine Renders Lgr5-
Positive Cells Dispensable.” Nature 478(7368): 255–59.  
Torlopp, Angela, Stephanie S Breher, Jan Schlüter, and Thomas Brand. 2006. 
“Comparative Analysis of mRNA and Protein Expression of Popdc1 (Bves) during 
Early Development in the Chick Embryo.” Developmental dynamics : an official 
publication of the American Association of Anatomists 235(3): 691–700.  
 181 
Trapnell, Cole et al. 2013. “Differential Analysis of Gene Regulation at Transcript 
Resolution with RNA-Seq.” Nature biotechnology 31(1): 46–53.  
Trapnell, Cole, Lior Pachter, and Steven L. Salzberg. 2009. “TopHat: Discovering Splice 
Junctions with RNA-Seq.” Bioinformatics 25(9): 1105–11. 
Turner, Jerrold R. 2009. “Intestinal Mucosal Barrier Function in Health and Disease.” 
Nature reviews. Immunology 9(11): 799–809.  
Ukabam, S O, J R Clamp, and B T Cooper. 1983. “Abnormal Small Intestinal 
Permeability to Sugars in Patients with Crohn’s Disease of the Terminal Ileum and 
Colon.” Digestion 27(2): 70–74.  
Vasavada, T. K., J. R. DiAngelo, and M. K. Duncan. 2004. “Developmental Expression 
of Pop1/Bves.” Journal of Histochemistry & Cytochemistry 52(3): 371–77.  
Vunta, Hema et al. 2008. “Selenium Attenuates pro-Inflammatory Gene Expression in 
Macrophages.” Molecular Nutrition and Food Research 52(11): 1316–23. 
Wada, A M, D E Reese, and D M Bader. 2001. “Bves: Prototype of a New Class of Cell 
Adhesion Molecules Expressed during Coronary Artery Development.” 
Development 128(11): 2085–93. 
Wang et al. 1998. “ETO , Fusion Partner in T ( 8 ; 21 ) Acute Myeloid Leukemia , 
Represses Transcription by Interaction with the Human.” Proceedings of the 
National Academy of Sciences of the United States of America 95(September): 
10860–65. 
Wang, Quan, Cheng Hui Fang, and Per-Olof Hasselgren. 2001. “Intestinal Permeability 
Is Reduced and IL-10 Levels Are Increased in Septic IL-6 Knockout Mice.” 
American journal of physiology Regulatory, integrative and comparative physiology 
281(3): R1013–23. 
Waterston, Robert H et al. 2002. “Initial Sequencing and Comparative Analysis of the 
Mouse Genome.” Nature 420(6915): 520–62. 
Wei, Olivia L., Ashley Hilliard, Daniel Kalman, and Melanie Sherman. 2005. “Mast 
Cells Limit Systemic Bacterial Dissemination but Not Colitis in Response to 
Citrobacter Rodentium.” Infection and Immunity 73(4): 1978–85. 
Welinder-Olsson, Christina, and Bertil Kaijser. 2005. “Enterohemorrhagic Escherichia 
Coli (EHEC).” Scandinavian journal of infectious diseases 37(6-7): 405–16. 
Williams, Christopher S et al. 2011. “BVES Regulates EMT in Human Corneal and 
Colon Cancer Cells and Is Silenced via Promoter Methylation in Human Colorectal 
Carcinoma.” Journal of Clinical Investigation 121(10): 4056–69.  
 182 
Williams, Christopher S et al. 2013. “MTG16 Contributes to Colonic Epithelial Integrity 
in Experimental Colitis.” Gut 62(10): 1446–55.  
Wirtz, Stefan, Clemens Neufert, Benno Weigmann, and Markus F Neurath. 2007. 
“Chemically Induced Mouse Models of Intestinal Inflammation.” Nature protocols 
2(3): 541–46. 
Wirtz, Stefan, and Markus F. Neurath. 2007. “Mouse Models of Inflammatory Bowel 
Disease.” Advanced Drug Delivery Reviews 59(11): 1073–83. 
Woodward, Wendy a et al. 2007. “WNT/beta-Catenin Mediates Radiation Resistance of 
Mouse Mammary Progenitor Cells.” Proceedings of the National Academy of 
Sciences of the United States of America 104(2): 618–23. 
Wyatt, J et al. 1993. “Intestinal Permeability and the Prediction of Relapse in Crohn’s 
Disease.” Lancet 341(8858): 1437–39.  
Xiao, Wusheng et al. 2013. “Selenoprotein P Regulates 1-(4-Chlorophenyl)-Benzo-2,5-
Quinone-Induced Oxidative Stress and Toxicity in Human Keratinocytes.” Free 
Radical Biology and Medicine 65: 70–77.  
Yamamoto, M, K Yoshizaki, T Kishimoto, and H Ito. 2000. “IL-6 Is Required for the 
Development of Th1 Cell-Mediated Murine Colitis.” Journal of immunology 
(Baltimore, Md. : 1950) 164(9): 4878–82. 
Yang, Wan Seok et al. 2014. “Regulation of Ferroptotic Cancer Cell Death by GPX4.” 
Cell 156(1-2): 317–31.  
Yap, A S. 1998. “The Morphogenetic Role of Cadherin Cell Adhesion Molecules in 
Human Cancer: A Thematic Review.” Cancer investigation 16(4): 252–61.  
Ye, Dongmei, Iris Ma, and Thomas Y Ma. 2006. “Molecular Mechanism of Tumor 
Necrosis Factor Alpha Modulation of Intestinal Epithelial Tight Junction Barrier.” 
American Journal of Physiology gastrointestinal Liver Physiology 290: 496–504. 
Young, Barbara, Geraldine O’Dowd, and Phillip Woodford. 2013. Wheater’s Functional 
Histology: A Text and Colour Atlas. 6th ed. Philadelphia, Pennsylvania: Elsevier 
Churchill Livingstone. 
Yui, Shiro et al. 2012. “Functional Engraftment of Colon Epithelium Expanded in Vitro 
from a Single Adult Lgr5+ Stem Cell.” Nature Medicine 18(4): 618–23.  
Zeisberg, M, and Eg Neilson. 2009. “Biomarkers for Epithelial-Mesenchymal 
Transitions.” The Journal of Clinical Investigation 119(6): 1429–37. 
 183 
Zeissig, S et al. 2007. “Changes in Expression and Distribution of Claudin 2, 5 and 8 
Lead to Discontinuous Tight Junctions and Barrier Dysfunction in Active Crohn’s 
Disease.” Gut 56(1): 61–72. 
Zhang, Xia, Ricardo Goncalves, and David M. Mosser. 2008. “The Isolation and 
Characterization of Murine Macrophages.” Current Protocols in Immunology 
(SUPPL. 83): 1–14. 
Zhang, Yuanyuan, and Xiaoli Chen. 2011. “Reducing Selenoprotein P Expression 
Suppresses Adipocyte Differentiation as a Result of Increased Preadipocyte 
Inflammation.” American journal of physiology. Endocrinology and metabolism 
300(1): E77–85. 
Zolotarevsky, Yevgeny et al. 2002. “A Membrane-Permeant Peptide That Inhibits MLC 
Kinase Restores Barrier Function in in Vitro Models of Intestinal Disease.” 
Gastroenterology 123(1): 163–72. 
 
 
 
 
